CancerPPD 2.0 - Year of Publication

Browsing Year-wise

Browse Results:

Filter by Length
Minimum Length
Maximum Length

ID	PMID	YEAR	Sequence	Name	Length	Linear/Cyclic	Chirality	Chem-MOD	C-ter MOD	N-ter MOD	Nature	Origin	Cell Line	Cancer Type	Assay	Activity	Testing Time	Tissue Affected	Patents
4674	15279899	2004	FRKSKEKIGKEFKRIVQRIKDFLRNLV	HCAP18(109-135)	27	Linear	L	None	Free	Free	Antimicrobial	hCAP18 synthetic peptide	SAS-H1	Oral Cancer	Not Available	Not Available	Not Available	Oral mucosa	None
4608	12417587	2003	YGRKKRRQRRR	Tat (47-57)	11	Linear	L	None	Free	Free	Antimicrobial	Synthetic	HeLa	Cervical Cancer	MTT/MTS assay	at 100 µM 60% viablity	6-h	Cervix	None
4607	12417587	2003	TRSSRAGLQWPVGRVHRLLRKGGC	BF2d	24	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	HeLa	Cervical Cancer	MTT/MTS assay	at 100 µM 90-100% viablity	6-h	Cervix	None
4605	12417587	2003	TRSSRAGLQWPVGRVHRLLRKGGC	BF2d	24	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	HeLa	Cervical Cancer	MTT/MTS assay	at 10 µM 90-95% viablity	6-h	Cervix	None
4606	12417587	2003	YGRKKRRQRRR	Tat (47-57)	11	Linear	L	None	Free	Free	Antimicrobial	Synthetic	HeLa	Cervical Cancer	MTT/MTS assay	at 10 µM 80% viablity	6-h	Cervix	None
4604	12417587	2003	YGRKKRRQRRR	Tat (47-57)	11	Linear	L	None	Free	Free	Antimicrobial	Synthetic	HeLa	Cervical Cancer	MTT/MTS assay	at 1 µM 90-100% viablity	6-h	Cervix	None
4603	12417587	2003	TRSSRAGLQWPVGRVHRLLRKGGC	BF2d	24	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	HeLa	Cervical Cancer	MTT/MTS assay	at 1 µM 90-100% viablity	6-h	Cervix	None
4602	12417587	2003	GIGKFLHSAKKWGKAFVGQIMNC	MG2d	23	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	HeLa	Cervical Cancer	MTT/MTS assay	at 1 µM 90-100% viablity	6-h	Cervix	None
4601	15496597	2004	KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL	CB	36	Linear	L	None	Free	Free	Antibacterial	Synthetic	Ags	Gastric Cancer	Not Available	Not Available	Not Available	Stomach	None
4450	15949629, 18957441	2005	KTCENLADTY	Sesquin	10	Not Available	L	None	Free	Free	Antimicrobial	Seeds, Vigna sesquipedalis, ground bean	Not Available	Colorectal Cancer	Not Available	Not Available	Not Available	Not Available	None
4449	16269344, 18957441	2005	KTCENLADTFRGPCFATSNC	Lunatusin	20	Not Available	L	None	Free	Free	Antimicrobial	Phaseolus lunatus L. (lima bean)	Not Available	Colorectal Cancer	Not Available	Not Available	Not Available	Not Available	None
4440	15700822, 18957441	2004	KSCCKNTTGRNIYNTCRFAGGSRERCAKLSGCKIISAST CPSDYPK	Viscotoxin B2	46	Not Available	L	None	Free	Free	Anticancer	Viscum coloratum (Kom.) Nakai	Not Available	Breast Cancer	Not Available	Not Available	Not Available	Not Available	None
4438	16129513, 18957441	2005	IDWKKLLDAAKQIL	Polybia-MPI	14	Not Available	L	None	Free	Free	Antibacterial	venom, social wasp,Polybia paulista	Not Available	Breast Cancer	Not Available	Not Available	Not Available	Not Available	None
4437	11713517, 18957441	2001	FFHHIFRGIVHVGKTIHRLVTG	Piscidin 1	22	Not Available	L	None	Free	Free	Antibacterial	Hybrid striped bass (Morone saxatilis x M. chrysops)	Not Available	Breast Cancer	Not Available	Not Available	Not Available	Not Available	None
4436	12581207, 18957441	2003	FFGWLIKGAIHAGKAIHGLIHRRRH	Chrysophsin-1	25	Not Available	L	None	Free	Free	Antibacterial	Red sea bream,Chrysophrys majororPagrus major	Not Available	Breast Cancer	Not Available	Not Available	Not Available	Not Available	None
4433	12804591, 19923233	2003	AIGSILGALAKGLPTLISWIKNR	Prepromelittin-related peptide	23	Not Available	L	None	Free	Free	Antibacterial	Rana tagoi [Tago frog]	Not Available	Fibrosarcoma	Not Available	Not Available	Not Available	Fibrous connective tissue	None
4429	15253156, 18957441	2004	ACSAG	EP5-1	5	Not Available	L	None	Free	Free	Anticancer	redworms, brandling worms, "tiger worms" and red wiggler worms, Eisenia foetida	Not Available	Fibrosarcoma	Not Available	Not Available	Not Available	Fibrous connective tissue	None
4419	12235362, 18957441	2002	HGVSGHGQHGVHG	Alloferon 1	13	Not Available	L	None	Free	Free	Antibacterial	Blow flyCalliphora vicina	Not Available	Skin Cancer	Not Available	Not Available	Not Available	Not Available	None
4417	11738090, 18957441	2001	GLLGPLLKIAAKVGSNLL	CPF-ST3	18	Not Available	L	None	Free	Free	Anticancer	Diploid clawed frogXenopus tropicalis, Africa	Not Available	Skin Cancer	Not Available	Not Available	Not Available	Not Available	None
4401	11835991, 18957441	2002	GIGTKILGGVKTALKGALKELASTYAN	Maximin 1	27	Not Available	L	None	Free	Free	Anticancer	Bombina maxima	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4400	11835991, 18957441	2002	GIGGVLLSAGKAALKGLAKVLAEKYAN	Maximin 4	27	Not Available	L	None	Free	Free	Anticancer	Bombina maxima	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4399	11835991, 18957441	2002	GIGGKILSGLKTALKGAAKELASTYLH	Maximin 3	27	Not Available	L	None	Free	Free	Antibacterial	Bombina maxima	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4398	11835991, 18957441	2002	ILGPVISTIGGVLGGLLKNL	Maximin H1	27	Not Available	L	None	Free	Free	Antibacterial	Bombina maxima	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4388	15207717, 18957441	2004	GFKDLLKGAAKALVKTVLF	Ascaphin-8	19	Not Available	L	None	Free	Free	Antibacterial	Coastal Tailed Frog,Ascaphus truei, Pacific Northwest, USA, North America	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4279	None	2004	DDAlRRllRRllRRl	DDA-DL6R6-25	15	Linear	Mix	None	Free	Free	Antimicrobial, Antifungal and Anticancer	Synthetic Peptide	CL-1	Tumor	MTT/MTS assay	LC₅₀=3.125 µM	Not Available	Pancreatic	AU_2004_246909_A1
4278	None	2004	DDAlRRllRRllRRl	DDA-DL6R6-25	15	Linear	Mix	None	Free	Free	Antimicrobial, Antifungal and Anticancer	Synthetic Peptide	22RV1	Prostate Cancer	MTT/MTS assay	LC₅₀=3.125 µM	Not Available	Prostate	AU_2004_246909_A1
4275	None	2004	lRRllRRllRRl	DL6R6	12	Linear	Mix	None	Free	Free	Antimicrobial, Antifungal and Anticancer	Synthetic Peptide	22RV1	Prostate Cancer	MTT/MTS assay	LC₅₀=50 µM	Not Available	Prostate	AU_2004_246909_A1
4276	None	2004	lRRllRRllRRl	DL6R6	12	Linear	Mix	None	Free	Free	Antimicrobial, Antifungal and Anticancer	Synthetic Peptide	CL-1	Tumor	MTT/MTS assay	LC₅₀>100 µM	Not Available	Pancreatic	AU_2004_246909_A1
4272	None	2004	lKKllKKllKKl	PA-DL6K6-24	12	Linear	Mix	None	Amidation	CH3(CH2)14CO	Antimicrobial, Antifungal and Anticancer	Synthetic Peptide	22RV1	Prostate Cancer	MTT/MTS assay	LC₅₀<3.125 µM	Not Available	Prostate	AU_2004_246909_A1
4273	None	2004	lKKllKKllKKl	PA-DL6K6-24	12	Linear	Mix	None	Amidation	CH3(CH2)14CO	Antimicrobial, Antifungal and Anticancer	Synthetic Peptide	CL-1	Tumor	MTT/MTS assay	LC₅₀=3.125 µM	Not Available	Pancreatic	AU_2004_246909_A1
4269	None	2004	lKKllKKllKKl	MA-DL6K6-23	12	Linear	Mix	None	Amidation	CH3(CH2)12CO	Antimicrobial, Antifungal and Anticancer	Synthetic Peptide	22RV1	Prostate Cancer	MTT/MTS assay	LC₅₀<3.125 µM	Not Available	Prostate	AU_2004_246909_A1
4270	None	2004	lKKllKKllKKl	MA-DL6K6-23	12	Linear	Mix	None	Amidation	CH3(CH2)12CO	Antimicrobial, Antifungal and Anticancer	Synthetic Peptide	CL-1	Tumor	MTT/MTS assay	LC₅₀<3.125 µM	Not Available	Pancreatic	AU_2004_246909_A1
4266	None	2004	lKKllKKllKKl	DDA-DL6K6-22	12	Linear	Mix	None	Amidation	CH3(CH2)10CO	Antimicrobial, Antifungal and Anticancer	Synthetic Peptide	22RV1	Prostate Cancer	MTT/MTS assay	LC₅₀<3.125 µM	Not Available	Prostate	AU_2004_246909_A1
4267	None	2004	lKKllKKllKKl	DDA-DL6K6-22	12	Linear	Mix	None	Amidation	CH3(CH2)10CO	Antimicrobial, Antifungal and Anticancer	Synthetic Peptide	CL-1	Tumor	MTT/MTS assay	LC₅₀<3.125 µM	Not Available	Pancreatic	AU_2004_246909_A1
4264	None	2004	lKKllKKllKKl	DL6K6	12	Linear	Mix	None	Amidation	Free	Antimicrobial, Antifungal and Anticancer	Synthetic Peptide	CL-1	Tumor	MTT/MTS assay	LC₅₀>100 µM	Not Available	Pancreatic	AU_2004_246909_A1
4263	None	2004	lKKllKKllKKl	DL6K6	12	Linear	Mix	None	Amidation	Free	Antimicrobial, Antifungal and Anticancer	Synthetic Peptide	22RV1	Prostate Cancer	MTT/MTS assay	LC₅₀>100 µM	Not Available	Prostate	AU_2004_246909_A1
4224	16091933	2005	YSL	Tyroserleutide	3	Linear	L	None	Free	Free	Antitumor	Synthetic Peptide	BEL-7402	Liver Cancer	MTT/MTS assay	20.8% cytotoxic at 1 µg/ml	96-h	Liver	None
4225	16091933	2005	YSL	Tyroserleutide	3	Linear	L	None	Free	Free	Antitumor	Synthetic Peptide	BEL-7402	Liver Cancer	MTT/MTS assay	33.8% cytotoxic at 10 µg/ml	96-h	Liver	None
4226	16091933	2005	YSL	Tyroserleutide	3	Linear	L	None	Free	Free	Antitumor	Synthetic Peptide	BEL-7402	Liver Cancer	MTT/MTS assay	35.6% cytotoxic at 100 µg/ml	96-h	Liver	None
4221	16091933	2005	YSL	Tyroserleutide	3	Linear	L	None	Free	Free	Antitumor	Synthetic Peptide	B16-F10	Skin Cancer	MTT/MTS assay	53.0% cytotoxic at 10 µg/ml	96-h	Skin	None
4222	16091933	2005	YSL	Tyroserleutide	3	Linear	L	None	Free	Free	Antitumor	Synthetic Peptide	B16-F10	Skin Cancer	MTT/MTS assay	61.2% cytotoxic at 100 µg/ml	96-h	Skin	None
4223	16091933	2005	YSL	Tyroserleutide	3	Linear	L	None	Free	Free	Antitumor	Synthetic Peptide	BEL-7402	Liver Cancer	MTT/MTS assay	39.0% cytotoxic at 0.1 µg/ml	96-h	Liver	None
4218	15887970	2005	Not Available	Sansalv amide A	Not Available	Cyclic	L	None	Free	Free	Antitumor	Synthetic Peptide	S2-13	Pancreatic Cancer	Cell Viability assay	EC₅₀=7.5 µM	72-h	Pancreatic	None
4219	16091933	2005	YSL	Tyroserleutide	3	Linear	L	None	Free	Free	Antitumor	Synthetic Peptide	B16-F10	Skin Cancer	MTT/MTS assay	49.4% cytotoxic at 0.1 µg/ml	96-h	Skin	None
4220	16091933	2005	YSL	Tyroserleutide	3	Linear	L	None	Free	Free	Antitumor	Synthetic Peptide	B16-F10	Skin Cancer	MTT/MTS assay	51.2% cytotoxic at 1 µg/ml	96-h	Skin	None
4216	15875779, 1429232	2005	A-Hleu-QN-MeIle-Hasn-TPLT-Ade-V-Hleu	Laxaphycin B	13	Cyclic	L	Ade = 3-aminodecanoyl, Hleu =hydroxyleucyl, Hasn = hydoxyasparaginyl	Free	Free	Antifungal	Terrestrial blue-green alga Anabaena laxa or the marine cyanobacterium Lyngbya Majuscula	CEM-VM1	Leukemia Cancer	Cell Viability assay	40% inhibition at 1 µM	96-h	Blood	None
4217	15875779, 1429232	2005	A-Hleu-QN-MeIle-Hasn-TPLT-Ade-V-Hleu	Laxaphycin B	13	Cyclic	L	Ade = 3-aminodecanoyl, Hleu =hydroxyleucyl, Hasn = hydoxyasparaginyl	Free	Free	Antifungal	Terrestrial blue-green alga Anabaena laxa or the marine cyanobacterium Lyngbya Majuscula	CEM-VLB	Leukemia Cancer	Cell Viability assay	40% inhibition at 1 µM	96-h	Blood	None
4214	15875779, 1429232	2005	A-Hleu-QN-MeIle-Hasn-TPLT-Ade-V-Hleu	Laxaphycin B	13	Cyclic	L	Ade = 3-aminodecanoyl, Hleu =hydroxyleucyl, Hasn = hydoxyasparaginyl	Free	Free	Antifungal	Terrestrial blue-green alga Anabaena laxa or the marine cyanobacterium Lyngbya Majuscula	CEM-VLB	Leukemia Cancer	Cell Viability assay	44% inhibition at 1 µM	96-h	Blood	None
4215	15875779, 1429232	2005	A-Hleu-QN-MeIle-Hasn-TPLT-Ade-V-Hleu	Laxaphycin B	13	Cyclic	L	Ade = 3-aminodecanoyl, Hleu =hydroxyleucyl, Hasn = hydoxyasparaginyl	Free	Free	Antifungal	Terrestrial blue-green alga Anabaena laxa or the marine cyanobacterium Lyngbya Majuscula	CEM-WT	Leukemia Cancer	Cell Viability assay	40% inhibition at 1 µM	96-h	Blood	None
4212	15875779, 1429232	2005	A-Hleu-QN-MeIle-Hasn-TPLT-Ade-V-Hleu	Laxaphycin B	13	Cyclic	L	Ade = 3-aminodecanoyl, Hleu =hydroxyleucyl, Hasn = hydoxyasparaginyl	Free	Free	Antifungal	Terrestrial blue-green alga Anabaena laxa or the marine cyanobacterium Lyngbya Majuscula	CEM-WT	Leukemia Cancer	Cell Viability assay	44% inhibition at 1 µM	96-h	Blood	None
4213	15875779, 1429232	2005	A-Hleu-QN-MeIle-Hasn-TPLT-Ade-V-Hleu	Laxaphycin B	13	Cyclic	L	Ade = 3-aminodecanoyl, Hleu =hydroxyleucyl, Hasn = hydoxyasparaginyl	Free	Free	Antifungal	Terrestrial blue-green alga Anabaena laxa or the marine cyanobacterium Lyngbya Majuscula	CEM-VM1	Leukemia Cancer	Cell Viability assay	44% inhibition at 1 µM	96-h	Blood	None
4210	15875779, 1429232	2005	Aoc-Hse-E-Dhb-Hyp-Hse-FLIILG	Laxaphycin A	12	Cyclic	L	Aoc = 3-aminooctanoic acid ,Hyp = 4- hydroxyproline, Dhb = didehydrobutyrine, Hse = Homoserine	Free	Free	Antifungal	Terrestrial blue-green alga Anabaena laxa or the marine cyanobacterium Lyngbya Majuscula	CEM-VM1	Leukemia Cancer	Cell Viability assay	No inhibition at 4 µM	96-h	Blood	None
4211	15875779, 1429232	2005	A-Hleu-QN-MeIle-Hasn-TPLT-Ade-V-Hleu	Laxaphycin B	13	Cyclic	L	Ade = 3-aminodecanoyl, Hleu =hydroxyleucyl, Hasn = hydoxyasparaginyl	Free	Free	Antifungal	Terrestrial blue-green alga Anabaena laxa or the marine cyanobacterium Lyngbya Majuscula	CEM-WT	Leukemia Cancer	Cell Viability assay	50% inhibition at 1 µM	96-h	Blood	None
4208	15875779, 1429232	2005	Aoc-Hse-E-Dhb-Hyp-Hse-FLIILG	Laxaphycin A	12	Cyclic	L	Aoc = 3-aminooctanoic acid ,Hyp = 4- hydroxyproline, Dhb = didehydrobutyrine, Hse = Homoserine	Free	Free	Antifungal	Terrestrial blue-green alga Anabaena laxa or the marine cyanobacterium Lyngbya Majuscula	CEM-WT	Leukemia Cancer	Cell Viability assay	No inhibition at 4 µM	96-h	Blood	None
4209	15875779, 1429232	2005	Aoc-Hse-E-Dhb-Hyp-Hse-FLIILG	Laxaphycin A	12	Cyclic	L	Aoc = 3-aminooctanoic acid ,Hyp = 4- hydroxyproline, Dhb = didehydrobutyrine, Hse = Homoserine	Free	Free	Antifungal	Terrestrial blue-green alga Anabaena laxa or the marine cyanobacterium Lyngbya Majuscula	CEM-VLB	Leukemia Cancer	Cell Viability assay	No inhibition at 4 µM	96-h	Blood	None
4207	15867360	2005	LGQSAASAHHAYIVLAIENSFMTASKKK	hP8	28	Linear	L	None	Free	Free	Antiangiogenesis	Human endostatin peptides	BxPC-3	Pancreatic Cancer	Matrigel Assay	No inhibition at 7 mg/kg/d	672-h	Pancreatic	None
4206	15867360	2005	ETWRTEAPSATGQASSLLGGRLLGQ	hP7	25	Linear	L	None	Free	Free	Antiangiogenesis	Human endostatin peptides	BxPC-3	Pancreatic Cancer	Matrigel Assay	No inhibition at 7 mg/kg/d	672-h	Pancreatic	None
4205	15867360	2005	HPTWPQKSVWHGSDPNGRRLTESY	hP6	24	Linear	L	None	Free	Free	Antiangiogenesis	Human endostatin peptides	BxPC-3	Pancreatic Cancer	Matrigel Assay	No inhibition at 7 mg/kg/d	672-h	Pancreatic	None
4204	15867360	2005	GSEGPLKPGARIFSFDGKDVLRHPT	hP5	25	Linear	L	None	Free	Free	Antiangiogenesis	Human endostatin peptides	BxPC-3	Pancreatic Cancer	Matrigel Assay	29% inhibition at 7 mg/kg/d	672-h	Pancreatic	None
4203	15867360	2005	AAVPIVNLKDELLFPSWEALFSGSE	hP4	25	Linear	L	None	Free	Free	Antiangiogenesis	Human endostatin peptides	BxPC-3	Pancreatic Cancer	Matrigel Assay	No inhibition at 7 mg/kg/d	672-h	Pancreatic	None
4202	15867360	2005	TFRAFLSSRLQDLYSIVRRADRAAV	hP3	25	Linear	L	None	Free	Free	Antiangiogenesis	Human endostatin peptides	BxPC-3	Pancreatic Cancer	Matrigel Assay	No inhibition at 7 mg/kg/d	672-h	Pancreatic	None
4201	15867360	2005	MRGIRGADFQAFQQARAVGLAGTFR	hP2	25	Linear	L	None	Free	Free	Antiangiogenesis	Human endostatin peptides	BxPC-3	Pancreatic Cancer	Matrigel Assay	19% inhibition at 7 mg/kg/d	672-h	Pancreatic	None
4199	15835725	2004	lw	Psychrophilin D (1)	Not Available	Cyclic	D	Anthranilic acid	Free	Free	Anticancer and Antiplasmodial	Penicillium algidum	P-388	Leukemia Cancer	Cell Viability assay	ID₅₀=10.1 µg/ml	Not Available	Blood	None
4200	15867360	2005	HSHRDFQPVLHLVALNSPLSGGMRG	hP1	25	Linear	L	None	Free	Free	Antiangiogenesis	Human endostatin peptides	BxPC-3	Pancreatic Cancer	Matrigel Assay	39% inhibition at 7 mg/kg/d	672-h	Pancreatic	None
4198	15467750	2004	GRKKRRQRRRGGWMWVTNLRTD	TAT-Ras-GAP317-326	22	Linear	L	None	Free	Free	Anticancer	Not Available	HeLa	Cervical Cancer	LDH leakage assay	79% apoptosis at 50 µM	16 to 24-h	Cervix	None
4197	15467750	2004	GRKKRRQRRRGGWMWVTNLRTD	TAT-Ras-GAP317-326	22	Linear	L	None	Free	Free	Anticancer	Not Available	HeLa	Cervical Cancer	LDH leakage assay	72% apoptosis at 30 µM	16 to 24-h	Cervix	None
4196	15467750	2004	GRKKRRQRRRGGWMWVTNLRTD	TAT-Ras-GAP317-326	22	Linear	L	None	Free	Free	Anticancer	Not Available	HeLa	Cervical Cancer	LDH leakage assay	47% apoptosis at 20 µM	16 to 24-h	Cervix	None
4194	15467750	2004	GRKKRRQRRR	HIV-TAT48-57	10	Linear	L	None	Free	Free	Anticancer	Not Available	HeLa	Cervical Cancer	LDH leakage assay	65% apoptosis at 50 µM	16 to 24-h	Cervix	None
4195	15467750	2004	GRKKRRQRRRGGWMWVTNLRTD	TAT-Ras-GAP317-326	22	Linear	L	None	Free	Free	Anticancer	Not Available	HeLa	Cervical Cancer	LDH leakage assay	15% apoptosis at 10 µM	16 to 24-h	Cervix	None
4192	15467750	2004	GRKKRRQRRR	HIV-TAT48-57	10	Linear	L	None	Free	Free	Anticancer	Not Available	HeLa	Cervical Cancer	LDH leakage assay	15% apoptosis at 20 µM	16 to 24-h	Cervix	None
4193	15467750	2004	GRKKRRQRRR	HIV-TAT48-57	10	Linear	L	None	Free	Free	Anticancer	Not Available	HeLa	Cervical Cancer	LDH leakage assay	35% apoptosis at 30 µM	16 to 24-h	Cervix	None
4191	15467750	2004	GRKKRRQRRR	HIV-TAT48-57	10	Linear	L	None	Free	Free	Anticancer	Not Available	HeLa	Cervical Cancer	LDH leakage assay	7% apoptosis at 10 µM	16 to 24-h	Cervix	None
4190	15313924	2004	HHPHGHHPHGHHPHGHHPHG	(HHPHG)4	20	Linear	L	None	Amidation	Acetylation	Antiangiogenesis and Antitumor	Synthetic Peptide	Not Available	Tumor	Tropomyosin binding assay	IC₅₀=0.245 µM	Not Available	Not Available	None
4189	15313924	2004	HHPHGHHPHGHHPHGHHPHG	(HHPHG)4	20	Linear	L	None	Free	Free	Antiangiogenesis and Antitumor	Synthetic Peptide	Not Available	Tumor	Tropomyosin binding assay	IC₅₀=0.256 µM	Not Available	Not Available	None
4187	15313924	2004	HHPHGHHPHGHHPHG	(HHPHG)3	15	Linear	L	None	Free	Free	Antiangiogenesis and Antitumor	Synthetic Peptide	Not Available	Tumor	Tropomyosin binding assay	IC₅₀=1.25 µM	Not Available	Not Available	None
4188	15313924	2004	HHPHGHHPHGHHPHG	(HHPHG)3	15	Linear	L	None	Amidation	Acetylation	Antiangiogenesis and Antitumor	Synthetic Peptide	Not Available	Tumor	Tropomyosin binding assay	IC₅₀=1.56 µM	Not Available	Not Available	None
4185	15313924	2004	HHPHGHHPHG	(HHPHG)2	10	Linear	L	None	Free	Free	Antiangiogenesis and Antitumor	Synthetic Peptide	Not Available	Tumor	Tropomyosin binding assay	IC₅₀=11.6 µM	Not Available	Not Available	None
4186	15313924	2004	HHPHGHHPHG	(HHPHG)2	10	Linear	L	None	Amidation	Acetylation	Antiangiogenesis and Antitumor	Synthetic Peptide	Not Available	Tumor	Tropomyosin binding assay	IC₅₀=26.9 µM	Not Available	Not Available	None
4183	14991605	2004	KIFGSLAFL	p369-CTL-A2xFVB	9	Linear	L	None	Free	Free	Antitumor	Synthetic Peptide	N202.A2	Tumor	Peptide dose curve assay	92% Inhibition at 10^-6 M	Not Available	Not Available	None
4184	15313924	2004	HHPHG	HHPHG	5	Linear	L	None	Free	Free	Antiangiogenesis and Antitumor	Synthetic Peptide	Not Available	Tumor	Tropomyosin binding assay	IC₅₀=92 µM	Not Available	Not Available	None
4182	14991605	2004	KIFGSLAFL	p369-CTL-A2xFVB	9	Linear	L	None	Free	Free	Antitumor	Synthetic Peptide	N202.A2	Tumor	Peptide dose curve assay	85% Inhibition at 10^-7 M	Not Available	Not Available	None
4180	14991605	2004	KIFGSLAFL	p369-CTL-A2xFVB	9	Linear	L	None	Free	Free	Antitumor	Synthetic Peptide	N202.A2	Tumor	Peptide dose curve assay	25% Inhibition at 10^-9 M	Not Available	Not Available	None
4181	14991605	2004	KIFGSLAFL	p369-CTL-A2xFVB	9	Linear	L	None	Free	Free	Antitumor	Synthetic Peptide	N202.A2	Tumor	Peptide dose curve assay	80% Inhibition at 10^-8 M	Not Available	Not Available	None
4179	14991605	2004	KIFGSLAFL	p369-CTL-A2xFVB	9	Linear	L	None	Free	Free	Antitumor	Synthetic Peptide	N202.A2	Tumor	Peptide dose curve assay	8% Inhibition at 10^-10 M	Not Available	Not Available	None
4178	14991605	2004	KIFGSLAFL	p369-CTL-A2xneu	9	Linear	L	None	Free	Free	Antitumor	Synthetic Peptide	N202.A2	Tumor	Peptide dose curve assay	20% Inhibition at 10^-6 M	Not Available	Not Available	None
4177	14991605	2004	KIFGSLAFL	p369-CTL-A2xneu	9	Linear	L	None	Free	Free	Antitumor	Synthetic Peptide	N202.A2	Tumor	Peptide dose curve assay	10% Inhibition at 10^-7 M	Not Available	Not Available	None
4176	14991605	2004	KIFGSLAFL	p369-CTL-A2xneu	9	Linear	L	None	Free	Free	Antitumor	Synthetic Peptide	N202.A2	Tumor	Peptide dose curve assay	5% Inhibition at 10^-8 M	Not Available	Not Available	None
4175	14991605	2004	KIFGSLAFL	p369-CTL-A2xneu	9	Linear	L	None	Free	Free	Antitumor	Synthetic Peptide	N202.A2	Tumor	Peptide dose curve assay	1% Inhibition at 10^-9 M	Not Available	Not Available	None
4174	14991605	2004	KIFGSLAFL	p369-CTL-A2xneu	9	Linear	L	None	Free	Free	Antitumor	Synthetic Peptide	N202.A2	Tumor	Peptide dose curve assay	0.1% Inhibition at 10^-10 M	Not Available	Not Available	None
4173	12631273, 9266696	2003	LGGIVSAVKKIVDFLG	retro	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Breast tumor cellline	Breast Cancer	Sulforhodamine B assay	IC₅₀= >10 µM	Not Available	Breast	None
4172	12631273, 9266696	2003	LGGIVSAVKKIVDFLG	retro	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Prostate tumor cellline	Prostate Cancer	Sulforhodamine B assay	IC₅₀= >10 µM	Not Available	Prostate	None
4171	12631273, 9266696	2003	LGGIVSAVKKIVDFLG	retro	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Liver tumor celline	Liver Cancer	Sulforhodamine B assay	IC₅₀= >10 µM	Not Available	Liver	None
4170	12631273, 9266696	2003	LGGIVSAVKKIVDFLG	retro	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Ovary tumor cellline	Ovarian Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Ovary	None
4169	12631273, 9266696	2003	LGGIVSAVKKIVDFLG	retro	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Skin tumor cellline	Skin Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Skin	None
4167	12631273, 9266696	2003	LGGIVSAVKKIVDFLG	retro	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Colon tumor cellline	Colon Cancer	Sulforhodamine B assay	IC₅₀= >10 µM	Not Available	Colon	None
4168	12631273, 9266696	2003	LGGIVSAVKKIVDFLG	retro	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Brain tumor cellline	Brain Tumor	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Brain	None
4166	12631273, 9266696	2003	LGGIVSAVKKIVDFLG	retro	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Lung tumor cellline	Lung Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Lung	None
4165	12631273, 9266696	2003	LGGIVSAVKKIVDFLG	retro	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Leukemia tumor cellline	Leukemia Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Blood	None
4163	12631273, 9266696	2003	GLFKVIKKVAKVIKKL	23	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Prostate tumor cellline	Prostate Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Prostate	None
4164	12631273, 9266696	2003	GLFKVIKKVAKVIKKL	23	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Breast tumor cellline	Breast Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Breast	None
4162	12631273, 9266696	2003	GLFKVIKKVAKVIKKL	23	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Liver tumor celline	Liver Cancer	Sulforhodamine B assay	IC₅₀= >10 µM	Not Available	Liver	None
4160	12631273, 9266696	2003	GLFKVIKKVAKVIKKL	23	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Skin tumor cellline	Skin Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Skin	None
4161	12631273, 9266696	2003	GLFKVIKKVAKVIKKL	23	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Ovary tumor cellline	Ovarian Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Ovary	None
4159	12631273, 9266696	2003	GLFKVIKKVAKVIKKL	23	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Brain tumor cellline	Brain Tumor	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Brain	None
4157	12631273, 9266696	2003	GLFKVIKKVAKVIKKL	23	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Lung tumor cellline	Lung Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Lung	None
4158	12631273, 9266696	2003	GLFKVIKKVAKVIKKL	23	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Colon tumor cellline	Colon Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Colon	None
4156	12631273, 9266696	2003	GLFKVIKKVAKVIKKL	23	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Leukemia tumor cellline	Leukemia Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Blood	None
4155	12631273, 9266696	2003	GLFKVIKKVASVIGGL	22	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Breast tumor cellline	Breast Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Breast	None
4153	12631273, 9266696	2003	GLFKVIKKVASVIGGL	22	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Liver tumor celline	Liver Cancer	Sulforhodamine B assay	IC₅₀= >10 µM	Not Available	Liver	None
4154	12631273, 9266696	2003	GLFKVIKKVASVIGGL	22	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Prostate tumor cellline	Prostate Cancer	Sulforhodamine B assay	IC₅₀= >10 µM	Not Available	Prostate	None
4152	12631273, 9266696	2003	GLFKVIKKVASVIGGL	22	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Ovary tumor cellline	Ovarian Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Ovary	None
4150	12631273, 9266696	2003	GLFKVIKKVASVIGGL	22	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Brain tumor cellline	Brain Tumor	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Brain	None
4151	12631273, 9266696	2003	GLFKVIKKVASVIGGL	22	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Skin tumor cellline	Skin Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Skin	None
4149	12631273, 9266696	2003	GLFKVIKKVASVIGGL	22	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Colon tumor cellline	Colon Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Colon	None
4147	12631273, 9266696	2003	GLFKVIKKVASVIGGL	22	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Leukemia tumor cellline	Leukemia Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Blood	None
4148	12631273, 9266696	2003	GLFKVIKKVASVIGGL	22	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Lung tumor cellline	Lung Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Lung	None
4146	12631273, 9266696	2003	GLFAVIKKVAKVIKKL	19	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Breast tumor cellline	Breast Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Breast	None
4145	12631273, 9266696	2003	GLFAVIKKVAKVIKKL	19	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Prostate tumor cellline	Prostate Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Prostate	None
4144	12631273, 9266696	2003	GLFAVIKKVAKVIKKL	19	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Liver tumor celline	Liver Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Liver	None
4143	12631273, 9266696	2003	GLFAVIKKVAKVIKKL	19	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Ovary tumor cellline	Ovarian Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Ovary	None
4142	12631273, 9266696	2003	GLFAVIKKVAKVIKKL	19	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Skin tumor cellline	Skin Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Skin	None
4140	12631273, 9266696	2003	GLFAVIKKVAKVIKKL	19	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Colon tumor cellline	Colon Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Colon	None
4141	12631273, 9266696	2003	GLFAVIKKVAKVIKKL	19	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Brain tumor cellline	Brain Tumor	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Brain	None
4139	12631273, 9266696	2003	GLFAVIKKVAKVIKKL	19	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Lung tumor cellline	Lung Cancer	Sulforhodamine B assay	IC₅₀= 6 M	Not Available	Lung	None
4138	12631273, 9266696	2003	GLFAVIKKVAKVIKKL	19	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Leukemia tumor cellline	Leukemia Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Blood	None
4137	12631273, 9266696	2003	GLFAVIKKVAAVIRRL	18	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Breast tumor cellline	Breast Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Breast	None
4135	12631273, 9266696	2003	GLFAVIKKVAAVIRRL	18	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Liver tumor celline	Liver Cancer	Sulforhodamine B assay	IC₅₀= >10 µM	Not Available	Liver	None
4136	12631273, 9266696	2003	GLFAVIKKVAAVIRRL	18	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Prostate tumor cellline	Prostate Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Prostate	None
4134	12631273, 9266696	2003	GLFAVIKKVAAVIRRL	18	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Ovary tumor cellline	Ovarian Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Ovary	None
4133	12631273, 9266696	2003	GLFAVIKKVAAVIRRL	18	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Skin tumor cellline	Skin Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Skin	None
4132	12631273, 9266696	2003	GLFAVIKKVAAVIRRL	18	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Brain tumor cellline	Brain Tumor	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Brain	None
4131	12631273, 9266696	2003	GLFAVIKKVAAVIRRL	18	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Colon tumor cellline	Colon Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Colon	None
4130	12631273, 9266696	2003	GLFAVIKKVAAVIRRL	18	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Lung tumor cellline	Lung Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Lung	None
4129	12631273, 9266696	2003	GLFAVIKKVAAVIRRL	18	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Leukemia tumor cellline	Leukemia Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Blood	None
4128	12631273, 9266696	2003	GLFAVIKKVAAVIKKL	17	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Breast tumor cellline	Breast Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Breast	None
4127	12631273, 9266696	2003	GLFAVIKKVAAVIKKL	17	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Prostate tumor cellline	Prostate Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Prostate	None
4126	12631273, 9266696	2003	GLFAVIKKVAAVIKKL	17	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Liver tumor celline	Liver Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Liver	None
4124	12631273, 9266696	2003	GLFAVIKKVAAVIKKL	17	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Skin tumor cellline	Skin Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Skin	None
4125	12631273, 9266696	2003	GLFAVIKKVAAVIKKL	17	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Ovary tumor cellline	Ovarian Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Ovary	None
4123	12631273, 9266696	2003	GLFAVIKKVAAVIKKL	17	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Brain tumor cellline	Brain Tumor	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Brain	None
4122	12631273, 9266696	2003	GLFAVIKKVAAVIKKL	17	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Colon tumor cellline	Colon Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Colon	None
4120	12631273, 9266696	2003	GLFAVIKKVAAVIKKL	17	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Leukemia tumor cellline	Leukemia Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Blood	None
4121	12631273, 9266696	2003	GLFAVIKKVAAVIKKL	17	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Lung tumor cellline	Lung Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Lung	None
4119	12631273, 9266696	2003	GLFAVIKKVASVIKKL	16	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Breast tumor cellline	Breast Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Breast	None
4118	12631273, 9266696	2003	GLFAVIKKVASVIKKL	16	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Prostate tumor cellline	Prostate Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Prostate	None
4116	12631273, 9266696	2003	GLFAVIKKVASVIKKL	16	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Ovary tumor cellline	Ovarian Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Ovary	None
4117	12631273, 9266696	2003	GLFAVIKKVASVIKKL	16	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Liver tumor celline	Liver Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Liver	None
4114	12631273, 9266696	2003	GLFAVIKKVASVIKKL	16	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Brain tumor cellline	Brain Tumor	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Brain	None
4115	12631273, 9266696	2003	GLFAVIKKVASVIKKL	16	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Skin tumor cellline	Skin Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Skin	None
4113	12631273, 9266696	2003	GLFAVIKKVASVIKKL	16	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Colon tumor cellline	Colon Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Colon	None
4111	12631273, 9266696	2003	GLFAVIKKVASVIKKL	16	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Leukemia tumor cellline	Leukemia Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Blood	None
4112	12631273, 9266696	2003	GLFAVIKKVASVIKKL	16	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Lung tumor cellline	Lung Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Lung	None
4110	12631273, 9266696	2003	GLFAVIKKVASVIKGL	15	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Breast tumor cellline	Breast Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Breast	None
4108	12631273, 9266696	2003	GLFAVIKKVASVIKGL	15	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Liver tumor celline	Liver Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Liver	None
4109	12631273, 9266696	2003	GLFAVIKKVASVIKGL	15	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Prostate tumor cellline	Prostate Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Prostate	None
4107	12631273, 9266696	2003	GLFAVIKKVASVIKGL	15	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Ovary tumor cellline	Ovarian Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Ovary	None
4105	12631273, 9266696	2003	GLFAVIKKVASVIKGL	15	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Brain tumor cellline	Brain Tumor	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Brain	None
4106	12631273, 9266696	2003	GLFAVIKKVASVIKGL	15	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Skin tumor cellline	Skin Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Skin	None
4103	12631273, 9266696	2003	GLFAVIKKVASVIKGL	15	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Lung tumor cellline	Lung Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Lung	None
4104	12631273, 9266696	2003	GLFAVIKKVASVIKGL	15	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Colon tumor cellline	Colon Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Colon	None
4100	12631273, 9266696	2003	GLFDVIAKVASVIKKL	14	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Prostate tumor cellline	Prostate Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Prostate	None
4101	12631273, 9266696	2003	GLFDVIAKVASVIKKL	14	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Breast tumor cellline	Breast Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Breast	None
4102	12631273, 9266696	2003	GLFAVIKKVASVIKGL	15	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Leukemia tumor cellline	Leukemia Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Blood	None
4099	12631273, 9266696	2003	GLFDVIAKVASVIKKL	14	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Liver tumor celline	Liver Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Liver	None
4098	12631273, 9266696	2003	GLFDVIAKVASVIKKL	14	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Ovary tumor cellline	Ovarian Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Ovary	None
4097	12631273, 9266696	2003	GLFDVIAKVASVIKKL	14	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Skin tumor cellline	Skin Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Skin	None
4096	12631273, 9266696	2003	GLFDVIAKVASVIKKL	14	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Brain tumor cellline	Brain Tumor	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Brain	None
4094	12631273, 9266696	2003	GLFDVIAKVASVIKKL	14	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Lung tumor cellline	Lung Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Lung	None
4095	12631273, 9266696	2003	GLFDVIAKVASVIKKL	14	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Colon tumor cellline	Colon Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Colon	None
4093	12631273, 9266696	2003	GLFDVIAKVASVIKKL	14	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Leukemia tumor cellline	Leukemia Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Blood	None
4092	12631273, 9266696	2003	GLFDVIKKVASVIKKL	13	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Breast tumor cellline	Breast Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Breast	None
4090	12631273, 9266696	2003	GLFDVIKKVASVIKKL	13	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Liver tumor celline	Liver Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Liver	None
4091	12631273, 9266696	2003	GLFDVIKKVASVIKKL	13	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Prostate tumor cellline	Prostate Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Prostate	None
4089	12631273, 9266696	2003	GLFDVIKKVASVIKKL	13	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Ovary tumor cellline	Ovarian Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Ovary	None
4088	12631273, 9266696	2003	GLFDVIKKVASVIKKL	13	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Skin tumor cellline	Skin Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Skin	None
4086	12631273, 9266696	2003	GLFDVIKKVASVIKKL	13	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Colon tumor cellline	Colon Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Colon	None
4087	12631273, 9266696	2003	GLFDVIKKVASVIKKL	13	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Brain tumor cellline	Brain Tumor	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Brain	None
4085	12631273, 9266696	2003	GLFDVIKKVASVIKKL	13	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Lung tumor cellline	Lung Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Lung	None
4083	12631273, 9266696	2003	GLFDVIKKVASVIKGL	11	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Breast tumor cellline	Breast Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Breast	None
4084	12631273, 9266696	2003	GLFDVIKKVASVIKKL	13	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Leukemia tumor cellline	Leukemia Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Blood	None
4082	12631273, 9266696	2003	GLFDVIKKVASVIKGL	11	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Prostate tumor cellline	Prostate Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Prostate	None
4081	12631273, 9266696	2003	GLFDVIKKVASVIKGL	11	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Liver tumor celline	Liver Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Liver	None
4079	12631273, 9266696	2003	GLFDVIKKVASVIKGL	11	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Skin tumor cellline	Skin Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Skin	None
4080	12631273, 9266696	2003	GLFDVIKKVASVIKGL	11	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Ovary tumor cellline	Ovarian Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Ovary	None
4078	12631273, 9266696	2003	GLFDVIKKVASVIKGL	11	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Brain tumor cellline	Brain Tumor	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Brain	None
4077	12631273, 9266696	2003	GLFDVIKKVASVIKGL	11	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Colon tumor cellline	Colon Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Colon	None
4076	12631273, 9266696	2003	GLFDVIKKVASVIKGL	11	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Lung tumor cellline	Lung Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Lung	None
4075	12631273, 9266696	2003	GLFDVIKKVASVIKGL	11	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Leukemia tumor cellline	Leukemia Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Blood	None
4074	12631273, 9266696	2003	GLFDVIKKVAAVIGGL	7	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Breast tumor cellline	Breast Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Breast	None
4073	12631273, 9266696	2003	GLFDVIKKVAAVIGGL	7	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Prostate tumor cellline	Prostate Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Prostate	None
4072	12631273, 9266696	2003	GLFDVIKKVAAVIGGL	7	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Liver tumor celline	Liver Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Liver	None
4071	12631273, 9266696	2003	GLFDVIKKVAAVIGGL	7	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Ovary tumor cellline	Ovarian Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Ovary	None
4070	12631273, 9266696	2003	GLFDVIKKVAAVIGGL	7	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Skin tumor cellline	Skin Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Skin	None
4068	12631273, 9266696	2003	GLFDVIKKVAAVIGGL	7	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Colon tumor cellline	Colon Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Colon	None
4069	12631273, 9266696	2003	GLFDVIKKVAAVIGGL	7	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Brain tumor cellline	Brain Tumor	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Brain	None
4067	12631273, 9266696	2003	GLFDVIKKVAAVIGGL	7	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Lung tumor cellline	Lung Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Lung	None
4065	12631273, 9266696	2003	GLFDVIKAVASVIGGL	5	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Breast tumor cellline	Breast Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Breast	None
4066	12631273, 9266696	2003	GLFDVIKKVAAVIGGL	7	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Leukemia tumor cellline	Leukemia Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Blood	None
4064	12631273, 9266696	2003	GLFDVIKAVASVIGGL	5	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Prostate tumor cellline	Prostate Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Prostate	None
4063	12631273, 9266696	2003	GLFDVIKAVASVIGGL	5	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Liver tumor celline	Liver Cancer	Sulforhodamine B assay	IC₅₀= >100 µM	Not Available	Liver	None
4062	12631273, 9266696	2003	GLFDVIKAVASVIGGL	5	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Ovary tumor cellline	Ovarian Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Ovary	None
4060	12631273, 9266696	2003	GLFDVIKAVASVIGGL	5	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Brain tumor cellline	Brain Tumor	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Brain	None
4061	12631273, 9266696	2003	GLFDVIKAVASVIGGL	5	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Skin tumor cellline	Skin Cancer	Sulforhodamine B assay	IC₅₀= >100 µM	Not Available	Skin	None
4059	12631273, 9266696	2003	GLFDVIKAVASVIGGL	5	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Colon tumor cellline	Colon Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Colon	None
4058	12631273, 9266696	2003	GLFDVIKAVASVIGGL	5	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Lung tumor cellline	Lung Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Lung	None
4056	12631273, 9266696	2003	GLFAVIKKVASVIGGL	3	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Breast tumor cellline	Breast Cancer	Sulforhodamine B assay	IC₅₀= 6 M	Not Available	Breast	None
4057	12631273, 9266696	2003	GLFDVIKAVASVIGGL	5	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Leukemia tumor cellline	Leukemia Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Blood	None
4054	12631273, 9266696	2003	GLFAVIKKVASVIGGL	3	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Liver tumor celline	Liver Cancer	Sulforhodamine B assay	IC₅₀= > 1 µM	Not Available	Liver	None
4055	12631273, 9266696	2003	GLFAVIKKVASVIGGL	3	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Prostate tumor cellline	Prostate Cancer	Sulforhodamine B assay	IC₅₀= 6 M	Not Available	Prostate	None
4053	12631273, 9266696	2003	GLFAVIKKVASVIGGL	3	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Ovary tumor cellline	Ovarian Cancer	Sulforhodamine B assay	IC₅₀= 6 M	Not Available	Ovary	None
4051	12631273, 9266696	2003	GLFAVIKKVASVIGGL	3	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Brain tumor cellline	Brain Tumor	Sulforhodamine B assay	IC₅₀= 6 M	Not Available	Brain	None
4052	12631273, 9266696	2003	GLFAVIKKVASVIGGL	3	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Skin tumor cellline	Skin Cancer	Sulforhodamine B assay	IC₅₀= 6 M	Not Available	Skin	None
4050	12631273, 9266696	2003	GLFAVIKKVASVIGGL	3	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Colon tumor cellline	Colon Cancer	Sulforhodamine B assay	IC₅₀= 6 M	Not Available	Colon	None
4048	12631273, 9266696	2003	GLFAVIKKVASVIGGL	3	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Leukemia tumor cellline	Leukemia Cancer	Sulforhodamine B assay	IC₅₀= 6 M	Not Available	Blood	None
4049	12631273, 9266696	2003	GLFAVIKKVASVIGGL	3	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Lung tumor cellline	Lung Cancer	Sulforhodamine B assay	IC₅₀= 6 M	Not Available	Lung	None
4047	12631273, 9266696	2003	glfdvikkvasviggl	Citropin 1.1D	16	Linear	D	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Breast tumor cellline	Breast Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Breast	None
4045	12631273, 9266696	2003	glfdvikkvasviggl	Citropin 1.1D	16	Linear	D	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Liver tumor celline	Liver Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Liver	None
4046	12631273, 9266696	2003	glfdvikkvasviggl	Citropin 1.1D	16	Linear	D	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Prostate tumor cellline	Prostate Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Prostate	None
4043	12631273, 9266696	2003	glfdvikkvasviggl	Citropin 1.1D	16	Linear	D	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Skin tumor cellline	Skin Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Skin	None
4044	12631273, 9266696	2003	glfdvikkvasviggl	Citropin 1.1D	16	Linear	D	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Ovary tumor cellline	Ovarian Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Ovary	None
4041	12631273, 9266696	2003	glfdvikkvasviggl	Citropin 1.1D	16	Linear	D	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Colon tumor cellline	Colon Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Colon	None
4042	12631273, 9266696	2003	glfdvikkvasviggl	Citropin 1.1D	16	Linear	D	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Brain tumor cellline	Brain Tumor	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Brain	None
4040	12631273, 9266696	2003	glfdvikkvasviggl	Citropin 1.1D	16	Linear	D	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Lung tumor cellline	Lung Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Lung	None
4038	12631273, 9266696	2003	GLFDVIKKVASVIGGL	Citropin 1.1	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Breast tumor cellline	Breast Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Breast	None
4039	12631273, 9266696	2003	glfdvikkvasviggl	Citropin 1.1D	16	Linear	D	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Leukemia tumor cellline	Leukemia Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Blood	None
4037	12631273, 9266696	2003	GLFDVIKKVASVIGGL	Citropin 1.1	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Prostate tumor cellline	Prostate Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Prostate	None
4036	12631273, 9266696	2003	GLFDVIKKVASVIGGL	Citropin 1.1	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Liver tumor celline	Liver Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Liver	None
4035	12631273, 9266696	2003	GLFDVIKKVASVIGGL	Citropin 1.1	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Ovary tumor cellline	Ovarian Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Ovary	None
4033	12631273, 9266696	2003	GLFDVIKKVASVIGGL	Citropin 1.1	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Brain tumor cellline	Brain Tumor	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Brain	None
4034	12631273, 9266696	2003	GLFDVIKKVASVIGGL	Citropin 1.1	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Skin tumor cellline	Skin Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Skin	None
4032	12631273, 9266696	2003	GLFDVIKKVASVIGGL	Citropin 1.1	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Colon tumor cellline	Colon Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Colon	None
4031	12631273, 9266696	2003	GLFDVIKKVASVIGGL	Citropin 1.1	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Lung tumor cellline	Lung Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Lung	None
4030	12631273, 9266696	2003	GLFDVIKKVASVIGGL	Citropin 1.1	16	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Amphibian skin secretions	Leukemia tumor cellline	Leukemia Cancer	Sulforhodamine B assay	IC₅₀= 5 M	Not Available	Blood	None
3361	None	2004	KWKKLLKKPPPLLKKLLKKL	Synthetic peptide	20	Linear	L	None	Free	Free	Antimicrobial and Anticancer, antibacterial, antifungal	Synthetic peptide	SNU-601	Gastric Cancer	MTT/MTS assay	0% survival rate at 100 µM	NA	Stomach	US_6800727_B2
3360	None	2004	KWKKLLKKPPPLLKKLLKKL	Synthetic peptide	20	Linear	L	None	Free	Free	Antimicrobial and Anticancer, antibacterial, antifungal	Synthetic peptide	SNU-601	Gastric Cancer	MTT/MTS assay	~20% survival rate at 10 µM	NA	Stomach	US_6800727_B2
3359	None	2004	KWKKLLKKPPPLLKKLLKKL	Synthetic peptide	20	Linear	L	None	Free	Free	Antimicrobial and Anticancer, antibacterial, antifungal	Synthetic peptide	Jurkat	Blood Cancer	MTT/MTS assay	0% survival rate at 100 µM	NA	Blood	US_6800727_B2
3358	None	2004	KWKKLLKKPPPLLKKLLKKL	Synthetic peptide	20	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer, antibacterial, antifungal	Synthetic peptide	Jurkat	Blood Cancer	MTT/MTS assay	~60% survival rate at 10 µM	NA	Blood	US_6800727_B2
3357	None	2004	KWKKLLKKPPPLLKKLLKKL	Synthetic peptide	20	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer, antibacterial, antifungal	Synthetic peptide	Calu-6	Lung Cancer	MTT/MTS assay	0% survival rate at 100 µM	NA	Lung	US_6800727_B2
3348	11943716	2002	Not Available	Hα-Defensin HNPs-2	Not Available	Not Available	Not Available	Not Available	Amidation	Not Available	Antimicrobial	Not Available	RCCs, HLA-DRB1*10301	Tumor	Cell Viability assay	Inhibition at 12.5 µg/ml	Not Available	Not Available	None
3349	11943716	2002	Not Available	Hα-Defensin HNPs-3	Not Available	Not Available	Not Available	Not Available	Amidation	Not Available	Antimicrobial	Not Available	RCCs, HLA-DRB1*10301	Tumor	Cell Viability assay	Inhibition at 12.5 µg/ml	Not Available	Not Available	None
3350	None	2004	KWKLFKKIGIGKFLHSAKKF	CA-MA	20	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer, antibacterial, antifungal	Ceropin-Melittin hybrid	Calu-6	Lung Cancer	MTT/MTS assay	~90% survival rate at 10 µM	NA	Lung	US_6800727_B2
3351	None	2004	KWKLFKKIGIGKFLHSAKKF	CA-MA	20	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer, antibacterial, antifungal	Ceropin-Melittin hybrid	Calu-6	Lung Cancer	MTT/MTS assay	<20% survival rate at 100 µM	NA	Lung	US_6800727_B2
3352	None	2004	KWKLFKKIGIGKFLHSAKKF	CA-MA	20	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer, antibacterial, antifungal	Ceropin-Melittin hybrid	Jurkat	Blood Cancer	MTT/MTS assay	100% survival rate at 10 µM	NA	Blood	US_6800727_B2
3353	None	2004	KWKLFKKIGIGKFLHSAKKF	CA-MA	20	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer, antibacterial, antifungal	Ceropin-Melittin hybrid	Jurkat	Blood Cancer	MTT/MTS assay	0% survival rate at 100 µM	NA	Blood	US_6800727_B2
3354	None	2004	KWKLFKKIGIGKFLHSAKKF	CA-MA	20	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer, antibacterial, antifungal	Ceropin-Melittin hybrid	SNU-601	Gastric Cancer	MTT/MTS assay	~80% survival rate at 10 µM	NA	Stomach	US_6800727_B2
3355	None	2004	KWKLFKKIGIGKFLHSAKKF	CA-MA	20	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer, antibacterial, antifungal	Ceropin-Melittin hybrid	SNU-601	Gastric Cancer	MTT/MTS assay	10% survival rate at 100 µM	NA	Stomach	US_6800727_B2
3356	None	2004	KWKKLLKKPPPLLKKLLKKL	Synthetic peptide	20	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer, antibacterial, antifungal	Synthetic peptide	Calu-6	Lung Cancer	MTT/MTS assay	35% survival rate at 10 µM	NA	Lung	US_6800727_B2
3347	11943716	2002	Not Available	Hα-Defensin HNPs-1	Not Available	Not Available	Not Available	Not Available	Amidation	Not Available	Antimicrobial	Not Available	RCCs, HLA-DRB1*10301	Tumor	Cell Viability assay	Inhibition at 12.5 µg/ml	Not Available	Not Available	None
3101	16004618	2005	MWKWFHNVLSSGQLLADKWWAWWYNWW	Pep27anal5	27	Linear	L	None	Free	Free	Anticancer	S. pneumoniae	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀=>70 µM	19.17-Min	Breast	None
3100	16004618	2005	MWKEFHNVLSSGQLLADKRWARWYNRW	Pep27anal4	27	Linear	L	None	Free	Free	Anticancer	S. pneumoniae	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀= 29 µM	19.15-Min	Breast	None
3099	16004618	2005	MRKWFHNVLSSGQLLADKWPAWDYNRK	Pep27anal3	27	Linear	L	None	Free	Free	Anticancer	S. pneumoniae	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀= 38 µM	20.08-Min	Breast	None
3098	16004618	2005	MWKWFHNVLSWWWLLADKRPARDYNRK	Pep27anal2	27	Linear	L	None	Free	Free	Anticancer	S. pneumoniae	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀= <10 µM	22.5-Min	Breast	None
3097	16004618	2005	MWKWFHNVLSSWQLLADKRPARDYNRK	Pep27anal1	27	Linear	L	None	Free	Free	Anticancer	S. pneumoniae	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀= 55 µM	18.67-Min	Breast	None
3096	16004618	2005	MRKEFHNVLSSGQLLADKRPARDYNRK	Pep27	27	Linear	L	None	Free	Free	Anticancer	S. pneumoniae	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀= >70 µM	14.54-Min	Breast	None
3095	16004618	2005	MWKWFHNVLSSGQLLADKWWAWWYNWW	Pep27anal5	27	Linear	L	None	Free	Free	Anticancer	S. pneumoniae	SNU-601	Gastric Cancer	MTT/MTS assay	IC₅₀=>70 µM	19.17-Min	Stomach	None
3094	16004618	2005	MWKEFHNVLSSGQLLADKRWARWYNRW	Pep27anal4	27	Linear	L	None	Free	Free	Anticancer	S. pneumoniae	SNU-601	Gastric Cancer	MTT/MTS assay	IC₅₀= 37 µM	19.15-Min	Stomach	None
3093	16004618	2005	MRKWFHNVLSSGQLLADKWPAWDYNRK	Pep27anal3	27	Linear	L	None	Free	Free	Anticancer	S. pneumoniae	SNU-601	Gastric Cancer	MTT/MTS assay	IC₅₀= 50 µM	20.08-Min	Stomach	None
3092	16004618	2005	MWKWFHNVLSWWWLLADKRPARDYNRK	Pep27anal2	27	Linear	L	None	Free	Free	Anticancer	S. pneumoniae	SNU-601	Gastric Cancer	MTT/MTS assay	IC₅₀= 25 µM	22.5-Min	Stomach	None
3091	16004618	2005	MWKWFHNVLSSWQLLADKRPARDYNRK	Pep27anal1	27	Linear	L	None	Free	Free	Anticancer	S. pneumoniae	SNU-601	Gastric Cancer	MTT/MTS assay	IC₅₀= 37 µM	18.67-Min	Stomach	None
3089	16004618	2005	MWKWFHNVLSSGQLLADKWWAWWYNWW	Pep27anal5	27	Linear	L	None	Free	Free	Anticancer	S. pneumoniae	Jurkat	Blood Cancer	MTT/MTS assay	IC₅₀=>70 µM	19.17-Min	Blood	None
3090	16004618	2005	MRKEFHNVLSSGQLLADKRPARDYNRK	Pep27	27	Linear	L	None	Free	Free	Anticancer	S. pneumoniae	SNU-601	Gastric Cancer	MTT/MTS assay	IC₅₀= >70 µM	14.54-Min	Stomach	None
3088	16004618	2005	MWKEFHNVLSSGQLLADKRWARWYNRW	Pep27anal4	27	Linear	L	None	Free	Free	Anticancer	S. pneumoniae	Jurkat	Blood Cancer	MTT/MTS assay	IC₅₀= 46 µM	19.15-Min	Blood	None
3087	16004618	2005	MRKWFHNVLSSGQLLADKWPAWDYNRK	Pep27anal3	27	Linear	L	None	Free	Free	Anticancer	S. pneumoniae	Jurkat	Blood Cancer	MTT/MTS assay	IC₅₀= 50 µM	20.08-Min	Blood	None
3086	16004618	2005	MWKWFHNVLSWWWLLADKRPARDYNRK	Pep27anal2	27	Linear	L	None	Free	Free	Anticancer	S. pneumoniae	Jurkat	Blood Cancer	MTT/MTS assay	IC₅₀= 23 µM	22.5-Min	Blood	None
3085	16004618	2005	MWKWFHNVLSSWQLLADKRPARDYNRK	Pep27anal1	27	Linear	L	None	Free	Free	Anticancer	S. pneumoniae	Jurkat	Blood Cancer	MTT/MTS assay	IC₅₀= 47 µM	18.67-Min	Blood	None
3084	16004618	2005	MRKEFHNVLSSGQLLADKRPARDYNRK	Pep27	27	Linear	L	None	Free	Free	Anticancer	S. pneumoniae	Jurkat	Blood Cancer	MTT/MTS assay	IC₅₀=>70 µM	14.54-Min	Blood	None
3083	16004618	2005	MWKWFHNVLSSGQLLADKWWAWWYNWW	Pep27anal5	27	Linear	L	None	Free	Free	Anticancer	S. pneumoniae	HL-60	Leukemia Cancer	MTT/MTS assay	IC₅₀= >70 µM	19.17-Min	Blood	None
3082	16004618	2005	MWKEFHNVLSSGQLLADKRWARWYNRW	Pep27anal4	27	Linear	L	None	Free	Free	Anticancer	S. pneumoniae	HL-60	Leukemia Cancer	MTT/MTS assay	IC₅₀=51 µM	19.15-Min	Blood	None
3081	16004618	2005	MRKWFHNVLSSGQLLADKWPAWDYNRK	Pep27anal3	27	Linear	L	None	Free	Free	Anticancer	S. pneumoniae	HL-60	Leukemia Cancer	MTT/MTS assay	IC₅₀= 52 µM	20.08-Min	Blood	None
3080	16004618	2005	MWKWFHNVLSWWWLLADKRPARDYNRK	Pep27anal2	27	Linear	L	None	Free	Free	Anticancer	S. pneumoniae	HL-60	Leukemia Cancer	MTT/MTS assay	IC₅₀= 20 µM	22.5-Min	Blood	None
3079	16004618	2005	MWKWFHNVLSSWQLLADKRPARDYNRK	Pep27anal1	27	Linear	L	None	Free	Free	Anticancer	S. pneumoniae	HL-60	Leukemia Cancer	MTT/MTS assay	IC₅₀= 53 µM	18.67-Min	Blood	None
3078	16004618	2005	MRKEFHNVLSSGQLLADKRPARDYNRK	Pep27	27	Linear	L	None	Free	Free	Anticancer	S. pneumoniae	HL-60	Leukemia Cancer	MTT/MTS assay	IC₅₀= >70 µM	14.54-Min	Blood	None
3077	16004618	2005	MWKWFHNVLSSGQLLADKWWAWWYNWW	Pep27anal5	27	Linear	L	None	Free	Free	Anticancer	S. pneumoniae	AML-2	Leukemia Cancer	MTT/MTS assay	IC₅₀= >70 µM	19.17-Min	Blood	None
3076	16004618	2005	MWKEFHNVLSSGQLLADKRWARWYNRW	Pep27anal4	27	Linear	L	None	Free	Free	Anticancer	S. pneumoniae	AML-2	Leukemia Cancer	MTT/MTS assay	IC₅₀= 50 µM	19.15-Min	Blood	None
3075	16004618	2005	MRKWFHNVLSSGQLLADKWPAWDYNRK	Pep27anal3	27	Linear	L	None	Free	Free	Anticancer	S. pneumoniae	AML-2	Leukemia Cancer	MTT/MTS assay	IC₅₀= 67 µM	20.08-Min	Blood	None
3074	16004618	2005	MWKWFHNVLSWWWLLADKRPARDYNRK	Pep27anal2	27	Linear	L	None	Free	Free	Anticancer	S. pneumoniae	AML-2	Leukemia Cancer	MTT/MTS assay	IC₅₀= 29 µM	22.5-Min	Blood	None
3073	16004618	2005	MWKWFHNVLSSWQLLADKRPARDYNRK	Pep27anal1	27	Linear	L	None	Free	Free	Anticancer	S. pneumoniae	AML-2	Leukemia Cancer	MTT/MTS assay	IC₅₀= 50 µM	18.67-Min	Blood	None
3072	16004618	2005	MRKEFHNVLSSGQLLADKRPARDYNRK	Pep27	27	Linear	L	None	Free	Free	Anticancer	S. pneumoniae	AML-2	Leukemia Cancer	MTT/MTS assay	Not Available	14.54-Min	Blood	None
2845	15634655	2004	ERRP	EGFR-related peptide	4	Linear	L	None	Free	Free	Anticancer	EGFR-related peptide	PC-3	Prostate Cancer	MTT/MTS assay	30% Cell viability at 5 µg/ml	48-h	Prostate	None
2809	None	2005	FAKKLAKKLKKLAKKLAKLAKKL	Anubis-2	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =100 µg/ml	24-h	Cervix	US_06875744_B2
2807	None	2005	FKVKFKVKVK	KSL-7	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Cervix	US_06875744_B2
2808	None	2005	LPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG	LSB-37	38	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =250 µg/ml	24-h	Cervix	US_06875744_B2
2806	None	2005	KKVVFKVKFK	KSL-1	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ = >1000 µg/ml	24-h	Cervix	US_06875744_B2
2805	None	2005	FAKKFAKKFKKFAKKFAKFAFAF	D2A21	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =170 µg/ml	24-h	Cervix	US_06875744_B2
2804	None	2005	GIGKFLHAAKKFAKAFVAEIMNS	Magainin2wisc	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =125 µg/ml	24-h	Cervix	US_06875744_B2
2802	None	2005	FALA	FLAK-120B	4	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ = >1000 µg/ml	24-h	Cervix	US_06875744_B2
2803	None	2005	WALAL	FLAK-120F	5	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =302 µg/ml	24-h	Cervix	US_06875744_B2
2801	None	2005	FALALKAKKL	FLAK-120C	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ = >1000 µg/ml	24-h	Cervix	US_06875744_B2
2800	None	2005	FALALKLKKL	FLAK-120D	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ = >1000 µg/ml	24-h	Cervix	US_06875744_B2
2798	None	2005	LKKLAKLALAF	Flak 96L	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ = >1000 µg/ml	24-h	Cervix	US_06875744_B2
2799	None	2005	VALALKALKKL	FLAK-120G	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =760 µg/ml	24-h	Cervix	US_06875744_B2
2796	None	2005	FALLKALLKKAL	Flak 96I	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =380 µg/ml	24-h	Cervix	US_06875744_B2
2797	None	2005	FALALKLAKKL	Flak 96J	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ = >1000 µg/ml	24-h	Cervix	US_06875744_B2
2787	None	2005	FALAKALKKAL	FLAK121	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Cervix	US_06875744_B2
2788	None	2005	FALALKLAKKAL	FLAK96B	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =325 µg/ml	24-h	Cervix	US_06875744_B2
2789	None	2005	FALLKL	FLAK96G	6	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ = >1000 µg/ml	24-h	Cervix	US_06875744_B2
2790	None	2005	FALALKALKK	FLAK96F	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ = >1000 µg/ml	24-h	Cervix	US_06875744_B2
2791	None	2005	FALKALKKAL	FLAK96C	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ = >1000 µg/ml	24-h	Cervix	US_06875744_B2
2792	None	2005	FALLKALKKAL	FLAK96D	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =820 µg/ml	24-h	Cervix	US_06875744_B2
2793	None	2005	KFKKLAKKF	Modelin-8D	9	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ = >1000 µg/ml	24-h	Cervix	US_06875744_B2
2794	None	2005	KFKKLAKKW	Modelin-8E	9	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =510 µg/ml	24-h	Cervix	US_06875744_B2
2795	None	2005	FALALKALKKA	Flak 96H	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ = >1000 µg/ml	24-h	Cervix	US_06875744_B2
2780	None	2005	VAKLLAKLAKKVL	FLAK50T8	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ = >1000 µg/ml	24-h	Cervix	US_06875744_B2
2781	None	2005	YAKLLAKLAKKAL	FLAK50T9	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ = >1000 µg/ml	24-h	Cervix	US_06875744_B2
2782	None	2005	KLLKLLLKLYKKLLKLL	FLAK100-CO2H	17	Linear	L	None	Free	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ = >1000 µg/ml	24-h	Cervix	US_06875744_B2
2783	None	2005	FAVGLRAIKRALKKLRRGVRKVAKDL	FAGVL	26	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ = >1000 µg/ml	24-h	Cervix	US_06875744_B2
2784	None	2005	KLAKKLAKLAKLAKAL	Modelin-5	16	Linear	L	None	Free	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =275 µg/ml	24-h	Cervix	US_06875744_B2
2785	None	2005	KLAKKLAKLAKLAKAL	Modelin-5-CO2H	16	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =550 µg/ml	24-h	Cervix	US_06875744_B2
2786	None	2005	FALALKALKKL	FLAK120	9	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =400 µg/ml	24-h	Cervix	US_06875744_B2
2773	None	2005	FKRLAKIKVLRLAKIKR	FKRLA	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ = >1000 µg/ml	24-h	Cervix	US_06875744_B2
2774	None	2005	FAKLAKKALAKLL	FLAK91B	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ = >1000 µg/ml	24-h	Cervix	US_06875744_B2
2775	None	2005	KAKLAKKALAKLL	FLAK92B	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ = >1000 µg/ml	24-h	Cervix	US_06875744_B2
2776	None	2005	KLALKLALKALKAAKLA	FLAK99	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =320 µg/ml	24-h	Cervix	US_06875744_B2
2777	None	2005	FAKLLAKLAKK	FLAK50T6	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Cervix	US_06875744_B2
2778	None	2005	FAKLLAKLAKKGL	FLAK50T7	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Cervix	US_06875744_B2
2779	None	2005	FALKALKKLKKALKKAL	FLAK95	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =140 µg/ml	24-h	Cervix	US_06875744_B2
2765	None	2005	FAKIIAKIAKIAKKIL	FLAK50 Z8	16	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ = >1000 µg/ml	24-h	Cervix	US_06875744_B2
2766	None	2005	FAFAKIIAKIAKKII	FLAK50 Z9	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =285 µg/ml	24-h	Cervix	US_06875744_B2
2767	None	2005	FALALKA	FLAK94	7	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ = >1000 µg/ml	24-h	Cervix	US_06875744_B2
2768	None	2005	KWKLAKKALALL	FLAK93B	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =55 µg/ml	24-h	Cervix	US_06875744_B2
2769	None	2005	FAKIIAKIAKKI	FLAK50 Z10	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Cervix	US_06875744_B2
2770	None	2005	FALALKALKKAL	FLAK96	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =275 µg/ml	24-h	Cervix	US_06875744_B2
2771	None	2005	FALKALKK	FLAK97	8	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =240 µg/ml	24-h	Cervix	US_06875744_B2
2772	None	2005	KYKKALKKLAKLL	FLAK98	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =640 µg/ml	24-h	Cervix	US_06875744_B2
2762	None	2005	FAKLWAKLAKKL	FLAK50 Z5	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =400 µg/ml	24-h	Cervix	US_06875744_B2
2763	None	2005	FAKGVGKVGKKAL	FLAK50 Z6	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ = >1000 µg/ml	24-h	Cervix	US_06875744_B2
2764	None	2005	FAFGKGIGKIGKKGL	FLAK50 Z7	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ = >1000 µg/ml	24-h	Cervix	US_06875744_B2
2761	None	2005	FAKLWAKLAFGKGIGKVGKKLL	FLAK50 Z4	22	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =215 µg/ml	24-h	Cervix	US_06875744_B2
2760	None	2005	FAKAIAKIAFGKGIGKVGKKLL	FLAK50 Z3	22	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ = >1000 µg/ml	24-h	Cervix	US_06875744_B2
2759	None	2005	FAFGKGIGKVGKKLL	FLAK50 Z2	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ = >1000 µg/ml	24-h	Cervix	US_06875744_B2
2756	None	2005	KAKLF	FLAK92	5	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ = >1000 µg/ml	24-h	Cervix	US_06875744_B2
2757	None	2005	KWKLF	FLAK93	5	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ = >1000 µg/ml	24-h	Cervix	US_06875744_B2
2758	None	2005	FGKGIGKVGKKLL	FLAK50 Z1	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ = >1000 µg/ml	24-h	Cervix	US_06875744_B2
2754	None	2005	FAKLA	FLAK90	5	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =700 µg/ml	24-h	Cervix	US_06875744_B2
2755	None	2005	FAKLF	FLAK91	5	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =550 µg/ml	24-h	Cervix	US_06875744_B2
2751	None	2005	FAKLLAKLAKKIL	FLAK50 T3	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =220 µg/ml	24-h	Cervix	US_06875744_B2
2752	None	2005	FAKLLAKLAKKEL	FLAK50 T4	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ = >1000 µg/ml	24-h	Cervix	US_06875744_B2
2753	None	2005	FAKLLAKLAKKSL	FLAK50 T5	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =610 µg/ml	24-h	Cervix	US_06875744_B2
2749	None	2005	FAKLLAKLAK	FLAK50 T1	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =940 µg/ml	24-h	Cervix	US_06875744_B2
2750	None	2005	FAKLLAKLAKKVL	FLAK50 T2	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =14 µg/ml	24-h	Cervix	US_06875744_B2
2747	None	2005	FAKLFAKLAKKFAL	FLAK50 Q9	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =830 µg/ml	24-h	Cervix	US_06875744_B2
2748	None	2005	FKLAFKLAKKAFL	FLAK50 Q10	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =780 µg/ml	24-h	Cervix	US_06875744_B2
2746	None	2005	FAKLLAKLAKKFAL	FLAK50 Q8	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =810 µg/ml	24-h	Cervix	US_06875744_B2
2745	None	2005	FAKLLAKALKKFAL	FLAK50 Q7	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =30 µg/ml	24-h	Cervix	US_06875744_B2
2743	None	2005	FAKLFAKAFKKAL	FLAK50 Q5	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ = >1000 µg/ml	24-h	Cervix	US_06875744_B2
2744	None	2005	FAKLLAKALKKFL	FLAK50 Q6	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =87 µg/ml	24-h	Cervix	US_06875744_B2
2742	None	2005	FAKLLAKAFKKAL	FLAK50 Q4	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ = >1000 µg/ml	24-h	Cervix	US_06875744_B2
2740	None	2005	FAKLLFKALKKAL	FLAK50 Q2	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =660 µg/ml	24-h	Cervix	US_06875744_B2
2741	None	2005	FAKLLAKFLKKAL	FLAK50 Q3	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =190 µg/ml	24-h	Cervix	US_06875744_B2
2738	None	2005	FAKKLLAKALKL	FLAG26-D3	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =540 µg/ml	24-h	Cervix	US_06875744_B2
2739	None	2005	FAKFLAKFLKKAL	FLAK50 Q1	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =7 µg/ml	24-h	Cervix	US_06875744_B2
2737	None	2005	FAKKLAKLAKKLAKAL	FLAK26-D2	16	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Cervix	US_06875744_B2
2736	None	2005	GIGAVLKVLTTGLPALISWIKRKRQQ	MELITTIIN	26	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =35 µg/ml	24-h	Cervix	US_06875744_B2
2734	None	2005	FAKKLAKLAKKL	FLAG26-D1	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =700 µg/ml	24-h	Cervix	US_06875744_B2
2735	None	2005	MPKEKVFLKIEKMGRNIRN	VISHNU3	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ = >1000 µg/ml	24-h	Cervix	US_06875744_B2
2732	None	2005	KWKLFKKALKKLKKALKKAL	CA(1-& HECATE(11/23)	20	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =130 µg/ml	24-h	Cervix	US_06875744_B2
2733	None	2005	KIAKVALAKLGIGAVLKVLTTGL	PYL-ME	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ = >1000 µg/ml	24-h	Cervix	US_06875744_B2
2731	None	2005	FAKLLAKALKKL	FLAK 50P	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =70 µg/ml	24-h	Cervix	US_06875744_B2
2730	None	2005	FAKLLAKALKKAL	FLAK 50O	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =43 µg/ml	24-h	Cervix	US_06875744_B2
2729	None	2005	FAKLLAKALKLKL	FLAK 50N	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =170 µg/ml	24-h	Cervix	US_06875744_B2
2728	None	2005	FAKKLAKKLKKLAKKLIGAVLKV	SHIVA 11[(1-16)ME(2-9]-COOH	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =180 µg/ml	24-h	Cervix	US_06875744_B2
2727	None	2005	FAKKLAKKLKKLAKKLAKLALALKALALKAL	Shiva-11	31	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =175 µg/ml	24-h	Cervix	US_06875744_B2
2726	None	2005	FAKLLAKLAKAKG	FLAK50L	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ = >1000 µg/ml	24-h	Cervix	US_06875744_B2
2725	None	2005	FAKLLAKLAKAKA	FLAK50K	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ = >1000 µg/ml	24-h	Cervix	US_06875744_B2
2724	None	2005	FAKLLALALKLKL	FLAK50I	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ = >1000 µg/ml	24-h	Cervix	US_06875744_B2
2723	None	2005	FAKLLAKLAKKAA	FLAK50J	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ = >1000 µg/ml	24-h	Cervix	US_06875744_B2
2722	None	2005	FAKALAKLAKKLL	FLAK50B	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =670 µg/ml	24-h	Cervix	US_06875744_B2
2721	None	2005	ILPWKWPWWPWRR	Indolocidin-ac	13	Linear	L	None	Free	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =20 µg/ml	24-h	Cervix	US_06875744_B2
2720	None	2005	KWKLFKKKTKLFKKFAKKLAKKL	CA(1-7) Shiva10(1-16)-COOH	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =19 µg/ml	24-h	Cervix	US_06875744_B2
2719	None	2005	KTKLFKKFAKKLAKKLKKLAKKL	SHIVA 10 (1-16) Ac	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =97 µg/ml	24-h	Cervix	US_06875744_B2
2718	None	2005	FAKKLKKLAKKL	FLAK 75	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Cervix	US_06875744_B2
2717	None	2005	FAKKLAKKAKLAKKL	FLAK 72	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Cervix	US_06875744_B2
2716	None	2005	FAKKLAKKLAKAAL	FLAK 58	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =380 µg/ml	24-h	Cervix	US_06875744_B2
2715	None	2005	FAKKLAKKLAKLL	FLAK 56	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =74 µg/ml	24-h	Cervix	US_06875744_B2
2714	None	2005	FAKKLAKKLAKAL	FLAK 54	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =260 µg/ml	24-h	Cervix	US_06875744_B2
2713	None	2005	KWKLFKKKTKLFKKFAKKLAKKL	CA(1-7) Shiva10(1-16)	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =270 µg/ml	24-h	Cervix	US_06875744_B2
2712	None	2005	FAKKLAKKLKKLAKKLAKKWKL	SHIVA 10 PEPTIDE 71 + KWKL	22	Linear	L	None	Free	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =240 µg/ml	24-h	Cervix	US_06875744_B2
2711	None	2005	FAKKLAKKLKKLAKKLAK	Shiva 10(1-18 AC)	18	Linear	L	None	Free	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =570 µg/ml	24-h	Cervix	US_06875744_B2
2710	None	2005	FAKKLAKKLKKLAKKLAKKWKL	SHIVA DERIV P69 + KWKL	22	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =28 µg/ml	24-h	Cervix	US_06875744_B2
2708	None	2005	FAKLLAKLAKAKL	FLAK 50H	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =210 µg/ml	24-h	Cervix	US_06875744_B2
2709	None	2005	FAKLLAKLAKLKL	FLAK 50G	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =140 µg/ml	24-h	Cervix	US_06875744_B2
2707	None	2005	FAKALKALLKALKAL	FLAK 17 C	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =30 µg/ml	24-h	Cervix	US_06875744_B2
2706	None	2005	ILPWKWPWWPWRR	Indolicidin	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =345 µg/ml	24-h	Cervix	US_06875744_B2
2704	None	2005	FAKLAKKLL	FLAK83M	9	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Cervix	US_06875744_B2
2705	None	2005	FAKKLAKLAKKLAKLAL	FLAK 26 Ac	17	Linear	L	None	Free	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =170 µg/ml	24-h	Cervix	US_06875744_B2
2702	None	2005	FAKKLAKALL	FLAK81	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Cervix	US_06875744_B2
2703	None	2005	FAKKLAKKLL	FLAK82	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	Not Available	24-h	Cervix	US_06875744_B2
2700	None	2005	FAKLLKLAAKKLL	FLAK 50E	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =300 µg/ml	24-h	Cervix	US_06875744_B2
2701	None	2005	FAKLLAKKLL	FLAK80	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =830 µg/ml	24-h	Cervix	US_06875744_B2
2699	None	2005	FAKLLAKALKKLL	FLAK50D	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =15 µg/ml	24-h	Cervix	US_06875744_B2
2697	None	2005	KWKLFKKIGAVLKVL	CAME-15	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =30 µg/ml	24-h	Cervix	US_06875744_B2
2698	None	2005	FAKLLAKLAKKAL	FLAK50C	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =190 µg/ml	24-h	Cervix	US_06875744_B2
2696	None	2005	VAKKLAKLAKKLAKLAL	FLAK26V AM	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =33 µg/ml	24-h	Cervix	US_06875744_B2
2695	None	2005	FAKLLAKLAKKL	FLAK50F	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	Not Available	24-h	Cervix	US_06875744_B2
2693	None	2005	FAKKALKALKKL	FLAK77	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Cervix	US_06875744_B2
2694	None	2005	VAKLLAKLAKKLL	FLAK50V	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =44 µg/ml	24-h	Cervix	US_06875744_B2
2692	None	2005	FAKKLKKLAKLAKKL	FLAK71	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =280 µg/ml	24-h	Cervix	US_06875744_B2
2691	None	2005	FAKKLAKKLAKLAL	FLAK57	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =160 µg/ml	24-h	Cervix	US_06875744_B2
2690	None	2005	FAKKLAKLALKLAKL	FLAK51	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =22 µg/ml	24-h	Cervix	US_06875744_B2
2689	None	2005	FAKLLAKLAKKLL	FLAK50	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =15 µg/ml	24-h	Cervix	US_06875744_B2
2688	None	2005	GIGKFLKKAKKFGKAFVKILKK	MSI-78 AM	22	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	Not Available	24-h	Cervix	US_06875744_B2
2687	None	2005	FAKKLAKKLKKLAKLALAK	FLAK 06R-AM	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =185 µg/ml	24-h	Cervix	US_06875744_B2
2685	None	2005	FAKKLAKLAKKALAL	FLAK44 AM	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =620 µg/ml	24-h	Cervix	US_06875744_B2
2686	None	2005	FALAKKALKKAKKAL	FLAK62 AM	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Cervix	US_06875744_B2
2684	None	2005	FAKKLAKLAKKLLAL	FLAK43 AM	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =35 µg/ml	24-h	Cervix	US_06875744_B2
2683	None	2005	FALALKALKKALkkLKKALKKAL	HECATE 2DAc	23	Linear	Mix	None	Free	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	Not Available	24-h	Cervix	US_06875744_B2
2682	None	2005	FAKKLAKLAKKLAKLALAL	FLAK 25 AM	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	Not Available	24-h	Cervix	US_06875744_B2
2681	None	2005	FAKKLAKLAKKLAKLAL	FLAK 26 AM	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =27 µg/ml	24-h	Cervix	US_06875744_B2
2680	None	2005	FALALKKALKALKKAL	FLAK 17 AM	16	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =62 µg/ml	24-h	Cervix	US_06875744_B2
2679	None	2005	VALALKALKKALKKLKKALKKAL	KAL V	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =190 µg/ml	24-h	Cervix	US_06875744_B2
2678	None	2005	FAKKLAKKLKKLAKLALAL	FLAK06 R-AC	19	Linear	L	None	Free	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =260 µg/ml	24-h	Cervix	US_06875744_B2
2676	None	2005	FALALKALKKLKKALKKAL	FLAK06 AM	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =25 µg/ml	24-h	Cervix	US_06875744_B2
2677	None	2005	FALALKALKKLKKALKKAL	FLAK06 AC	19	Linear	L	None	Free	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =80 µg/ml	24-h	Cervix	US_06875744_B2
2675	None	2005	FALAKLAKKAKAKLKKALKAL	FLAK05 AM	21	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =150 µg/ml	24-h	Cervix	US_06875744_B2
2674	None	2005	FALALKALKKLAKKLKKLAKKAL	FLAK04 AM	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =20 µg/ml	24-h	Cervix	US_06875744_B2
2673	None	2005	FALALKALKKLLKKLKKLAKKAL	FLAK03 AM	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =145 µg/ml	24-h	Cervix	US_06875744_B2
2672	None	2005	FALAAKALKKLAKKLKKLAKKAL	FLAK01 AM	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =82 µg/ml	24-h	Cervix	US_06875744_B2
2671	None	2005	FAKKLAKKLKKLAKKLAKLALAL	SHIVA 10 AC	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Cervix	US_06875744_B2
2670	None	2005	MPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG	SB-37 AM	38	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Cervix	US_06875744_B2
2669	None	2005	MPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG	SB-37 AC	38	Linear	L	None	Free	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =150 µg/ml	24-h	Cervix	US_06875744_B2
2668	None	2005	FALALKALKKALKKLKKALKKAL	Hecate AM	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =50 µg/ml	24-h	Cervix	US_06875744_B2
2667	None	2005	FALALKALKKALKKLKKALKKAL	Hecate AC	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =95 µg/ml	24-h	Cervix	US_06875744_B2
2666	None	2005	FAKKLAKKLKKLAKKLAKLAKKL	Anubis-2	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =66 µg/ml	24-h	Prostate	US_06875744_B2
2665	None	2005	LPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG	LSB-37	38	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =370 µg/ml	24-h	Prostate	US_06875744_B2
2663	None	2005	KKVVFKVKFK	KSL-1	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2664	None	2005	FKVKFKVKVK	KSL-7	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =530 µg/ml	24-h	Prostate	US_06875744_B2
2662	None	2005	FAKKFAKKFKKFAKKFAKFAFAF	D2A21	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =45 µg/ml	24-h	Prostate	US_06875744_B2
2661	None	2005	GIGKFLHAAKKFAKAFVAEIMNS	Magainin2wisc	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =45 µg/ml	24-h	Prostate	US_06875744_B2
2660	None	2005	WALAL	FLAK-120F	5	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =570 µg/ml	24-h	Prostate	US_06875744_B2
2659	None	2005	FALA	FLAK-120B	4	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2658	None	2005	FALALKAKKL	FLAK-120C	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2657	None	2005	FALALKLKKL	FLAK-120D	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2656	None	2005	VALALKALKKL	FLAK-120G	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2655	None	2005	LKKLAKLALAF	Flak 96L	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2654	None	2005	FALALKLAKKL	Flak 96J	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2653	None	2005	FALLKALLKKAL	Flak 96I	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =120 µg/ml	24-h	Prostate	US_06875744_B2
2652	None	2005	FALALKALKKA	Flak 96H	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2651	None	2005	KFKKLAKKW	Modelin-8E	9	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2650	None	2005	KFKKLAKKF	Modelin-8D	9	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2649	None	2005	FALLKALKKAL	FLAK96D	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =600 µg/ml	24-h	Prostate	US_06875744_B2
2648	None	2005	FALKALKKAL	FLAK96C	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2647	None	2005	FALALKALKK	FLAK96F	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2646	None	2005	FALLKL	FLAK96G	6	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2645	None	2005	FALALKLAKKAL	FLAK96B	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =320 µg/ml	24-h	Prostate	US_06875744_B2
2643	None	2005	FALALKALKKL	FLAK120	9	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =340 µg/ml	24-h	Prostate	US_06875744_B2
2644	None	2005	FALAKALKKAL	FLAK121	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2642	None	2005	KLAKKLAKLAKLAKAL	Modelin-5-CO2H	16	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =450 µg/ml	24-h	Prostate	US_06875744_B2
2641	None	2005	KLAKKLAKLAKLAKAL	Modelin-5	16	Linear	L	None	Free	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =145 µg/ml	24-h	Prostate	US_06875744_B2
2640	None	2005	FAVGLRAIKRALKKLRRGVRKVAKDL	FAGVL	26	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =375 µg/ml	24-h	Prostate	US_06875744_B2
2639	None	2005	KLLKLLLKLYKKLLKLL	FLAK100-CO2H	17	Linear	L	None	Free	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =260 µg/ml	24-h	Prostate	US_06875744_B2
2638	None	2005	YAKLLAKLAKKAL	FLAK50T9	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	Not Available	24-h	Prostate	US_06875744_B2
2637	None	2005	VAKLLAKLAKKVL	FLAK50T8	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =640 µg/ml	24-h	Prostate	US_06875744_B2
2636	None	2005	FALKALKKLKKALKKAL	FLAK95	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =97 µg/ml	24-h	Prostate	US_06875744_B2
2635	None	2005	FAKLLAKLAKKGL	FLAK50T7	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2634	None	2005	FAKLLAKLAKK	FLAK50T6	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2633	None	2005	KLALKLALKALKAAKLA	FLAK99	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =74 µg/ml	24-h	Prostate	US_06875744_B2
2631	None	2005	FAKLAKKALAKLL	FLAK91B	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2632	None	2005	KAKLAKKALAKLL	FLAK92B	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2630	None	2005	FKRLAKIKVLRLAKIKR	FKRLA	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =340 µg/ml	24-h	Prostate	US_06875744_B2
2628	None	2005	FALKALKK	FLAK97	8	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2629	None	2005	KYKKALKKLAKLL	FLAK98	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =440 µg/ml	24-h	Prostate	US_06875744_B2
2626	None	2005	FAKIIAKIAKKI	FLAK50 Z10	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2627	None	2005	FALALKALKKAL	FLAK96	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =350 µg/ml	24-h	Prostate	US_06875744_B2
2624	None	2005	FALALKA	FLAK94	7	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	Not Available	24-h	Prostate	US_06875744_B2
2625	None	2005	KWKLAKKALALL	FLAK93B	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =60 µg/ml	24-h	Prostate	US_06875744_B2
2623	None	2005	FAFAKIIAKIAKKII	FLAK50 Z9	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2622	None	2005	FAKIIAKIAKIAKKIL	FLAK50 Z8	16	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2620	None	2005	FAKGVGKVGKKAL	FLAK50 Z6	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2621	None	2005	FAFGKGIGKIGKKGL	FLAK50 Z7	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2619	None	2005	FAKLWAKLAKKL	FLAK50 Z5	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =900 µg/ml	24-h	Prostate	US_06875744_B2
2618	None	2005	FAKLWAKLAFGKGIGKVGKKLL	FLAK50 Z4	22	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =310 µg/ml	24-h	Prostate	US_06875744_B2
2617	None	2005	FAKAIAKIAFGKGIGKVGKKLL	FLAK50 Z3	22	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2616	None	2005	FAFGKGIGKVGKKLL	FLAK50 Z2	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2614	None	2005	KWKLF	FLAK93	5	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2615	None	2005	FGKGIGKVGKKLL	FLAK50 Z1	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2612	None	2005	FAKLF	FLAK91	5	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2613	None	2005	KAKLF	FLAK92	5	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2611	None	2005	FAKLA	FLAK90	5	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2609	None	2005	FAKLLAKLAKKEL	FLAK50 T4	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2610	None	2005	FAKLLAKLAKKSL	FLAK50 T5	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2608	None	2005	FAKLLAKLAKKIL	FLAK50 T3	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =145 µg/ml	24-h	Prostate	US_06875744_B2
2607	None	2005	FAKLLAKLAKKVL	FLAK50 T2	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =10 µg/ml	24-h	Prostate	US_06875744_B2
2605	None	2005	FKLAFKLAKKAFL	FLAK50 Q10	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =800 µg/ml	24-h	Prostate	US_06875744_B2
2606	None	2005	FAKLLAKLAK	FLAK50 T1	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2604	None	2005	FAKLFAKLAKKFAL	FLAK50 Q9	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2603	None	2005	FAKLLAKLAKKFAL	FLAK50 Q8	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2602	None	2005	FAKLLAKALKKFAL	FLAK50 Q7	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =140 µg/ml	24-h	Prostate	US_06875744_B2
2601	None	2005	FAKLLAKALKKFL	FLAK50 Q6	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =330 µg/ml	24-h	Prostate	US_06875744_B2
2599	None	2005	FAKLLAKAFKKAL	FLAK50 Q4	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2600	None	2005	FAKLFAKAFKKAL	FLAK50 Q5	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2598	None	2005	FAKLLAKFLKKAL	FLAK50 Q3	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =240 µg/ml	24-h	Prostate	US_06875744_B2
2597	None	2005	FAKLLFKALKKAL	FLAK50 Q2	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =640 µg/ml	24-h	Prostate	US_06875744_B2
2596	None	2005	FAKFLAKFLKKAL	FLAK50 Q1	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =11 µg/ml	24-h	Prostate	US_06875744_B2
2594	None	2005	FAKKLAKLAKKLAKAL	FLAK26-D2	16	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2595	None	2005	FAKKLLAKALKL	FLAG26-D3	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2593	None	2005	GIGAVLKVLTTGLPALISWIKRKRQQ	MELITTIIN	26	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =13 µg/ml	24-h	Prostate	US_06875744_B2
2592	None	2005	MPKEKVFLKIEKMGRNIRN	VISHNU3	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2591	None	2005	FAKKLAKLAKKL	FLAG26-D1	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2590	None	2005	KIAKVALAKLGIGAVLKVLTTGL	PYL-ME	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	Not Available	24-h	Prostate	US_06875744_B2
2588	None	2005	FAKLLAKALKKL	FLAK 50P	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =330 µg/ml	24-h	Prostate	US_06875744_B2
2589	None	2005	KWKLFKKALKKLKKALKKAL	CA(1-& HECATE(11/23)	20	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =18 µg/ml	24-h	Prostate	US_06875744_B2
2587	None	2005	FAKLLAKALKKAL	FLAK 50O	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =66 µg/ml	24-h	Prostate	US_06875744_B2
2586	None	2005	FAKLLAKALKLKL	FLAK 50N	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =730 µg/ml	24-h	Prostate	US_06875744_B2
2585	None	2005	FAKKLAKKLKKLAKKLIGAVLKV	SHIVA 11[(1-16)ME(2-9]-COOH	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =28 µg/ml	24-h	Prostate	US_06875744_B2
2583	None	2005	FAKLLAKLAKAKG	FLAK50L	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2584	None	2005	FAKKLAKKLKKLAKKLAKLALALKALALKAL	Shiva-11	31	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =52 µg/ml	24-h	Prostate	US_06875744_B2
2582	None	2005	FAKLLAKLAKAKA	FLAK50K	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2581	None	2005	FAKLLALALKLKL	FLAK50I	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	Not Available	24-h	Prostate	US_06875744_B2
2579	None	2005	FAKALAKLAKKLL	FLAK50B	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =83 µg/ml	24-h	Prostate	US_06875744_B2
2580	None	2005	FAKLLAKLAKKAA	FLAK50J	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =690 µg/ml	24-h	Prostate	US_06875744_B2
2578	None	2005	ILPWKWPWWPWRR	Indolocidin-ac	13	Linear	L	None	Free	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =31 µg/ml	24-h	Prostate	US_06875744_B2
2577	None	2005	KWKLFKKKTKLFKKFAKKLAKKL	CA(1-7) Shiva10(1-16)-COOH	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =170 µg/ml	24-h	Prostate	US_06875744_B2
2575	None	2005	FAKKLKKLAKKL	FLAK 75	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2576	None	2005	KTKLFKKFAKKLAKKLKKLAKKL	SHIVA 10 (1-16) Ac	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =28 µg/ml	24-h	Prostate	US_06875744_B2
2574	None	2005	FAKKLAKKAKLAKKL	FLAK 72	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2573	None	2005	FAKKLAKKLAKAAL	FLAK 58	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =675 µg/ml	24-h	Prostate	US_06875744_B2
2572	None	2005	FAKKLAKKLAKLL	FLAK 56	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =54 µg/ml	24-h	Prostate	US_06875744_B2
2571	None	2005	FAKKLAKKLAKAL	FLAK 54	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =660 µg/ml	24-h	Prostate	US_06875744_B2
2570	None	2005	KWKLFKKKTKLFKKFAKKLAKKL	CA(1-7)Shiva10(1-16)	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =97 µg/ml	24-h	Prostate	US_06875744_B2
2569	None	2005	FAKKLAKKLKKLAKKLAKKWKL	SHIVA 10 PEPTIDE 71 + KWKL	22	Linear	L	None	Free	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =63 µg/ml	24-h	Prostate	US_06875744_B2
2568	None	2005	FAKKLAKKLKKLAKKLAK	Shiva 10(1-18 AC)	18	Linear	L	None	Free	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =270 µg/ml	24-h	Prostate	US_06875744_B2
2567	None	2005	FAKKLAKKLKKLAKKLAKKWKL	SHIVA DERIV P69 + KWKL	22	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =82 µg/ml	24-h	Prostate	US_06875744_B2
2565	None	2005	FAKLLAKLAKAKL	FLAK 50H	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =470 µg/ml	24-h	Prostate	US_06875744_B2
2566	None	2005	FAKLLAKLAKLKL	FLAK 50G	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =170 µg/ml	24-h	Prostate	US_06875744_B2
2564	None	2005	FAKALKALLKALKAL	FLAK 17 C	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =46 µg/ml	24-h	Prostate	US_06875744_B2
2563	None	2005	ILPWKWPWWPWRR	Indolicidin	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =290 µg/ml	24-h	Prostate	US_06875744_B2
2562	None	2005	FAKKLAKLAKKLAKLAL	FLAK 26 Ac	17	Linear	L	None	Free	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =66 µg/ml	24-h	Prostate	US_06875744_B2
2560	None	2005	FAKKLAKKLL	FLAK82	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =81 µg/ml	24-h	Prostate	US_06875744_B2
2561	None	2005	FAKLAKKLL	FLAK83M	9	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2558	None	2005	FAKLLAKKLL	FLAK80	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2559	None	2005	FAKKLAKALL	FLAK81	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2556	None	2005	FAKLLAKALKKLL	FLAK50D	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =47 µg/ml	24-h	Prostate	US_06875744_B2
2557	None	2005	FAKLLKLAAKKLL	FLAK 50E	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =435 µg/ml	24-h	Prostate	US_06875744_B2
2555	None	2005	FAKLLAKLAKKAL	FLAK50C	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =90 µg/ml	24-h	Prostate	US_06875744_B2
2554	None	2005	KWKLFKKIGAVLKVL	CAME-15	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =40 µg/ml	24-h	Prostate	US_06875744_B2
2553	None	2005	VAKKLAKLAKKLAKLAL	FLAK26V AM	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =54 µg/ml	24-h	Prostate	US_06875744_B2
2552	None	2005	FAKLLAKLAKKL	FLAK50F	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =77 µg/ml	24-h	Prostate	US_06875744_B2
2551	None	2005	VAKLLAKLAKKLL	FLAK50V	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =32 µg/ml	24-h	Prostate	US_06875744_B2
2550	None	2005	FAKKALKALKKL	FLAK77	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2549	None	2005	FAKKLKKLAKLAKKL	FLAK71	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =280 µg/ml	24-h	Prostate	US_06875744_B2
2548	None	2005	FAKKLAKKLAKLAL	FLAK57	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =170 µg/ml	24-h	Prostate	US_06875744_B2
2547	None	2005	FAKKLAKLALKLAKL	FLAK51	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =45 µg/ml	24-h	Prostate	US_06875744_B2
2546	None	2005	FAKLLAKLAKKLL	FLAK50	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =12 µg/ml	24-h	Prostate	US_06875744_B2
2545	None	2005	GIGKFLKKAKKFGKAFVKILKK	MSI-78 AM	22	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =66 µg/ml	24-h	Prostate	US_06875744_B2
2543	None	2005	FALAKKALKKAKKAL	FLAK62 AM	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =435 µg/ml	24-h	Prostate	US_06875744_B2
2544	None	2005	FAKKLAKKLKKLAKLALAK	FLAK 06R-AM	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =140 µg/ml	24-h	Prostate	US_06875744_B2
2542	None	2005	FAKKLAKLAKKALAL	FLAK44 AM	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =310 µg/ml	24-h	Prostate	US_06875744_B2
2541	None	2005	FAKKLAKLAKKLLAL	FLAK43 AM	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =10 µg/ml	24-h	Prostate	US_06875744_B2
2540	None	2005	FALALKALKKALkkLKKALKKAL	HECATE 2DAc	23	Linear	Mix	None	Free	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =64 µg/ml	24-h	Prostate	US_06875744_B2
2539	None	2005	FAKKLAKLAKKLAKLALAL	FLAK 25 AM	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =19 µg/ml	24-h	Prostate	US_06875744_B2
2538	None	2005	FAKKLAKLAKKLAKLAL	FLAK 26 AM	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =5 µg/ml	24-h	Prostate	US_06875744_B2
2537	None	2005	FALALKKALKALKKAL	FLAK 17 AM	16	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =9 µg/ml	24-h	Prostate	US_06875744_B2
2536	None	2005	VALALKALKKALKKLKKALKKAL	KAL V	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =65 µg/ml	24-h	Prostate	US_06875744_B2
2535	None	2005	FAKKLAKKLKKLAKLALAL	FLAK06 R-AC	19	Linear	L	None	Free	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =280 µg/ml	24-h	Prostate	US_06875744_B2
2534	None	2005	FALALKALKKLKKALKKAL	FLAK06 AC	19	Linear	L	None	Free	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =16 µg/ml	24-h	Prostate	US_06875744_B2
2533	None	2005	FALALKALKKLKKALKKAL	FLAK06 AM	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =8 µg/ml	24-h	Prostate	US_06875744_B2
2532	None	2005	FALAKLAKKAKAKLKKALKAL	FLAK05 AM	21	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =125 µg/ml	24-h	Prostate	US_06875744_B2
2531	None	2005	FALALKALKKLAKKLKKLAKKAL	FLAK04 AM	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =12 µg/ml	24-h	Prostate	US_06875744_B2
2530	None	2005	FALALKALKKLLKKLKKLAKKAL	FLAK03 AM	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =38 µg/ml	24-h	Prostate	US_06875744_B2
2529	None	2005	FALAAKALKKLAKKLKKLAKKAL	FLAK01 AM	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =41 µg/ml	24-h	Prostate	US_06875744_B2
2528	None	2005	FAKKLAKKLKKLAKKLAKLALAL	SHIVA 10 AC	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =83 µg/ml	24-h	Prostate	US_06875744_B2
2526	None	2005	MPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG	SB-37 AC	38	Linear	L	None	Free	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	Not Available	24-h	Prostate	US_06875744_B2
2527	None	2005	MPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG	SB-37 AM	38	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =630 µg/ml	24-h	Prostate	US_06875744_B2
2525	None	2005	FALALKALKKALKKLKKALKKAL	Hecate AM	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =44 µg/ml	24-h	Prostate	US_06875744_B2
2523	None	2005	FAKKLAKKLKKLAKKLAKLAKKL	Anubis-2	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =160 µg/ml	24-h	Lung	US_06875744_B2
2524	None	2005	FALALKALKKALKKLKKALKKAL	Hecate AC	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =61 µg/ml	24-h	Prostate	US_06875744_B2
2522	None	2005	LPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG	LSB-37	38	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =120 µg/ml	24-h	Lung	US_06875744_B2
2521	None	2005	FKVKFKVKVK	KSL-7	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =345 µg/ml	24-h	Lung	US_06875744_B2
2520	None	2005	KKVVFKVKFK	KSL-1	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =720 µg/ml	24-h	Lung	US_06875744_B2
2519	None	2005	FAKKFAKKFKKFAKKFAKFAFAF	D2A21	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =77 µg/ml	24-h	Lung	US_06875744_B2
2516	None	2005	FALA	FLAK-120B	4	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2517	None	2005	WALAL	FLAK-120F	5	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =370 µg/ml	24-h	Lung	US_06875744_B2
2518	None	2005	GIGKFLHAAKKFAKAFVAEIMNS	Magainin2wisc	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =60 µg/ml	24-h	Lung	US_06875744_B2
2515	None	2005	FALALKAKKL	FLAK-120C	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2514	None	2005	FALALKLKKL	FLAK-120D	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2512	None	2005	LKKLAKLALAF	Flak 96L	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2513	None	2005	VALALKALKKL	FLAK-120G	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2510	None	2005	FALLKALLKKAL	Flak 96I	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =240 µg/ml	24-h	Lung	US_06875744_B2
2511	None	2005	FALALKLAKKL	Flak 96J	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2508	None	2005	KFKKLAKKW	Modelin-8E	9	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2509	None	2005	FALALKALKKA	Flak 96H	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2506	None	2005	FALLKALKKAL	FLAK96D	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =540 µg/ml	24-h	Lung	US_06875744_B2
2507	None	2005	KFKKLAKKF	Modelin-8D	9	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2504	None	2005	FALALKALKK	FLAK96F	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =640 µg/ml	24-h	Lung	US_06875744_B2
2505	None	2005	FALKALKKAL	FLAK96C	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2502	None	2005	FALALKLAKKAL	FLAK96B	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =300 µg/ml	24-h	Lung	US_06875744_B2
2503	None	2005	FALLKL	FLAK96G	6	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2500	None	2005	FALALKALKKL	FLAK120	9	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =56 µg/ml	24-h	Lung	US_06875744_B2
2501	None	2005	FALAKALKKAL	FLAK121	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2498	None	2005	KLAKKLAKLAKLAKAL	Modelin-5	16	Linear	L	None	Free	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =74 µg/ml	24-h	Lung	US_06875744_B2
2499	None	2005	KLAKKLAKLAKLAKAL	Modelin-5-CO2H	16	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =470 µg/ml	24-h	Lung	US_06875744_B2
2497	None	2005	FAVGLRAIKRALKKLRRGVRKVAKDL	FAGVL	26	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =315 µg/ml	24-h	Lung	US_06875744_B2
2494	None	2005	VAKLLAKLAKKVL	FLAK50T8	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =400 µg/ml	24-h	Lung	US_06875744_B2
2495	None	2005	YAKLLAKLAKKAL	FLAK50T9	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2496	None	2005	KLLKLLLKLYKKLLKLL	FLAK100-CO2H	17	Linear	L	None	Free	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	Not Available	24-h	Lung	US_06875744_B2
2492	None	2005	FAKLLAKLAKKGL	FLAK50T7	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =410 µg/ml	24-h	Lung	US_06875744_B2
2493	None	2005	FALKALKKLKKALKKAL	FLAK95	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =50 µg/ml	24-h	Lung	US_06875744_B2
2489	None	2005	KAKLAKKALAKLL	FLAK92B	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2490	None	2005	KLALKLALKALKAAKLA	FLAK99	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =185 µg/ml	24-h	Lung	US_06875744_B2
2491	None	2005	FAKLLAKLAKK	FLAK50T6	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2488	None	2005	FAKLAKKALAKLL	FLAK91B	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =660 µg/ml	24-h	Lung	US_06875744_B2
2487	None	2005	FKRLAKIKVLRLAKIKR	FKRLA	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =93 µg/ml	24-h	Lung	US_06875744_B2
2485	None	2005	FALKALKK	FLAK97	8	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2486	None	2005	KYKKALKKLAKLL	FLAK98	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =93 µg/ml	24-h	Lung	US_06875744_B2
2484	None	2005	FALALKALKKAL	FLAK96	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =225 µg/ml	24-h	Lung	US_06875744_B2
2482	None	2005	KWKLAKKALALL	FLAK93B	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =115 µg/ml	24-h	Lung	US_06875744_B2
2483	None	2005	FAKIIAKIAKKI	FLAK50 Z10	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2481	None	2005	FALALKA	FLAK94	7	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2480	None	2005	FAFAKIIAKIAKKII	FLAK50 Z9	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2479	None	2005	FAKIIAKIAKIAKKIL	FLAK50 Z8	16	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =850 µg/ml	24-h	Lung	US_06875744_B2
2478	None	2005	FAFGKGIGKIGKKGL	FLAK50 Z7	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2477	None	2005	FAKGVGKVGKKAL	FLAK50 Z6	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2476	None	2005	FAKLWAKLAKKL	FLAK50 Z5	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =450 µg/ml	24-h	Lung	US_06875744_B2
2475	None	2005	FAKLWAKLAFGKGIGKVGKKLL	FLAK50 Z4	22	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =115 µg/ml	24-h	Lung	US_06875744_B2
2474	None	2005	FAKAIAKIAFGKGIGKVGKKLL	FLAK50 Z3	22	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2473	None	2005	FAFGKGIGKVGKKLL	FLAK50 Z2	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2472	None	2005	FGKGIGKVGKKLL	FLAK50 Z1	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2471	None	2005	KWKLF	FLAK93	5	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2470	None	2005	KAKLF	FLAK92	5	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2469	None	2005	FAKLF	FLAK91	5	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =790 µg/ml	24-h	Lung	US_06875744_B2
2468	None	2005	FAKLA	FLAK90	5	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2467	None	2005	FAKLLAKLAKKSL	FLAK50 T5	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =770 µg/ml	24-h	Lung	US_06875744_B2
2466	None	2005	FAKLLAKLAKKEL	FLAK50 T4	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2465	None	2005	FAKLLAKLAKKIL	FLAK50 T3	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =76 µg/ml	24-h	Lung	US_06875744_B2
2464	None	2005	FAKLLAKLAKKVL	FLAK50 T2	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =30 µg/ml	24-h	Lung	US_06875744_B2
2463	None	2005	FAKLLAKLAK	FLAK50 T1	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2462	None	2005	FKLAFKLAKKAFL	FLAK50 Q10	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =830 µg/ml	24-h	Lung	US_06875744_B2
2461	None	2005	FAKLFAKLAKKFAL	FLAK50 Q9	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =460 µg/ml	24-h	Lung	US_06875744_B2
2460	None	2005	FAKLLAKLAKKFAL	FLAK50 Q8	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =620 µg/ml	24-h	Lung	US_06875744_B2
2459	None	2005	FAKLLAKALKKFAL	FLAK50 Q7	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =33 µg/ml	24-h	Lung	US_06875744_B2
2458	None	2005	FAKLLAKALKKFL	FLAK50 Q6	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =74 µg/ml	24-h	Lung	US_06875744_B2
2457	None	2005	FAKLFAKAFKKAL	FLAK50 Q5	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2456	None	2005	FAKLLAKAFKKAL	FLAK50 Q4	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2455	None	2005	FAKLLAKFLKKAL	FLAK50 Q3	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =50 µg/ml	24-h	Lung	US_06875744_B2
2454	None	2005	FAKLLFKALKKAL	FLAK50 Q2	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =470 µg/ml	24-h	Lung	US_06875744_B2
2453	None	2005	FAKFLAKFLKKAL	FLAK50 Q1	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =8 µg/ml	24-h	Lung	US_06875744_B2
2452	None	2005	FAKKLLAKALKL	FLAG26-D3	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =95 µg/ml	24-h	Lung	US_06875744_B2
2451	None	2005	FAKKLAKLAKKLAKAL	FLAK26-D2	16	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2450	None	2005	GIGAVLKVLTTGLPALISWIKRKRQQ	MELITTIIN	26	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =25 µg/ml	24-h	Lung	US_06875744_B2
2449	None	2005	MPKEKVFLKIEKMGRNIRN	VISHNU3	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2448	None	2005	FAKKLAKLAKKL	FLAG26-D1	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =920 µg/ml	24-h	Lung	US_06875744_B2
2447	None	2005	KIAKVALAKLGIGAVLKVLTTGL	PYL-ME	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2446	None	2005	KWKLFKKALKKLKKALKKAL	CA(1-& HECATE(11/23)	20	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =52 µg/ml	24-h	Lung	US_06875744_B2
2445	None	2005	FAKLLAKALKKL	FLAK 50P	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =150 µg/ml	24-h	Lung	US_06875744_B2
2444	None	2005	FAKLLAKALKKAL	FLAK 50O	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =27 µg/ml	24-h	Lung	US_06875744_B2
2443	None	2005	FAKLLAKALKLKL	FLAK 50N	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =340 µg/ml	24-h	Lung	US_06875744_B2
2442	None	2005	FAKKLAKKLKKLAKKLIGAVLKV	SHIVA 11[(1-16)ME(2-9]-COOH	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =54 µg/ml	24-h	Lung	US_06875744_B2
2441	None	2005	FAKKLAKKLKKLAKKLAKLALALKALALKAL	Shiva-11	31	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =53 µg/ml	24-h	Lung	US_06875744_B2
2440	None	2005	FAKLLAKLAKAKG	FLAK50L	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2439	None	2005	FAKLLAKLAKAKA	FLAK50K	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2438	None	2005	FAKLLALALKLKL	FLAK50I	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	Not Available	24-h	Lung	US_06875744_B2
2437	None	2005	FAKLLAKLAKKAA	FLAK50J	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =320 µg/ml	24-h	Lung	US_06875744_B2
2436	None	2005	FAKALAKLAKKLL	FLAK50B	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =25 µg/ml	24-h	Lung	US_06875744_B2
2435	None	2005	ILPWKWPWWPWRR	Indolocidin-ac	13	Linear	L	None	Free	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =64 µg/ml	24-h	Lung	US_06875744_B2
2434	None	2005	KWKLFKKKTKLFKKFAKKLAKKL	CA(1-7) Shiva10(1-16)	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =22 µg/ml	24-h	Lung	US_06875744_B2
2433	None	2005	KTKLFKKFAKKLAKKLKKLAKKL	SHIVA 10 (1-16)	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =64 µg/ml	24-h	Lung	US_06875744_B2
2432	None	2005	FAKKLKKLAKKL	FLAK 75	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2431	None	2005	FAKKLAKKAKLAKKL	FLAK 72	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2430	None	2005	FAKKLAKKLAKAAL	FLAK 58	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =860 µg/ml	24-h	Lung	US_06875744_B2
2429	None	2005	FAKKLAKKLAKLL	FLAK 56	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =80 µg/ml	24-h	Lung	US_06875744_B2
2428	None	2005	FAKKLAKKLAKAL	FLAK 54	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =670 µg/ml	24-h	Lung	US_06875744_B2
2427	None	2005	KWKLFKKKTKLFKKFAKKLAKKL	CA(1-7)Shiva10(1-16)	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =115 µg/ml	24-h	Lung	US_06875744_B2
2426	None	2005	FAKKLAKKLKKLAKKLAKKWKL	SHIVA 10 PEPTIDE 71 + KWKL	22	Linear	L	None	Free	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =160 µg/ml	24-h	Lung	US_06875744_B2
2425	None	2005	FAKKLAKKLKKLAKKLAK	Shiva 10(1-18 AC)	18	Linear	L	None	Free	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =320 µg/ml	24-h	Lung	US_06875744_B2
2424	None	2005	FAKKLAKKLKKLAKKLAKKWKL	SHIVA DERIV P69 + KWKL	22	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =63 µg/ml	24-h	Lung	US_06875744_B2
2423	None	2005	FAKLLAKLAKLKL	FLAK 50G	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =130 µg/ml	24-h	Lung	US_06875744_B2
2422	None	2005	FAKLLAKLAKAKL	FLAK 50H	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =450 µg/ml	24-h	Lung	US_06875744_B2
2421	None	2005	FAKALKALLKALKAL	FLAK 17 C	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =30 µg/ml	24-h	Lung	US_06875744_B2
2420	None	2005	ILPWKWPWWPWRR	Indolicidin	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =270 µg/ml	24-h	Lung	US_06875744_B2
2419	None	2005	FAKKLAKLAKKLAKLAL	FLAK 26 Ac	17	Linear	L	None	Free	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =127 µg/ml	24-h	Lung	US_06875744_B2
2418	None	2005	FAKLAKKLL	FLAK83M	9	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2417	None	2005	FAKKLAKKLL	FLAK82	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =180 µg/ml	24-h	Lung	US_06875744_B2
2416	None	2005	FAKKLAKALL	FLAK81	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2415	None	2005	FAKLLAKKLL	FLAK80	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2414	None	2005	FAKLLKLAAKKLL	FLAK 50E	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =370 µg/ml	24-h	Lung	US_06875744_B2
2413	None	2005	FAKLLAKALKKLL	FLAK50D	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =7 µg/ml	24-h	Lung	US_06875744_B2
2412	None	2005	FAKLLAKLAKKAL	FLAK50C	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =80 µg/ml	24-h	Lung	US_06875744_B2
2411	None	2005	KWKLFKKIGAVLKVL	CAME-15	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =65 µg/ml	24-h	Lung	US_06875744_B2
2410	None	2005	VAKKLAKLAKKLAKLAL	FLAK26V AM	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =7 µg/ml	24-h	Lung	US_06875744_B2
2409	None	2005	FAKLLAKLAKKL	FLAK50F	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =140 µg/ml	24-h	Lung	US_06875744_B2
2408	None	2005	VAKLLAKLAKKLL	FLAK50V	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =17 µg/ml	24-h	Lung	US_06875744_B2
2407	None	2005	FAKKALKALKKL	FLAK77	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2406	None	2005	FAKKLKKLAKLAKKL	FLAK71	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =290 µg/ml	24-h	Lung	US_06875744_B2
2405	None	2005	FAKKLAKKLAKLAL	FLAK57	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =330 µg/ml	24-h	Lung	US_06875744_B2
2404	None	2005	FAKKLAKLALKLAKL	FLAK51	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =72 µg/ml	24-h	Lung	US_06875744_B2
2403	None	2005	FAKLLAKLAKKLL	FLAK50	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =6 µg/ml	24-h	Lung	US_06875744_B2
2402	None	2005	GIGKFLKKAKKFGKAFVKILKK	MSI-78 AM	22	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =150 µg/ml	24-h	Lung	US_06875744_B2
2401	None	2005	FAKKLAKKLKKLAKLALAK	FLAK 06R-AM	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =245 µg/ml	24-h	Lung	US_06875744_B2
2400	None	2005	FALAKKALKKAKKAL	FLAK62 AM	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2399	None	2005	FAKKLAKLAKKALAL	FLAK44 AM	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =420 µg/ml	24-h	Lung	US_06875744_B2
2398	None	2005	FAKKLAKLAKKLLAL	FLAK43 AM	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =33 µg/ml	24-h	Lung	US_06875744_B2
2397	None	2005	FALALKALKKALkkLKKALKKAL	HECATE 2DAc	23	Linear	Mix	None	Free	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =150 µg/ml	24-h	Lung	US_06875744_B2
2396	None	2005	FAKKLAKLAKKLAKLALAL	FLAK 25 AM	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =57 µg/ml	24-h	Lung	US_06875744_B2
2395	None	2005	FAKKLAKLAKKLAKLAL	FLAK 26 AM	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =16 µg/ml	24-h	Lung	US_06875744_B2
2394	None	2005	FALALKKALKALKKAL	FLAK 17 AM	16	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =24 µg/ml	24-h	Lung	US_06875744_B2
2393	None	2005	VALALKALKKALKKLKKALKKAL	KAL V	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =125 µg/ml	24-h	Lung	US_06875744_B2
2392	None	2005	FAKKLAKKLKKLAKLALAL	FLAK06 AM	19	Linear	L	None	Free	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =170 µg/ml	24-h	Lung	US_06875744_B2
2391	None	2005	FALALKALKKLKKALKKAL	FLAK06 AC	19	Linear	L	None	Free	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =54 µg/ml	24-h	Lung	US_06875744_B2
2390	None	2005	FALALKALKKLKKALKKAL	FLAK06 AM	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =16 µg/ml	24-h	Lung	US_06875744_B2
2389	None	2005	FALAKLAKKAKAKLKKALKAL	FLAK05 AM	21	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =84 µg/ml	24-h	Lung	US_06875744_B2
2388	None	2005	FALALKALKKLAKKLKKLAKKAL	FLAK04 AM	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =37 µg/ml	24-h	Lung	US_06875744_B2
2387	None	2005	FALALKALKKLLKKLKKLAKKAL	FLAK03 AM	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =72 µg/ml	24-h	Lung	US_06875744_B2
2386	None	2005	FALAAKALKKLAKKLKKLAKKAL	FLAK01 AM	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =64 µg/ml	24-h	Lung	US_06875744_B2
2385	None	2005	FAKKLAKKLKKLAKKLAKLALAL	SHIVA 10 AC	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2384	None	2005	MPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG	SB-37 AM	38	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =720 µg/ml	24-h	Lung	US_06875744_B2
2383	None	2005	MPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG	SB-37 AC	38	Linear	L	None	Free	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =220 µg/ml	24-h	Lung	US_06875744_B2
2382	None	2005	FALALKALKKALKKLKKALKKAL	Hecate AM	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =140 µg/ml	24-h	Lung	US_06875744_B2
2381	None	2005	FALALKALKKALKKLKKALKKAL	Hecate AC	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =44 µg/ml	24-h	Lung	US_06875744_B2
2380	None	2005	FAKLLAKLAKKAA	FLAK50J	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	Not Available	24-h	Skin	US_06875744_B2
2379	None	2005	VALALKALKKLAKKLKKLAKKAL	FLAK04 AM V	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	Not Available	24-h	Skin	US_06875744_B2
2378	None	2005	VALALKALKKALKKLKKALKKAL	Hecate AC V	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	Not Available	24-h	Skin	US_06875744_B2
2377	None	2005	VALALKALKKALKKLKKALKKAL	Hecate AM V	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	Not Available	24-h	Skin	US_06875744_B2
2376	None	2005	VAKLLAKALKKLL	FLAK50D V	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	Not Available	24-h	Skin	US_06875744_B2
2375	None	2005	VAKKLAKLAKKLLAL	FLAK43 AM V	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	Not Available	24-h	Skin	US_06875744_B2
2374	None	2005	VAKKLAKLAKKLAKLALAL	FLAK 25 AM V	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	Not Available	24-h	Skin	US_06875744_B2
2373	None	2005	VAKKFAKKFKKFAKKFAKFAFAF	D2A21V	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	Not Available	24-h	Skin	US_06875744_B2
2372	None	2005	VAKFLAKFLKKAL	FLAK50 Q1V	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	Not Available	24-h	Skin	US_06875744_B2
2371	None	2005	VAKALAKALLKALKAL	FLAK 17 CV	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	Not Available	24-h	Skin	US_06875744_B2
2370	None	2005	FAKKLAKKLKKLAKKLAKLAKKL	Anubis-2	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =83 µg/ml	24-h	Skin	US_06875744_B2
2369	None	2005	LPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG	LSB-37	38	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =170 µg/ml	24-h	Skin	US_06875744_B2
2368	None	2005	FKVKFKVKVK	KSL-7	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =330 µg/ml	24-h	Skin	US_06875744_B2
2367	None	2005	KKVVFKVKFK	KSL-1	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =700 µg/ml	24-h	Skin	US_06875744_B2
2366	None	2005	FAKKFAKKFKKFAKKFAKFAFAF	D2A21	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =140 µg/ml	24-h	Skin	US_06875744_B2
2364	None	2005	WALAL	FLAK-120F	5	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =600 µg/ml	24-h	Skin	US_06875744_B2
2365	None	2005	GIGKFLHAAKKFAKAFVAEIMNS	Magainin2wisc	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =130 µg/ml	24-h	Skin	US_06875744_B2
2362	None	2005	FALALKAKKL	FLAK-120C	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2363	None	2005	FALA	FLAK-120B	4	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2361	None	2005	FALALKLKKL	FLAK-120D	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =830 µg/ml	24-h	Skin	US_06875744_B2
2360	None	2005	VALALKALKKL	FLAK-120G	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =770 µg/ml	24-h	Skin	US_06875744_B2
2359	None	2005	LKKLAKLALAF	Flak 96L	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =920 µg/ml	24-h	Skin	US_06875744_B2
2358	None	2005	FALALKLAKKL	Flak 96J	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =640 µg/ml	24-h	Skin	US_06875744_B2
2357	None	2005	FALLKALLKKAL	Flak 96I	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =310 µg/ml	24-h	Skin	US_06875744_B2
2356	None	2005	FALALKALKKA	Flak 96H	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2355	None	2005	KFKKLAKKW	Modelin-8E	9	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2354	None	2005	KFKKLAKKF	Modelin-8D	9	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2353	None	2005	FALLKALKKAL	FLAK96D	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =600 µg/ml	24-h	Skin	US_06875744_B2
2352	None	2005	FALKALKKAL	FLAK96C	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2351	None	2005	FALALKALKK	FLAK96F	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =530 µg/ml	24-h	Skin	US_06875744_B2
2350	None	2005	FALLKL	FLAK96G	6	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =590 µg/ml	24-h	Skin	US_06875744_B2
2349	None	2005	FALALKLAKKAL	FLAK96B	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =240 µg/ml	24-h	Skin	US_06875744_B2
2348	None	2005	FALAKALKKAL	FLAK121	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2347	None	2005	FALALKALKKL	FLAK120	9	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =240 µg/ml	24-h	Skin	US_06875744_B2
2346	None	2005	KLAKKLAKLAKLAKAL	Modelin-5-CO2H	16	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =220 µg/ml	24-h	Skin	US_06875744_B2
2345	None	2005	KLAKKLAKLAKLAKAL	Modelin-5	16	Linear	L	None	Free	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =140 µg/ml	24-h	Skin	US_06875744_B2
2344	None	2005	FAVGLRAIKRALKKLRRGVRKVAKDL	FAGVL	26	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =600 µg/ml	24-h	Skin	US_06875744_B2
2343	None	2005	KLLKLLLKLYKKLLKLL	FLAK100-CO2H	17	Linear	L	None	Free	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =520 µg/ml	24-h	Skin	US_06875744_B2
2342	None	2005	YAKLLAKLAKKAL	FLAK50T9	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2341	None	2005	VAKLLAKLAKKVL	FLAK50T8	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =330 µg/ml	24-h	Skin	US_06875744_B2
2340	None	2005	FALKALKKLKKALKKAL	FLAK95	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =165 µg/ml	24-h	Skin	US_06875744_B2
2339	None	2005	FAKLLAKLAKKGL	FLAK50T7	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2338	None	2005	FAKLLAKLAKK	FLAK50T6	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2337	None	2005	KLALKLALKALKAAKLA	FLAK99	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =190 µg/ml	24-h	Skin	US_06875744_B2
2335	None	2005	FAKLAKKALAKLL	FLAK91B	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =330 µg/ml	24-h	Skin	US_06875744_B2
2336	None	2005	KAKLAKKALAKLL	FLAK92B	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2334	None	2005	FKRLAKIKVLRLAKIKR	FKRLA	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =110 µg/ml	24-h	Skin	US_06875744_B2
2332	None	2005	FALKALKK	FLAK97	8	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2333	None	2005	KYKKALKKLAKLL	FLAK98	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =185 µg/ml	24-h	Skin	US_06875744_B2
2331	None	2005	FALALKALKKAL	FLAK96	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =250 µg/ml	24-h	Skin	US_06875744_B2
2317	None	2005	KAKLF	FLAK92	5	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2318	None	2005	KWKLF	FLAK93	5	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2319	None	2005	FGKGIGKVGKKLL	FLAK50 Z1	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2320	None	2005	FAFGKGIGKVGKKLL	FLAK50 Z2	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2321	None	2005	FAKAIAKIAFGKGIGKVGKKLL	FLAK50 Z3	22	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2322	None	2005	FAKLWAKLAFGKGIGKVGKKLL	FLAK50 Z4	22	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =155 µg/ml	24-h	Skin	US_06875744_B2
2323	None	2005	FAKLWAKLAKKL	FLAK50 Z5	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =530 µg/ml	24-h	Skin	US_06875744_B2
2324	None	2005	FAKGVGKVGKKAL	FLAK50 Z6	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2325	None	2005	FAFGKGIGKIGKKGL	FLAK50 Z7	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2326	None	2005	FAKIIAKIAKIAKKIL	FLAK50 Z8	16	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =525 µg/ml	24-h	Skin	US_06875744_B2
2327	None	2005	FAFAKIIAKIAKKII	FLAK50 Z9	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2328	None	2005	FALALKA	FLAK94	7	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =465 µg/ml	24-h	Skin	US_06875744_B2
2329	None	2005	KWKLAKKALALL	FLAK93B	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =38 µg/ml	24-h	Skin	US_06875744_B2
2330	None	2005	FAKIIAKIAKKI	FLAK50 Z10	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2304	None	2005	FAKLFAKAFKKAL	FLAK50 Q5	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2305	None	2005	FAKLLAKALKKFL	FLAK50 Q6	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =135 µg/ml	24-h	Skin	US_06875744_B2
2306	None	2005	FAKLLAKALKKFAL	FLAK50 Q7	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =36 µg/ml	24-h	Skin	US_06875744_B2
2307	None	2005	FAKLLAKLAKKFAL	FLAK50 Q8	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =660 µg/ml	24-h	Skin	US_06875744_B2
2308	None	2005	FAKLFAKLAKKFAL	FLAK50 Q9	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =670 µg/ml	24-h	Skin	US_06875744_B2
2309	None	2005	FKLAFKLAKKAFL	FLAK50 Q10	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =700 µg/ml	24-h	Skin	US_06875744_B2
2310	None	2005	FAKLLAKLAK	FLAK50 T1	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =635 µg/ml	24-h	Skin	US_06875744_B2
2311	None	2005	FAKLLAKLAKKVL	FLAK50 T2	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =10 µg/ml	24-h	Skin	US_06875744_B2
2312	None	2005	FAKLLAKLAKKIL	FLAK50 T3	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =220 µg/ml	24-h	Skin	US_06875744_B2
2313	None	2005	FAKLLAKLAKKEL	FLAK50 T4	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2314	None	2005	FAKLLAKLAKKSL	FLAK50 T5	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =535 µg/ml	24-h	Skin	US_06875744_B2
2315	None	2005	FAKLA	FLAK90	5	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =330 µg/ml	24-h	Skin	US_06875744_B2
2316	None	2005	FAKLF	FLAK91	5	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2292	None	2005	FAKLLAKALKKL	FLAK 50P	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =75 µg/ml	24-h	Skin	US_06875744_B2
2293	None	2005	KWKLFKKALKKLKKALKKAL	CA(1-& HECATE(11/23)	20	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =100 µg/ml	24-h	Skin	US_06875744_B2
2294	None	2005	KIAKVALAKLGIGAVLKVLTTGL	PYL-ME	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	Not Available	24-h	Skin	US_06875744_B2
2295	None	2005	FAKKLAKLAKKL	FLAG26-D1	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =690 µg/ml	24-h	Skin	US_06875744_B2
2296	None	2005	MPKEKVFLKIEKMGRNIRN	VISHNU3	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2297	None	2005	GIGAVLKVLTTGLPALISWIKRKRQQ	MELITTIIN	26	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =18 µg/ml	24-h	Skin	US_06875744_B2
2298	None	2005	FAKKLAKLAKKLAKAL	FLAK26-D2	16	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2299	None	2005	FAKKLLAKALKL	FLAG26-D3	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =400 µg/ml	24-h	Skin	US_06875744_B2
2300	None	2005	FAKFLAKFLKKAL	FLAK50 Q1	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =26 µg/ml	24-h	Skin	US_06875744_B2
2301	None	2005	FAKLLFKALKKAL	FLAK50 Q2	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =445 µg/ml	24-h	Skin	US_06875744_B2
2302	None	2005	FAKLLAKFLKKAL	FLAK50 Q3	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =115 µg/ml	24-h	Skin	US_06875744_B2
2303	None	2005	FAKLLAKAFKKAL	FLAK50 Q4	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2291	None	2005	FAKLLAKALKKAL	FLAK 50O	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =60 µg/ml	24-h	Skin	US_06875744_B2
2290	None	2005	FAKLLAKALKLKL	FLAK 50N	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =160 µg/ml	24-h	Skin	US_06875744_B2
2289	None	2005	FAKKLAKKLKKLAKKLIGAVLKV	SHIVA 11[(1-16)ME(2-9]-COOH	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =94 µg/ml	24-h	Skin	US_06875744_B2
2288	None	2005	FAKKLAKKLKKLAKKLAKLALALKALALKAL	Shiva-11	31	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =94 µg/ml	24-h	Skin	US_06875744_B2
2286	None	2005	FAKLLAKLAKAKA	FLAK50K	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =820 µg/ml	24-h	Skin	US_06875744_B2
2287	None	2005	FAKLLAKLAKAKG	FLAK50L	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2285	None	2005	FAKLLALALKLKL	FLAK50I	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =11 µg/ml	24-h	Skin	US_06875744_B2
2284	None	2005	FAKALAKLAKKLL	FLAK50B	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =46 µg/ml	24-h	Skin	US_06875744_B2
2283	None	2005	ILPWKWPWWPWRR	Indolocidin-ac	13	Linear	L	None	Free	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =180 µg/ml	24-h	Skin	US_06875744_B2
2282	None	2005	KWKLFKKKTKLFKKFAKKLAKKL	CA(1-7) Shiva10(1-16)-COOH	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =12 µg/ml	24-h	Skin	US_06875744_B2
2281	None	2005	KTKLFKKFAKKLAKKLKKLAKKL	SHIVA 10 (1-16) Ac	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =76 µg/ml	24-h	Skin	US_06875744_B2
2280	None	2005	FAKKLKKLAKKL	FLAK 75	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =830 µg/ml	24-h	Skin	US_06875744_B2
2279	None	2005	FAKKLAKKAKLAKKL	FLAK 72	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =125 µg/ml	24-h	Skin	US_06875744_B2
2278	None	2005	FAKKLAKKLAKAAL	FLAK 58	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =750 µg/ml	24-h	Skin	US_06875744_B2
2277	None	2005	FAKKLAKKLAKLL	FLAK 56	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =24 µg/ml	24-h	Skin	US_06875744_B2
2276	None	2005	FAKKLAKKLAKAL	FLAK 54	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =460 µg/ml	24-h	Skin	US_06875744_B2
2275	None	2005	KWKLFKKKTKLFKKFAKKLAKKL	CA(1-7)Shiva10(1-16)	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =360 µg/ml	24-h	Skin	US_06875744_B2
2274	None	2005	FAKKLAKKLKKLAKKLAKKWKL	SHIVA 10 PEPTIDE 71 + KWKL	22	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =290 µg/ml	24-h	Skin	US_06875744_B2
2273	None	2005	FAKKLAKKLKKLAKKLAK	Shiva 10(1-18 AC)	18	Linear	L	None	Free	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =445 µg/ml	24-h	Skin	US_06875744_B2
2272	None	2005	FAKKLAKKLKKLAKKLAKKWKL	SHIVA DERIV P69 + KWKL	22	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =94 µg/ml	24-h	Skin	US_06875744_B2
2271	None	2005	FAKLLAKLAKLKL	FLAK 50G	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =200 µg/ml	24-h	Skin	US_06875744_B2
2270	None	2005	FAKLLAKLAKAKL	FLAK 50H	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =250 µg/ml	24-h	Skin	US_06875744_B2
2269	None	2005	FAKALKALLKALKAL	FLAK 17 C	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =35 µg/ml	24-h	Skin	US_06875744_B2
2268	None	2005	ILPWKWPWWPWRR	Indolicidin	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =200 µg/ml	24-h	Skin	US_06875744_B2
2267	None	2005	FAKKLAKLAKKLAKLAL	FLAK 26 Ac	17	Linear	L	None	Free	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =140 µg/ml	24-h	Skin	US_06875744_B2
2266	None	2005	FAKLAKKLL	FLAK83M	9	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2264	None	2005	FAKKLAKALL	FLAK81	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2265	None	2005	FAKKLAKKLL	FLAK82	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =155 µg/ml	24-h	Skin	US_06875744_B2
2263	None	2005	FAKLLAKKLL	FLAK80	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =740 µg/ml	24-h	Skin	US_06875744_B2
2262	None	2005	FAKLLKLAAKKLL	FLAK 50E	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =205 µg/ml	24-h	Skin	US_06875744_B2
2261	None	2005	FAKLLAKALKKLL	FLAK50D	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =16 µg/ml	24-h	Skin	US_06875744_B2
2260	None	2005	FAKLLAKLAKKAL	FLAK50C	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =90 µg/ml	24-h	Skin	US_06875744_B2
2259	None	2005	KWKLFKKIGAVLKVL	CAME-15	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =40 µg/ml	24-h	Skin	US_06875744_B2
2258	None	2005	VAKKLAKLAKKLAKLAL	FLAK26V AM	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =40 µg/ml	24-h	Skin	US_06875744_B2
2256	None	2005	VAKLLAKLAKKLL	FLAK50V	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =43 µg/ml	24-h	Skin	US_06875744_B2
2257	None	2005	FAKLLAKLAKKL	FLAK50F	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =115 µg/ml	24-h	Skin	US_06875744_B2
2255	None	2005	FAKKALKALKKL	FLAK77	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =700 µg/ml	24-h	Skin	US_06875744_B2
2254	None	2005	FAKKLKKLAKLAKKL	FLAK71	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =150 µg/ml	24-h	Skin	US_06875744_B2
2253	None	2005	FAKKLAKKLAKLAL	FLAK57	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =160 µg/ml	24-h	Skin	US_06875744_B2
2252	None	2005	FAKKLAKLALKLAKL	FLAK51	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =47 µg/ml	24-h	Skin	US_06875744_B2
2250	None	2005	GIGKFLKKAKKFGKAFVKILKK	MSI-78 AM	22	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =140 µg/ml	24-h	Skin	US_06875744_B2
2251	None	2005	FAKLLAKLAKKLL	FLAK50	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =7 µg/ml	24-h	Skin	US_06875744_B2
2249	None	2005	FAKKLAKKLKKLAKLALAK	FLAK 06R-AM	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =290 µg/ml	24-h	Skin	US_06875744_B2
2247	None	2005	FAKKLAKLAKKALAL	FLAK44 AM	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =510 µg/ml	24-h	Skin	US_06875744_B2
2248	None	2005	FALAKKALKKAKKAL	FLAK62 AM	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2246	None	2005	FAKKLAKLAKKLLAL	FLAK43 AM	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =21 µg/ml	24-h	Skin	US_06875744_B2
2245	None	2005	FALALKALKKALkkLKKALKKAL	HECATE 2DAc	23	Linear	Mix	None	Free	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =150 µg/ml	24-h	Skin	US_06875744_B2
2244	None	2005	FAKKLAKLAKKLAKLALAL	FLAK 25 AM	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =56 µg/ml	24-h	Skin	US_06875744_B2
2243	None	2005	FAKKLAKLAKKLAKLAL	FLAK 26 AM	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =7 µg/ml	24-h	Skin	US_06875744_B2
2242	None	2005	FALALKKALKALKKAL	FLAK 17 AM	16	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =53 µg/ml	24-h	Skin	US_06875744_B2
2241	None	2005	VALALKALKKALKKLKKALKKAL	KAL V	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =140 µg/ml	24-h	Skin	US_06875744_B2
2235	None	2005	FALALKALKKLLKKLKKLAKKAL	FLAK03 AM	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =85 µg/ml	24-h	Skin	US_06875744_B2
2236	None	2005	FALALKALKKLAKKLKKLAKKAL	FLAK04 AM	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =36 µg/ml	24-h	Skin	US_06875744_B2
2237	None	2005	FALAKLAKKAKAKLKKALKAL	FLAK05 AM	21	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =94 µg/ml	24-h	Skin	US_06875744_B2
2238	None	2005	FALALKALKKLKKALKKAL	FLAK06 AM	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =44 µg/ml	24-h	Skin	US_06875744_B2
2239	None	2005	FALALKALKKLKKALKKAL	FLAK06 AC	19	Linear	L	None	Free	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =93 µg/ml	24-h	Skin	US_06875744_B2
2240	None	2005	FAKKLAKKLKKLAKLALAL	FLAK06 R-AC	19	Linear	L	None	Free	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =300 µg/ml	24-h	Skin	US_06875744_B2
2231	None	2005	MPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG	SB-37 AC	38	Linear	L	None	Free	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =120 µg/ml	24-h	Skin	US_06875744_B2
2232	None	2005	MPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG	SB-37 AM	38	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2233	None	2005	FAKKLAKKLKKLAKKLAKLALAL	SHIVA 10 AC	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	Not Available	24-h	Skin	US_06875744_B2
2234	None	2005	FALAAKALKKLAKKLKKLAKKAL	FLAK01 AM	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =27 µg/ml	24-h	Skin	US_06875744_B2
2230	None	2005	FALALKALKKALKKLKKALKKAL	Hecate AM	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =128 µg/ml	24-h	Skin	US_06875744_B2
2228	None	2005	FAKLLAKLAKKAA	FLAK50J	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	Not Available	24-h	Skin	US_06875744_B2
2229	None	2005	FALALKALKKALKKLKKALKKAL	Hecate AC	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =72 µg/ml	24-h	Skin	US_06875744_B2
2227	None	2005	FALALKALKKLAKKLKKLAKKAL	FLAK04 AM V	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	Not Available	24-h	Skin	US_06875744_B2
2226	None	2005	VALALKALKKALKKLKKALKKAL	Hecate AC V	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	Not Available	24-h	Skin	US_06875744_B2
2225	None	2005	VALALKALKKALKKLKKALKKAL	Hecate AM V	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	Not Available	24-h	Skin	US_06875744_B2
2224	None	2005	VAKLLAKALKKLL	FLAK50D V	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	Not Available	24-h	Skin	US_06875744_B2
2223	None	2005	VAKKLAKLAKKLLAL	FLAK43 AM V	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	Not Available	24-h	Skin	US_06875744_B2
2222	None	2005	VAKKLAKLAKKLAKLALAL	FLAK 25 AM V	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	Not Available	24-h	Skin	US_06875744_B2
2220	None	2005	VAKFLAKFLKKAL	FLAK50 Q1V	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	Not Available	24-h	Skin	US_06875744_B2
2221	None	2005	VAKKFAKKFKKFAKKFAKFAFAF	D2A21V	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	Not Available	24-h	Skin	US_06875744_B2
2219	None	2005	VAKALKALLKALKAL	FLAK 17 CV	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	Not Available	24-h	Skin	US_06875744_B2
2218	None	2005	FAKKLAKKLKKLAKKLAKLAKKL	Anubis-2	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =83 µg/ml	24-h	Skin	US_06875744_B2
2217	None	2005	LPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG	LSB-37	38	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =170 µg/ml	24-h	Skin	US_06875744_B2
2215	None	2005	KKVVFKVKFK	KSL-1	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =700 µg/ml	24-h	Skin	US_06875744_B2
2216	None	2005	FKVKFKVKVK	KSL-7	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =330 µg/ml	24-h	Skin	US_06875744_B2
2214	None	2005	FAKKFAKKFKKFAKKFAKFAFAF	D2A21	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =140 µg/ml	24-h	Skin	US_06875744_B2
2213	None	2005	GIGKFLHAAKKFAKAFVAEIMNS	Magainin2wisc	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =130 µg/ml	24-h	Skin	US_06875744_B2
2211	None	2005	FALA	FLAK-120B	4	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2212	None	2005	WALAL	FLAK-120F	5	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =600 µg/ml	24-h	Skin	US_06875744_B2
2209	None	2005	FALALKLKKL	FLAK-120D	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =830 µg/ml	24-h	Skin	US_06875744_B2
2210	None	2005	FALALKAKKL	FLAK-120C	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2207	None	2005	LKKLAKLALAF	Flak 96L	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =920 µg/ml	24-h	Skin	US_06875744_B2
2208	None	2005	VALALKALKKL	FLAK-120G	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =770 µg/ml	24-h	Skin	US_06875744_B2
2206	None	2005	FALALKLAKKL	Flak 96J	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =640 µg/ml	24-h	Skin	US_06875744_B2
2205	None	2005	FALLKALLKKAL	Flak 96I	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =310 µg/ml	24-h	Skin	US_06875744_B2
2201	None	2005	FALLKALKKAL	FLAK96D	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =600 µg/ml	24-h	Skin	US_06875744_B2
2202	None	2005	KFKKLAKKF	Modelin-8D	9	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2203	None	2005	KFKKLAKKW	Modelin-8E	9	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2204	None	2005	FALALKALKKA	Flak 96H	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2199	None	2005	FALALKALKK	FLAK96F	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =530 µg/ml	24-h	Skin	US_06875744_B2
2200	None	2005	FALKALKKAL	FLAK96C	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2197	None	2005	FALALKLAKKAL	FLAK96B	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =240 µg/ml	24-h	Skin	US_06875744_B2
2198	None	2005	FALLKL	FLAK96G	6	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =590 µg/ml	24-h	Skin	US_06875744_B2
2195	None	2005	FALALKALKKL	FLAK120	9	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =240 µg/ml	24-h	Skin	US_06875744_B2
2196	None	2005	FALAKALKKAL	FLAK121	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2194	None	2005	KLAKKLAKLAKLAKAL	Modelin-5-CO2H	16	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =220 µg/ml	24-h	Skin	US_06875744_B2
2193	None	2005	KLAKKLAKLAKLAKAL	Modelin-5	16	Linear	L	None	Free	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =140 µg/ml	24-h	Skin	US_06875744_B2
2192	None	2005	FAVGLRAIKRALKKLRRGVRKVAKDL	FAGVL	26	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =600 µg/ml	24-h	Skin	US_06875744_B2
2191	None	2005	KLLKLLLKLYKKLLKLL	FLAK100-CO2H	17	Linear	L	None	Free	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =520 µg/ml	24-h	Skin	US_06875744_B2
2190	None	2005	YAKLLAKLAKKAL	FLAK50T9	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2189	None	2005	VAKLLAKLAKKVL	FLAK50T8	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =330 µg/ml	24-h	Skin	US_06875744_B2
2188	None	2005	FALKALKKLKKALKKAL	FLAK95	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =165 µg/ml	24-h	Skin	US_06875744_B2
2187	None	2005	FAKLLAKLAKKGL	FLAK50T7	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2186	None	2005	FAKLLAKLAKK	FLAK50T6	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2185	None	2005	KLALKLALKALKAAKLA	FLAK99	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =190 µg/ml	24-h	Skin	US_06875744_B2
2184	None	2005	KAKLAKKALAKLL	FLAK92B	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2183	None	2005	FAKLAKKALAKLL	FLAK91B	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =330 µg/ml	24-h	Skin	US_06875744_B2
2180	None	2005	FALKALKK	FLAK97	8	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2181	None	2005	KYKKALKKLAKLL	FLAK98	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =185 µg/ml	24-h	Skin	US_06875744_B2
2182	None	2005	FKRLAKIKVLRLAKIKR	FKRLA	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =110 µg/ml	24-h	Skin	US_06875744_B2
2179	None	2005	FALALKALKKAL	FLAK96	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =250 µg/ml	24-h	Skin	US_06875744_B2
2177	None	2005	KWKLAKKALALL	FLAK93B	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =38 µg/ml	24-h	Skin	US_06875744_B2
2178	None	2005	FAKIIAKIAKKI	FLAK50 Z10	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2176	None	2005	FALALKA	FLAK94	7	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =465 µg/ml	24-h	Skin	US_06875744_B2
2174	None	2005	FAKIIAKIAKIAKKIL	FLAK50 Z8	16	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =525 µg/ml	24-h	Skin	US_06875744_B2
2175	None	2005	FAFAKIIAKIAKKII	FLAK50 Z9	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2173	None	2005	FAFGKGIGKIGKKGL	FLAK50 Z7	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2172	None	2005	FAKGVGKVGKKAL	FLAK50 Z6	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2171	None	2005	FAKLWAKLAKKL	FLAK50 Z5	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =530 µg/ml	24-h	Skin	US_06875744_B2
2169	None	2005	FAKAIAKIAFGKGIGKVGKKLL	FLAK50 Z3	22	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2170	None	2005	FAKLWAKLAFGKGIGKVGKKLL	FLAK50 Z4	22	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =155 µg/ml	24-h	Skin	US_06875744_B2
2168	None	2005	FAFGKGIGKVGKKLL	FLAK50 Z2	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2167	None	2005	FGKGIGKVGKKLL	FLAK50 Z1	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2165	None	2005	KAKLF	FLAK92	5	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2166	None	2005	KWKLF	FLAK93	5	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2163	None	2005	FAKLA	FLAK90	5	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =330 µg/ml	24-h	Skin	US_06875744_B2
2164	None	2005	FAKLF	FLAK91	5	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2162	None	2005	FAKLLAKLAKKSL	FLAK50 T5	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =535 µg/ml	24-h	Skin	US_06875744_B2
2161	None	2005	FAKLLAKLAKKEL	FLAK50 T4	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2160	None	2005	FAKLLAKLAKKIL	FLAK50 T3	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =220 µg/ml	24-h	Skin	US_06875744_B2
2158	None	2005	FAKLLAKLAK	FLAK50 T1	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =635 µg/ml	24-h	Skin	US_06875744_B2
2159	None	2005	FAKLLAKLAKKVL	FLAK50 T2	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =10 µg/ml	24-h	Skin	US_06875744_B2
2157	None	2005	FKLAFKLAKKAFL	FLAK50 Q10	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =700 µg/ml	24-h	Skin	US_06875744_B2
2156	None	2005	FAKLFAKLAKKFAL	FLAK50 Q9	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =670 µg/ml	24-h	Skin	US_06875744_B2
2155	None	2005	FAKLLAKLAKKFAL	FLAK50 Q8	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =660 µg/ml	24-h	Skin	US_06875744_B2
2154	None	2005	FAKLLAKALKKFAL	FLAK50 Q7	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =36 µg/ml	24-h	Skin	US_06875744_B2
2153	None	2005	FAKLLAKALKKFL	FLAK50 Q6	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =135 µg/ml	24-h	Skin	US_06875744_B2
2152	None	2005	FAKLFAKAFKKAL	FLAK50 Q5	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2151	None	2005	FAKLLAKAFKKAL	FLAK50 Q4	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2150	None	2005	FAKLLAKFLKKAL	FLAK50 Q3	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =115 µg/ml	24-h	Skin	US_06875744_B2
2148	None	2005	FAKFLAKFLKKAL	FLAK50 Q1	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =26 µg/ml	24-h	Skin	US_06875744_B2
2149	None	2005	FAKLLFKALKKAL	FLAK50 Q2	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =445 µg/ml	24-h	Skin	US_06875744_B2
2147	None	2005	FAKKLLAKALKL	FLAG26-D3	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =400 µg/ml	24-h	Skin	US_06875744_B2
2146	None	2005	FAKKLAKLAKKLAKAL	FLAK26-D2	16	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2145	None	2005	GIGAVLKVLTTGLPALISWIKRKRQQ	MELITTIIN	26	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =18 µg/ml	24-h	Skin	US_06875744_B2
2143	None	2005	FAKKLAKLAKKL	FLAG26-D1	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =690 µg/ml	24-h	Skin	US_06875744_B2
2144	None	2005	MPKEKVFLKIEKMGRNIRN	VISHNU3	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2142	None	2005	KIAKVALAKLGIGAVLKVLTTGL	PYL-ME	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	Not Available	24-h	Skin	US_06875744_B2
2139	None	2005	FAKLLAKALKKAL	FLAK 50O	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =60 µg/ml	24-h	Skin	US_06875744_B2
2140	None	2005	FAKLLAKALKKL	FLAK 50P	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =75 µg/ml	24-h	Skin	US_06875744_B2
2141	None	2005	KWKLFKKALKKLKKALKKAL	CA(1-& HECATE(11/23)	20	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =100 µg/ml	24-h	Skin	US_06875744_B2
2137	None	2005	FAKKLAKKLKKLAKKLIGAVLKV	SHIVA 11[(1-16)ME(2-9]-COOH	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =94 µg/ml	24-h	Skin	US_06875744_B2
2138	None	2005	FAKLLAKALKLKL	FLAK 50N	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =160 µg/ml	24-h	Skin	US_06875744_B2
2136	None	2005	FAKKLAKKLKKLAKKLAKLALALKALALKAL	Shiva-11	31	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =94 µg/ml	24-h	Skin	US_06875744_B2
2135	None	2005	FAKLLAKLAKAKG	FLAK50L	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2134	None	2005	FAKLLAKLAKAKA	FLAK50K	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =820 µg/ml	24-h	Skin	US_06875744_B2
2133	None	2005	FAKLLALALKLKL	FLAK50I	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =11 µg/ml	24-h	Skin	US_06875744_B2
2132	None	2005	FAKALAKLAKKLL	FLAK50B	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =46 µg/ml	24-h	Skin	US_06875744_B2
2131	None	2005	ILPWKWPWWPWRR	Indolocidin-ac	13	Linear	L	None	Free	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =180 µg/ml	24-h	Skin	US_06875744_B2
2130	None	2005	KWKLFKKKTKLFKKFAKKLAKKL	CA(1-7) Shiva10(1-16)-COOH	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =12 µg/ml	24-h	Skin	US_06875744_B2
2129	None	2005	KTKLFKKFAKKLAKKLKKLAKKL	SHIVA 10 (1-16) Ac	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =76 µg/ml	24-h	Skin	US_06875744_B2
2128	None	2005	FAKKLKKLAKKL	FLAK 75	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =830 µg/ml	24-h	Skin	US_06875744_B2
2127	None	2005	FAKKLAKKAKLAKKL	FLAK 72	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =125 µg/ml	24-h	Skin	US_06875744_B2
2126	None	2005	FAKKLAKKLAKAAL	FLAK 58	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =750 µg/ml	24-h	Skin	US_06875744_B2
2125	None	2005	FAKKLAKKLAKLL	FLAK 56	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =24 µg/ml	24-h	Skin	US_06875744_B2
2124	None	2005	FAKKLAKKLAKAL	FLAK 54	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =460 µg/ml	24-h	Skin	US_06875744_B2
2123	None	2005	KWKLFKKKTKLFKKFAKKLAKKL	CA(1-7)Shiva10(1-16)	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =360 µg/ml	24-h	Skin	US_06875744_B2
2122	None	2005	FAKKLAKKLKKLAKKLAKKWKL	SHIVA 10 PEPTIDE 71 + KWKL	22	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =290 µg/ml	24-h	Skin	US_06875744_B2
2121	None	2005	FAKKLAKKLKKLAKKLAK	Shiva 10(1-18 AC)	18	Linear	L	None	Free	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =445 µg/ml	24-h	Skin	US_06875744_B2
2120	None	2005	FAKKLAKKLKKLAKKLAKKWKL	SHIVA DERIV P69 + KWKL	22	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =94 µg/ml	24-h	Skin	US_06875744_B2
2119	None	2005	FAKLLAKLAKLKL	FLAK 50G	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =200 µg/ml	24-h	Skin	US_06875744_B2
2118	None	2005	FAKLLAKLAKAKL	FLAK 50H	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =250 µg/ml	24-h	Skin	US_06875744_B2
2117	None	2005	FAKALKALLKALKAL	FLAK 17 C	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =35 µg/ml	24-h	Skin	US_06875744_B2
2116	None	2005	ILPWKWPWWPWRR	Indolicidin	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =200 µg/ml	24-h	Skin	US_06875744_B2
2115	None	2005	FAKKLAKLAKKLAKLAL	FLAK 26 Ac	17	Linear	L	None	Free	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =140 µg/ml	24-h	Skin	US_06875744_B2
2114	None	2005	FAKLAKKLL	FLAK83M	9	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2113	None	2005	FAKKLAKKLL	FLAK82	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =155 µg/ml	24-h	Skin	US_06875744_B2
2112	None	2005	FAKKLAKALL	FLAK81	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2111	None	2005	FAKLLAKKLL	FLAK80	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =740 µg/ml	24-h	Skin	US_06875744_B2
2110	None	2005	FAKLLKLAAKKLL	FLAK 50E	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =205 µg/ml	24-h	Skin	US_06875744_B2
2109	None	2005	FAKLLAKALKKLL	FLAK50D	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =16 µg/ml	24-h	Skin	US_06875744_B2
2108	None	2005	FAKLLAKLAKKAL	FLAK50C	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =90 µg/ml	24-h	Skin	US_06875744_B2
2107	None	2005	KWKLFKKIGAVLKVL	CAME-15	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =40 µg/ml	24-h	Skin	US_06875744_B2
2106	None	2005	VAKKLAKLAKKLAKLAL	FLAK26V AM	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =40 µg/ml	24-h	Skin	US_06875744_B2
2105	None	2005	FAKLLAKLAKKL	FLAK50F	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =115 µg/ml	24-h	Skin	US_06875744_B2
2104	None	2005	VAKLLAKLAKKLL	FLAK50V	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =43 µg/ml	24-h	Skin	US_06875744_B2
2103	None	2005	FAKKALKALKKL	FLAK77	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =700 µg/ml	24-h	Skin	US_06875744_B2
2102	None	2005	FAKKLKKLAKLAKKL	FLAK71	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =150 µg/ml	24-h	Skin	US_06875744_B2
2101	None	2005	FAKKLAKKLAKLAL	FLAK57	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =160 µg/ml	24-h	Skin	US_06875744_B2
2100	None	2005	FAKKLAKLALKLAKL	FLAK51	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =47 µg/ml	24-h	Skin	US_06875744_B2
2099	None	2005	FAKLLAKLAKKLL	FLAK50	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =7 µg/ml	24-h	Skin	US_06875744_B2
2098	None	2005	GIGKFLKKAKKFGKAFVKILKK	MSI-78 AM	22	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =140 µg/ml	24-h	Skin	US_06875744_B2
2097	None	2005	FAKKLAKKLKKLAKLALAK	FLAK 06R-AM	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =290 µg/ml	24-h	Skin	US_06875744_B2
2096	None	2005	FALAKKALKKAKKAL	FLAK62 AM	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2095	None	2005	FAKKLAKLAKKALAL	FLAK44 AM	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =510 µg/ml	24-h	Skin	US_06875744_B2
2094	None	2005	FAKKLAKLAKKLLAL	FLAK43 AM	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =21 µg/ml	24-h	Skin	US_06875744_B2
2093	None	2005	FALALKALKKALkkLKKALKKAL	HECATE 2DAc	23	Linear	Mix	None	Free	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =150 µg/ml	24-h	Skin	US_06875744_B2
2092	None	2005	FAKKLAKLAKKLAKLALAL	FLAK 25 AM	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =56 µg/ml	24-h	Skin	US_06875744_B2
2091	None	2005	FAKKLAKLAKKLAKLAL	FLAK 26 AM	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =7 µg/ml	24-h	Skin	US_06875744_B2
2090	None	2005	FALALKKALKALKKAL	FLAK 17 AM	16	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =53 µg/ml	24-h	Skin	US_06875744_B2
2089	None	2005	VALALKALKKALKKLKKALKKAL	KAL V	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =140 µg/ml	24-h	Skin	US_06875744_B2
2088	None	2005	FAKKLAKKLKKLAKLALAL	FLAK06 AM	19	Linear	L	None	Free	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =300 µg/ml	24-h	Skin	US_06875744_B2
2087	None	2005	FALALKALKKLKKALKKAL	FLAK06 AC	19	Linear	L	None	Free	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =93 µg/ml	24-h	Skin	US_06875744_B2
2086	None	2005	FALALKALKKLKKALKKAL	FLAK06 AM	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =44 µg/ml	24-h	Skin	US_06875744_B2
2085	None	2005	FALAKLAKKAKAKLKKALKAL	FLAK05 AM	21	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =94 µg/ml	24-h	Skin	US_06875744_B2
2084	None	2005	FALALKALKKLAKKLKKLAKKAL	FLAK04 AM	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =36 µg/ml	24-h	Skin	US_06875744_B2
2083	None	2005	FALALKALKKLLKKLKKLAKKAL	FLAK03 AM	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =85 µg/ml	24-h	Skin	US_06875744_B2
2082	None	2005	FALAAKALKKLAKKLKKLAKKAL	FLAK01 AM	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =27 µg/ml	24-h	Skin	US_06875744_B2
2081	None	2005	FAKKLAKKLKKLAKKLAKLALAL	SHIVA 10 AC	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	Not Available	24-h	Skin	US_06875744_B2
2080	None	2005	MPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG	SB-37 AM	38	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2079	None	2005	MPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG	SB-37 AC	38	Linear	L	None	Free	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =120 µg/ml	24-h	Skin	US_06875744_B2
2078	None	2005	FALALKALKKALKKLKKALKKAL	Hecate AM	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =128 µg/ml	24-h	Skin	US_06875744_B2
2077	None	2005	FALALKALKKALKKLKKALKKAL	Hecate AC	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =72 µg/ml	24-h	Skin	US_06875744_B2
2076	None	2005	FAKLLAKLAKKAA	FLAK50J	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	Not Available	24-h	Colon	US_06875744_B2
2075	None	2005	FALALKALKKLAKKLKKLAKKAL	FLAK04 AM V	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	Not Available	24-h	Colon	US_06875744_B2
2074	None	2005	VALALKALKKALKKLKKALKKAL	Hecate AC V	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	Not Available	24-h	Colon	US_06875744_B2
2073	None	2005	VALALKALKKALKKLKKALKKAL	Hecate AM V	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	Not Available	24-h	Colon	US_06875744_B2
2072	None	2005	VAKLLAKALKKLL	FLAK50D V	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	Not Available	24-h	Colon	US_06875744_B2
2071	None	2005	FAKKLAKLAKKLLAL	FLAK43 AM V	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	Not Available	24-h	Colon	US_06875744_B2
2070	None	2005	FAKKLAKLAKKLAKLALAL	FLAK 25 AM V	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	Not Available	24-h	Colon	US_06875744_B2
2068	None	2005	VAKFLAKFLKKAL	FLAK50 Q1V	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	Not Available	24-h	Colon	US_06875744_B2
2069	None	2005	VAKKFAKKFKKFAKKFAKFAFAF	D2A21V	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	Not Available	24-h	Colon	US_06875744_B2
2067	None	2005	FAKKLAKLAKKLAKLALAL	FLAK 17 CV	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	Not Available	24-h	Colon	US_06875744_B2
2066	None	2005	FAKKLAKKLKKLAKKLAKLAKKL	Anubis-2	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =73 µg/ml	24-h	Colon	US_06875744_B2
2065	None	2005	LPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG	LSB-37	38	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =240 µg/ml	24-h	Colon	US_06875744_B2
2063	None	2005	KKVVFKVKFK	KSL-1	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
2064	None	2005	FKVKFKVKVK	KSL-7	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =530 µg/ml	24-h	Colon	US_06875744_B2
2062	None	2005	FAKKFAKKFKKFAKKFAKFAFAF	D2A21	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =76 µg/ml	24-h	Colon	US_06875744_B2
2061	None	2005	GIGKFLHAAKKFAKAFVAEIMNS	Magainin2wisc	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =60 µg/ml	24-h	Colon	US_06875744_B2
2059	None	2005	FALA	FLAK-120B	4	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
2060	None	2005	WALAL	FLAK-120F	5	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =440 µg/ml	24-h	Colon	US_06875744_B2
2058	None	2005	FALALKAKKL	FLAK-120C	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
2056	None	2005	VALALKALKKL	FLAK-120G	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =600 µg/ml	24-h	Colon	US_06875744_B2
2057	None	2005	FALALKLKKL	FLAK-120D	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =870 µg/ml	24-h	Colon	US_06875744_B2
2055	None	2005	LKKLAKLALAF	Flak 96L	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
2053	None	2005	FALLKALLKKAL	Flak 96I	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =310 µg/ml	24-h	Colon	US_06875744_B2
2054	None	2005	FALALKLAKKL	Flak 96J	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
2051	None	2005	KFKKLAKKW	Modelin-8E	9	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =70 µg/ml	24-h	Colon	US_06875744_B2
2052	None	2005	FALALKALKKA	Flak 96H	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
2050	None	2005	KFKKLAKKF	Modelin-8D	9	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
2048	None	2005	FALKALKKAL	FLAK96C	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
2049	None	2005	FALLKALKKAL	FLAK96D	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =770 µg/ml	24-h	Colon	US_06875744_B2
2046	None	2005	FALLKL	FLAK96G	6	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
2047	None	2005	FALALKALKK	FLAK96F	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
2045	None	2005	FALALKLAKKAL	FLAK96B	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =360 µg/ml	24-h	Colon	US_06875744_B2
2043	None	2005	KWKKLAKKW	FLAK120	9	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =240 µg/ml	24-h	Colon	US_06875744_B2
2044	None	2005	FALAKALKKAL	FLAK121	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
2042	None	2005	KLAKKLAKLAKLAKAL	Modelin-5-CO2H	16	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =370 µg/ml	24-h	Colon	US_06875744_B2
2041	None	2005	KLAKKLAKLAKLAKAL	Modelin-5	16	Linear	L	None	Free	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =140 µg/ml	24-h	Colon	US_06875744_B2
2040	None	2005	FAVGLRAIKRALKKLRRGVRKVAKDL	FAGVL	26	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =530 µg/ml	24-h	Colon	US_06875744_B2
2038	None	2005	YAKLLAKLAKKAL	FLAK50T9	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
2039	None	2005	KLLKLLLKLYKKLLKLL	FLAK100-CO2H	17	Linear	L	None	Free	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =345 µg/ml	24-h	Colon	US_06875744_B2
2037	None	2005	VAKLLAKLAKKVL	FLAK50T8	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =750 µg/ml	24-h	Colon	US_06875744_B2
2036	None	2005	FALKALKKLKKALKKAL	FLAK95	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =61 µg/ml	24-h	Colon	US_06875744_B2
2034	None	2005	FAKLLAKLAKK	FLAK50T6	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
2035	None	2005	FAKLLAKLAKKGL	FLAK50T7	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =740 µg/ml	24-h	Colon	US_06875744_B2
2033	None	2005	KLALKLALKALKAAKLA	FLAK99	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =235 µg/ml	24-h	Colon	US_06875744_B2
2032	None	2005	KAKLAKKALAKLL	FLAK92B	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
2031	None	2005	FAKLAKKALAKLL	FLAK91B	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
2029	None	2005	KYKKALKKLAKLL	FLAK98	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =380 µg/ml	24-h	Colon	US_06875744_B2
2030	None	2005	FKRLAKIKVLRLAKIKR	FKRLA	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =185 µg/ml	24-h	Colon	US_06875744_B2
2027	None	2005	FALALKALKKAL	FLAK96	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =285 µg/ml	24-h	Colon	US_06875744_B2
2028	None	2005	FALKALKK	FLAK97	8	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
2026	None	2005	FAKIIAKIAKKI	FLAK50 Z10	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
2024	None	2005	FALALKA	FLAK94	7	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =560 µg/ml	24-h	Colon	US_06875744_B2
2025	None	2005	KWKLAKKALALL	FLAK93B	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =38 µg/ml	24-h	Colon	US_06875744_B2
2023	None	2005	FAFAKIIAKIAKKII	FLAK50 Z9	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
2021	None	2005	FAFGKGIGKIGKKGL	FLAK50 Z7	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
2022	None	2005	FAKIIAKIAKIAKKIL	FLAK50 Z8	16	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
2019	None	2005	FAKLWAKLAKKL	FLAK50 Z5	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =600 µg/ml	24-h	Colon	US_06875744_B2
2020	None	2005	FAKGVGKVGKKAL	FLAK50 Z6	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
2018	None	2005	FAKLWAKLAFGKGIGKVGKKLL	FLAK50 Z4	22	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =80 µg/ml	24-h	Colon	US_06875744_B2
2017	None	2005	FAKAIAKIAFGKGIGKVGKKLL	FLAK50 Z3	22	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =740 µg/ml	24-h	Colon	US_06875744_B2
2016	None	2005	FAFGKGIGKVGKKLL	FLAK50 Z2	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
2015	None	2005	FGKGIGKVGKKLL	FLAK50 Z1	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
2014	None	2005	KWKLF	FLAK93	5	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =555 µg/ml	24-h	Colon	US_06875744_B2
2013	None	2005	KAKLF	FLAK92	5	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
2012	None	2005	FAKLF	FLAK91	5	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =550 µg/ml	24-h	Colon	US_06875744_B2
2011	None	2005	FAKLA	FLAK90	5	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =530 µg/ml	24-h	Colon	US_06875744_B2
2010	None	2005	FAKLLAKLAKKSL	FLAK50 T5	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =400 µg/ml	24-h	Colon	US_06875744_B2
2009	None	2005	FAKLLAKLAKKEL	FLAK50 T4	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
2008	None	2005	FAKLLAKLAKKIL	FLAK50 T3	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =125 µg/ml	24-h	Colon	US_06875744_B2
2006	None	2005	FAKLLAKLAK	FLAK50 T1	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
2007	None	2005	FAKLLAKLAKKVL	FLAK50 T2	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =9 µg/ml	24-h	Colon	US_06875744_B2
2005	None	2005	FKLAFKLAKKAFL	FLAK50 Q10	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =570 µg/ml	24-h	Colon	US_06875744_B2
2004	None	2005	FAKLFAKLAKKFAL	FLAK50 Q9	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =800 µg/ml	24-h	Colon	US_06875744_B2
2003	None	2005	FAKLLAKLAKKFAL	FLAK50 Q8	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =630 µg/ml	24-h	Colon	US_06875744_B2
2001	None	2005	FAKLLAKALKKFL	FLAK50 Q6	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =115 µg/ml	24-h	Colon	US_06875744_B2
2002	None	2005	FAKLLAKALKKFAL	FLAK50 Q7	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =46 µg/ml	24-h	Colon	US_06875744_B2
1999	None	2005	FAKLLAKAFKKAL	FLAK50 Q4	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
2000	None	2005	FAKLFAKAFKKAL	FLAK50 Q5	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
1998	None	2005	FAKLLAKFLKKAL	FLAK50 Q3	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =180 µg/ml	24-h	Colon	US_06875744_B2
1996	None	2005	FAKFLAKFLKKAL	FLAK50 Q1	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =27 µg/ml	24-h	Colon	US_06875744_B2
1997	None	2005	FAKLLFKALKKAL	FLAK50 Q2	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =800 µg/ml	24-h	Colon	US_06875744_B2
1994	None	2005	FAKKLAKLAKKLAKAL	FLAK26-D2	16	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
1995	None	2005	FAKKLLAKALKL	FLAG26-D3	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =325 µg/ml	24-h	Colon	US_06875744_B2
1993	None	2005	GIGAVLKVLTTGLPALISWIKRKRQQ	MELITTIIN	26	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =23 µg/ml	24-h	Colon	US_06875744_B2
1992	None	2005	MPKEKVFLKIEKMGRNIRN	VISHNU3	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
1990	None	2005	KIAKVALAKLGIGAVLKVLTTGL	PYL-ME	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
1991	None	2005	FAKKLAKLAKKL	FLAG26-D1	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =570 µg/ml	24-h	Colon	US_06875744_B2
1989	None	2005	KWKLFKKALKKLKKALKKAL	CA(1-& HECATE(11/23)	20	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =54 µg/ml	24-h	Colon	US_06875744_B2
1987	None	2005	FAKLLAKALKKAL	FLAK 50O	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =57 µg/ml	24-h	Colon	US_06875744_B2
1988	None	2005	FAKLLAKALKKL	FLAK 50P	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =90 µg/ml	24-h	Colon	US_06875744_B2
1986	None	2005	FAKLLAKALKLKL	FLAK 50N	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =170 µg/ml	24-h	Colon	US_06875744_B2
1985	None	2005	FAKKLAKKLKKLAKKLIGAVLKV	SHIVA 11[(1-16)ME(2-9]-COOH	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =120 µg/ml	24-h	Colon	US_06875744_B2
1983	None	2005	FAKLLAKLAKAKG	FLAK50L	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
1984	None	2005	FAKKLAKKLKKLAKKLAKLALALKALALKAL	Shiva-11	31	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =125 µg/ml	24-h	Colon	US_06875744_B2
1982	None	2005	FAKLLAKLAKAKA	FLAK50K	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
1980	None	2005	FAKALAKLAKKLL	FLAK50B	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =51 µg/ml	24-h	Colon	US_06875744_B2
1981	None	2005	FAKLLALALKLKL	FLAK50I	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	Not Available	24-h	Colon	US_06875744_B2
1979	None	2005	ILPWKWPWWPWRR	Indolocidin-ac	13	Linear	L	None	Free	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =30 µg/ml	24-h	Colon	US_06875744_B2
1978	None	2005	KWKLFKKKTKLFKKFAKKLAKKL	CA(1-7) Shiva10(1-16)-COOH	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =13 µg/ml	24-h	Colon	US_06875744_B2
1977	None	2005	KTKLFKKFAKKLAKKLKKLAKKL	SHIVA 10 (1-16) Ac	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =35 µg/ml	24-h	Colon	US_06875744_B2
1976	None	2005	FAKKLKKLAKKL	FLAK 75	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
1975	None	2005	FAKKLAKKAKLAKKL	FLAK 72	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
1974	None	2005	FAKKLAKKLAKAAL	FLAK 58	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =400 µg/ml	24-h	Colon	US_06875744_B2
1972	None	2005	FAKKLAKKLAKAL	FLAK 54	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =340 µg/ml	24-h	Colon	US_06875744_B2
1973	None	2005	FAKKLAKKLAKLL	FLAK 56	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =17 µg/ml	24-h	Colon	US_06875744_B2
1971	None	2005	KWKLFKKKTKLFKKFAKKLAKKL	CA(1-7) Shiva10(1-16)	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =70 µg/ml	24-h	Colon	US_06875744_B2
1970	None	2005	FAKKLAKKLKKLAKKLAKKWKL	SHIVA 10 PEPTIDE 71 + KWKL	22	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =82 µg/ml	24-h	Colon	US_06875744_B2
1969	None	2005	FAKKLAKKLKKLAKKLAK	Shiva 10(1-18 AC)	18	Linear	L	None	Free	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =250 µg/ml	24-h	Colon	US_06875744_B2
1967	None	2005	FAKLLAKLAKLKL	FLAK 50G	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =145 µg/ml	24-h	Colon	US_06875744_B2
1968	None	2005	FAKKLAKKLKKLAKKLAKKWKL	SHIVA DERIV P69 + KWKL	22	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =11 µg/ml	24-h	Colon	US_06875744_B2
1966	None	2005	FAKLLAKLAKAKL	FLAK 50H	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =345 µg/ml	24-h	Colon	US_06875744_B2
1964	None	2005	ILPWKWPWWPWRR	Indolicidin	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =345 µg/ml	24-h	Colon	US_06875744_B2
1965	None	2005	FAKALKALLKALKAL	FLAK 17 C	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ = µg/ml	24-h	Colon	US_06875744_B2
1962	None	2005	FAKLAKKLL	FLAK83M	9	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
1963	None	2005	FAKKLAKLAKKLAKLAL	FLAK 26 Ac	17	Linear	L	None	Free	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =100 µg/ml	24-h	Colon	US_06875744_B2
1960	None	2005	FAKKLAKALL	FLAK81	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
1961	None	2005	FAKKLAKKLL	FLAK82	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =42 µg/ml	24-h	Colon	US_06875744_B2
1958	None	2005	FAKLLKLAAKKLL	FLAK 50E	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =215 µg/ml	24-h	Colon	US_06875744_B2
1959	None	2005	FAKLLAKKLL	FLAK80	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =740 µg/ml	24-h	Colon	US_06875744_B2
1957	None	2005	FAKLLAKALKKLL	FLAK50D	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =14 µg/ml	24-h	Colon	US_06875744_B2
1956	None	2005	FAKLLAKLAKKAL	FLAK50C	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	Not Available	24-h	Colon	US_06875744_B2
1955	None	2005	KWKLFKKIGAVLKVL	CAME-15	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	Not Available	24-h	Colon	US_06875744_B2
1954	None	2005	VAKKLAKLAKKLAKLAL	FLAK26V AM	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =46 µg/ml	24-h	Colon	US_06875744_B2
1953	None	2005	FAKLLAKLAKKL	FLAK50F	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =100 µg/ml	24-h	Colon	US_06875744_B2
1952	None	2005	VAKLLAKLAKKLL	FLAK50V	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =47 µg/ml	24-h	Colon	US_06875744_B2
1951	None	2005	FAKKALKALKKL	FLAK77	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
1950	None	2005	FAKKLKKLAKLAKKL	FLAK71	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =160 µg/ml	24-h	Colon	US_06875744_B2
1949	None	2005	FAKKLAKKLAKLAL	FLAK57	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =180 µg/ml	24-h	Colon	US_06875744_B2
1948	None	2005	FAKKLAKLALKLAKL	FLAK51	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =32 µg/ml	24-h	Colon	US_06875744_B2
1947	None	2005	FAKLLAKLAKKLL	FLAK50	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =9 µg/ml	24-h	Colon	US_06875744_B2
1946	None	2005	GIGKFLKKAKKFGKAFVKILKK	MSI-78 AM	22	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =34 µg/ml	24-h	Colon	US_06875744_B2
1944	None	2005	FALAKKALKKAKKAL	FLAK62 AM	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
1945	None	2005	FAKKLAKKLKKLAKLALAK	FLAK 06R-AM	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =120 µg/ml	24-h	Colon	US_06875744_B2
1943	None	2005	FAKKLAKLAKKALAL	FLAK44 AM	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =435 µg/ml	24-h	Colon	US_06875744_B2
1942	None	2005	FAKKLAKLAKKLLAL	FLAK43 AM	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =13 µg/ml	24-h	Colon	US_06875744_B2
1941	None	2005	FALALKALKKALkkLKKALKKAL	HECATE 2DAc	23	Linear	Mix	None	Free	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =57 µg/ml	24-h	Colon	US_06875744_B2
1940	None	2005	FAKKLAKLAKKLAKLALAL	FLAK 25 AM	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =30 µg/ml	24-h	Colon	US_06875744_B2
1939	None	2005	FAKKLAKLAKKLAKLAL	FLAK 26 AM	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =14 µg/ml	24-h	Colon	US_06875744_B2
1938	None	2005	FALALKKALKALKKAL	FLAK 17 AM	16	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =35 µg/ml	24-h	Colon	US_06875744_B2
1937	None	2005	VALALKALKKALKKLKKALKKAL	KAL V	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =62 µg/ml	24-h	Colon	US_06875744_B2
1936	None	2005	FAKKLAKKLKKLAKLALAL	FLAK06 R-AC	19	Linear	L	None	Free	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =210 µg/ml	24-h	Colon	US_06875744_B2
1935	None	2005	FALALKALKKLKKALKKAL	FLAK06 AC	19	Linear	L	None	Free	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =59 µg/ml	24-h	Colon	US_06875744_B2
1934	None	2005	FALALKALKKLKKALKKAL	FLAK06 AM	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =26 µg/ml	24-h	Colon	US_06875744_B2
1933	None	2005	FALAKLAKKAKAKLKKALKAL	FLAK05 AM	21	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =8 µg/ml	24-h	Colon	US_06875744_B2
1932	None	2005	FALALKALKKLAKKLKKLAKKAL	FLAK04 AM	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =12 µg/ml	24-h	Colon	US_06875744_B2
1931	None	2005	FALALKALKKLLKKLKKLAKKAL	FLAK03 AM	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =38 µg/ml	24-h	Colon	US_06875744_B2
1930	None	2005	FALAAKALKKLAKKLKKLAKKAL	FLAK01 AM	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =5 µg/ml	24-h	Colon	US_06875744_B2
1929	None	2005	FAKKLAKKLKKLAKKLAKLALAL	SHIVA 10 AC	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	Not Available	24-h	Colon	US_06875744_B2
1928	None	2005	MPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG	SB-37 AM	38	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
1927	None	2005	MPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG	SB-37 AC	38	Linear	L	None	Free	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =82 µg/ml	24-h	Colon	US_06875744_B2
1926	None	2005	FALALKALKKALKKLKKALKKAL	Hecate AM	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =46 µg/ml	24-h	Colon	US_06875744_B2
1925	None	2005	FALALKALKKALKKLKKALKKAL	Hecate AC	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =6 µg/ml	24-h	Colon	US_06875744_B2
1924	None	2005	FAKLLAKLAKKAA	FLAK50J	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	Not Available	24-h	Breast	US_06875744_B2
1923	None	2005	VALALKALKKLAKKLKKLAKKAL	FLAK04 AM V	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =84 µg/ml	24-h	Breast	US_06875744_B2
1922	None	2005	VALALKALKKALKKLKKALKKAL	Hecate AC V	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =160 µg/ml	24-h	Breast	US_06875744_B2
1920	None	2005	VAKLLAKALKKLL	FLAK50D V	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =45 µg/ml	24-h	Breast	US_06875744_B2
1921	None	2005	VALALKALKKALKKLKKALKKAL	Hecate AM V	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =340 µg/ml	24-h	Breast	US_06875744_B2
1918	None	2005	VAKKLAKLAKKLAKLALAL	FLAK 25 AM V	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =130 µg/ml	24-h	Breast	US_06875744_B2
1919	None	2005	VAKKLAKLAKKLLAL	FLAK43 AM V	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =86 µg/ml	24-h	Breast	US_06875744_B2
1916	None	2005	VAKFLAKFLKKAL	FLAK50 Q1V	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =92 µg/ml	24-h	Breast	US_06875744_B2
1917	None	2005	VAKKFAKKFKKFAKKFAKFAFAF	D2A21V	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =210 µg/ml	24-h	Breast	US_06875744_B2
1915	None	2005	FAKKLAKLAKKLAKLALAL	FLAK 17 CV	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =23 µg/ml	24-h	Breast	US_06875744_B2
1914	None	2005	FAKKLAKKLKKLAKKLAKLAKKL	Anubis-2	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =38 µg/ml	24-h	Breast	US_06875744_B2
1913	None	2005	LPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG	LSB-37	38	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =50 µg/ml	24-h	Breast	US_06875744_B2
1912	None	2005	FKVKFKVKVK	KSL-7	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =315 µg/ml	24-h	Breast	US_06875744_B2
1911	None	2005	KKVVFKVKFK	KSL-1	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =340 µg/ml	24-h	Breast	US_06875744_B2
1910	None	2005	FAKKFAKKFKKFAKKFAKFAFAF	D2A21	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =64 µg/ml	24-h	Breast	US_06875744_B2
1909	None	2005	GIGKFLHAAKKFAKAFVAEIMNS	Magainin2wisc	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =22 µg/ml	24-h	Breast	US_06875744_B2
1908	None	2005	WALAL	FLAK-120F	5	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =260 µg/ml	24-h	Breast	US_06875744_B2
1907	None	2005	FALA	FLAK-120B	4	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Breast	US_06875744_B2
1906	None	2005	FALALKAKKL	FLAK-120C	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Breast	US_06875744_B2
1905	None	2005	FALALKLKKL	FLAK-120D	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =550 µg/ml	24-h	Breast	US_06875744_B2
1904	None	2005	VALALKALKKL	FLAK-120G	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =950 µg/ml	24-h	Breast	US_06875744_B2
1903	None	2005	LKKLAKLALAF	Flak 96L	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =555 µg/ml	24-h	Breast	US_06875744_B2
1901	None	2005	FALLKALLKKAL	Flak 96I	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =190 µg/ml	24-h	Breast	US_06875744_B2
1902	None	2005	FALALKLAKKL	Flak 96J	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =770 µg/ml	24-h	Breast	US_06875744_B2
1900	None	2005	FALALKALKKA	Flak 96H	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Breast	US_06875744_B2
1899	None	2005	KFKKLAKKW	Modelin-8E	9	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Breast	US_06875744_B2
1897	None	2005	FALLKALKKAL	FLAK96D	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =305 µg/ml	24-h	Breast	US_06875744_B2
1898	None	2005	KFKKLAKKF	Modelin-8D	9	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Breast	US_06875744_B2
1895	None	2005	FALALKALKK	FLAK96F	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =510 µg/ml	24-h	Breast	US_06875744_B2
1896	None	2005	FALKALKKAL	FLAK96C	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =940 µg/ml	24-h	Breast	US_06875744_B2
1893	None	2005	FALALKLAKKAL	FLAK96B	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =230 µg/ml	24-h	Breast	US_06875744_B2
1894	None	2005	FALLKL	FLAK96G	6	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =630 µg/ml	24-h	Breast	US_06875744_B2
1892	None	2005	FALAKALKKAL	FLAK121	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Breast	US_06875744_B2
1891	None	2005	FALALKALKKL	FLAK120	9	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =360 µg/ml	24-h	Breast	US_06875744_B2
1890	None	2005	KLAKKLAKLAKLAKAL	Modelin-5-CO2H	16	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =320 µg/ml	24-h	Breast	US_06875744_B2
1889	None	2005	KLAKKLAKLAKLAKAL	Modelin-5	16	Linear	L	None	Free	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =61 µg/ml	24-h	Breast	US_06875744_B2
1888	None	2005	FAVGLRAIKRALKKLRRGVRKVAKDL	FAGVL	26	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =240 µg/ml	24-h	Breast	US_06875744_B2
1886	None	2005	YAKLLAKLAKKAL	FLAK50T9	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Breast	US_06875744_B2
1887	None	2005	KLLKLLLKLYKKLLKLL	FLAK100-CO2H	17	Linear	L	None	Free	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =135 µg/ml	24-h	Breast	US_06875744_B2
1885	None	2005	VAKLLAKLAKKVL	FLAK50T8	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =315 µg/ml	24-h	Breast	US_06875744_B2
1884	None	2005	FALKALKKLKKALKKAL	FLAK95	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =64 µg/ml	24-h	Breast	US_06875744_B2
1882	None	2005	FAKLLAKLAKK	FLAK50T6	11	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Breast	US_06875744_B2
1883	None	2005	FAKLLAKLAKKGL	FLAK50T7	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =430 µg/ml	24-h	Breast	US_06875744_B2
1880	None	2005	KAKLAKKALAKLL	FLAK92B	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Breast	US_06875744_B2
1881	None	2005	KLALKLALKALKAAKLA	FLAK99	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =160 µg/ml	24-h	Breast	US_06875744_B2
1879	None	2005	FAKLAKKALAKLL	FLAK91B	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =315 µg/ml	24-h	Breast	US_06875744_B2
1878	None	2005	FKRLAKIKVLRLAKIKR	FKRLA	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =106 µg/ml	24-h	Breast	US_06875744_B2
1876	None	2005	FALKALKK	FLAK97	8	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Breast	US_06875744_B2
1877	None	2005	KYKKALKKLAKLL	FLAK98	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =110 µg/ml	24-h	Breast	US_06875744_B2
1875	None	2005	FALALKALKKAL	FLAK96	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =150 µg/ml	24-h	Breast	US_06875744_B2
1873	None	2005	KWKLAKKALALL	FLAK93B	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =44 µg/ml	24-h	Breast	US_06875744_B2
1874	None	2005	FAKIIAKIAKKI	FLAK50 Z10	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Breast	US_06875744_B2
1872	None	2005	FALALKA	FLAK94	7	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =430 µg/ml	24-h	Breast	US_06875744_B2
1871	None	2005	FAFAKIIAKIAKKII	FLAK50 Z9	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Breast	US_06875744_B2
1869	None	2005	FAFGKGIGKIGKKGL	FLAK50 Z7	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Breast	US_06875744_B2
1870	None	2005	FAKIIAKIAKIAKKIL	FLAK50 Z8	16	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =625 µg/ml	24-h	Breast	US_06875744_B2
1868	None	2005	FAKGVGKVGKKAL	FLAK50 Z6	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Breast	US_06875744_B2
1867	None	2005	FAKLWAKLAKKL	FLAK50 Z5	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =500 µg/ml	24-h	Breast	US_06875744_B2
1866	None	2005	FAKLWAKLAFGKGIGKVGKKLL	FLAK50 Z4	22	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =54 µg/ml	24-h	Breast	US_06875744_B2
1865	None	2005	FAKAIAKIAFGKGIGKVGKKLL	FLAK50 Z3	22	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Breast	US_06875744_B2
1864	None	2005	FAFGKGIGKVGKKLL	FLAK50 Z2	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Breast	US_06875744_B2
1863	None	2005	FGKGIGKVGKKLL	FLAK50 Z1	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Breast	US_06875744_B2
1862	None	2005	KWKLF	FLAK93	5	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =600 µg/ml	24-h	Breast	US_06875744_B2
1861	None	2005	KAKLF	FLAK92	5	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Breast	US_06875744_B2
1860	None	2005	FAKLF	FLAK91	5	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Breast	US_06875744_B2
1859	None	2005	FAKLA	FLAK90	5	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =500 µg/ml	24-h	Breast	US_06875744_B2
1858	None	2005	FAKLLAKLAKKSL	FLAK50 T5	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =440 µg/ml	24-h	Breast	US_06875744_B2
1856	None	2005	FAKLLAKLAKKIL	FLAK50 T3	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =90 µg/ml	24-h	Breast	US_06875744_B2
1857	None	2005	FAKLLAKLAKKEL	FLAK50 T4	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Breast	US_06875744_B2
1854	None	2005	FAKLLAKLAK	FLAK50 T1	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =615 µg/ml	24-h	Breast	US_06875744_B2
1855	None	2005	FAKLLAKLAKKVL	FLAK50 T2	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =18 µg/ml	24-h	Breast	US_06875744_B2
1853	None	2005	FKLAFKLAKKAFL	FLAK50 Q10	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =360 µg/ml	24-h	Breast	US_06875744_B2
1851	None	2005	FAKLLAKLAKKFAL	FLAK50 Q8	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =730 µg/ml	24-h	Breast	US_06875744_B2
1852	None	2005	FAKLFAKLAKKFAL	FLAK50 Q9	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =400 µg/ml	24-h	Breast	US_06875744_B2
1850	None	2005	FAKLLAKALKKFAL	FLAK50 Q7	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =54 µg/ml	24-h	Breast	US_06875744_B2
1849	None	2005	FAKLLAKALKKFL	FLAK50 Q6	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =70 µg/ml	24-h	Breast	US_06875744_B2
1848	None	2005	FAKLFAKAFKKAL	FLAK50 Q5	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Breast	US_06875744_B2
1847	None	2005	FAKLLAKAFKKAL	FLAK50 Q4	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =730 µg/ml	24-h	Breast	US_06875744_B2
1846	None	2005	FAKLLAKFLKKAL	FLAK50 Q3	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =150 µg/ml	24-h	Breast	US_06875744_B2
1845	None	2005	FAKLLFKALKKAL	FLAK50 Q2	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =500 µg/ml	24-h	Breast	US_06875744_B2
1844	None	2005	FAKFLAKFLKKAL	FLAK50 Q1	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =35 µg/ml	24-h	Breast	US_06875744_B2
1843	None	2005	FAKKLLAKALKL	FLAG26-D3	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =180 µg/ml	24-h	Breast	US_06875744_B2
1842	None	2005	FAKKLAKLAKKLAKAL	FLAK26-D2	16	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Breast	US_06875744_B2
1841	None	2005	GIGAVLKVLTTGLPALISWIKRKRQQ	MELITTIIN	26	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =9 µg/ml	24-h	Breast	US_06875744_B2
1840	None	2005	MPKEKVFLKIEKMGRNIRN	VISHNU3	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Breast	US_06875744_B2
1839	None	2005	FAKKLAKLAKKL	FLAG26-D1	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =620 µg/ml	24-h	Breast	US_06875744_B2
1838	None	2005	KIAKVALAKLGIGAVLKVLTTGL	PYL-ME	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =635 µg/ml	24-h	Breast	US_06875744_B2
1837	None	2005	KWKLFKKALKKLKKALKKAL	CA(1-& HECATE(11/23)	20	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =11 µg/ml	24-h	Breast	US_06875744_B2
1836	None	2005	FAKLLAKALKKL	FLAK 50P	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =46 µg/ml	24-h	Breast	US_06875744_B2
1835	None	2005	FAKLLAKALKKAL	FLAK 50O	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =60 µg/ml	24-h	Breast	US_06875744_B2
1834	None	2005	FAKLLAKALKLKL	FLAK 50N	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =250 µg/ml	24-h	Breast	US_06875744_B2
1833	None	2005	FAKKLAKKLKKLAKKLIGAVLKV	SHIVA 11[(1-16)ME(2-9]-COOH	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =95 µg/ml	24-h	Breast	US_06875744_B2
1832	None	2005	FAKKLAKKLKKLAKKLAKLALALKALALKAL	Shiva-11	31	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =96 µg/ml	24-h	Breast	US_06875744_B2
1830	None	2005	FAKLLAKLAKAKA	FLAK50K	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Breast	US_06875744_B2
1831	None	2005	FAKLLAKLAKAKG	FLAK50L	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Breast	US_06875744_B2
1829	None	2005	FAKLLALALKLKL	FLAK50I	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =65 µg/ml	24-h	Breast	US_06875744_B2
1828	None	2005	FAKALAKLAKKLL	FLAK50B	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =23 µg/ml	24-h	Breast	US_06875744_B2
1827	None	2005	ILPWKWPWWPWRR	Indolocidin-ac	13	Linear	L	None	Free	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =12 µg/ml	24-h	Breast	US_06875744_B2
1826	None	2005	KWKLFKKKTKLFKKFAKKLAKKL	CA(1-7) Shiva10(1-16)-COOH	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =63 µg/ml	24-h	Breast	US_06875744_B2
1825	None	2005	KTKLFKKFAKKLAKKLKKLAKKL	SHIVA 10 (1-16) Ac	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =29 µg/ml	24-h	Breast	US_06875744_B2
1824	None	2005	FAKKLKKLAKKL	FLAK 75	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =540 µg/ml	24-h	Breast	US_06875744_B2
1823	None	2005	FAKKLAKKAKLAKKL	FLAK 72	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Breast	US_06875744_B2
1821	None	2005	FAKKLAKKLAKLL	FLAK 56	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =42 µg/ml	24-h	Breast	US_06875744_B2
1822	None	2005	FAKKLAKKLAKAAL	FLAK 58	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =970 µg/ml	24-h	Breast	US_06875744_B2
1820	None	2005	FAKKLAKKLAKAL	FLAK 54	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =465 µg/ml	24-h	Breast	US_06875744_B2
1819	None	2005	KWKLFKKKTKLFKKFAKKLAKKL	CA (1-7) Shiva10 (1-16)	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =150 µg/ml	24-h	Breast	US_06875744_B2
1818	None	2005	FAKKLAKKLKKLAKKLAKKWKL	SHIVA 10 PEPTIDE 71 + KWKL	22	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =93 µg/ml	24-h	Breast	US_06875744_B2
1817	None	2005	FAKKLAKKLKKLAKKLAK	Shiva 10(1-18 AC)	18	Linear	L	None	Free	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =190 µg/ml	24-h	Breast	US_06875744_B2
1816	None	2005	FAKKLAKKLKKLAKKLAKKWKL	SHIVA DERIV P69 + KWKL	22	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =44 µg/ml	24-h	Breast	US_06875744_B2
1815	None	2005	FAKLLAKLAKLKL	FLAK 50G	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =90 µg/ml	24-h	Breast	US_06875744_B2
1814	None	2005	FAKLLAKLAKAKL	FLAK 50H	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =475 µg/ml	24-h	Breast	US_06875744_B2
1813	None	2005	FAKALKALLKALKAL	FLAK 17 C	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =80 µg/ml	24-h	Breast	US_06875744_B2
1812	None	2005	ILPWKWPWWPWRR	Indolicidin	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =64 µg/ml	24-h	Breast	US_06875744_B2
1811	None	2005	FAKKLAKLAKKLAKLAL	FLAK 26 Ac	17	Linear	L	None	Free	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =105 µg/ml	24-h	Breast	US_06875744_B2
1810	None	2005	FAKLAKKLL	FLAK83M	9	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Breast	US_06875744_B2
1809	None	2005	FAKKLAKKLL	FLAK82	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =31 µg/ml	24-h	Breast	US_06875744_B2
1808	None	2005	FAKKLAKALL	FLAK81	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Breast	US_06875744_B2
1807	None	2005	FAKLLAKKLL	FLAK80	10	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Breast	US_06875744_B2
1806	None	2005	FAKLLKLAAKKLL	FLAK 50E	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =500 µg/ml	24-h	Breast	US_06875744_B2
1805	None	2005	FAKLLAKALKKLL	FLAK50D	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =16 µg/ml	24-h	Breast	US_06875744_B2
1804	None	2005	FAKLLAKLAKKAL	FLAK50C	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =60 µg/ml	24-h	Breast	US_06875744_B2
1803	None	2005	KWKLFKKIGAVLKVL	CAME-15	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =45 µg/ml	24-h	Breast	US_06875744_B2
1802	None	2005	VAKKLAKLAKKLAKLAL	FLAK26V AM	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =32 µg/ml	24-h	Breast	US_06875744_B2
1801	None	2005	FAKLLAKLAKKL	FLAK50F	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =40 µg/ml	24-h	Breast	US_06875744_B2
1800	None	2005	VAKLLAKLAKKLL	FLAK50V	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =23 µg/ml	24-h	Breast	US_06875744_B2
1799	None	2005	FAKKALKALKKL	FLAK77	12	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =575 µg/ml	24-h	Breast	US_06875744_B2
1798	None	2005	FAKKLKKLAKLAKKL	FLAK71	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =300 µg/ml	24-h	Breast	US_06875744_B2
1797	None	2005	FAKKLAKKLAKLAL	FLAK57	14	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =260 µg/ml	24-h	Breast	US_06875744_B2
1796	None	2005	FAKKLAKLALKLAKL	FLAK51	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =140 µg/ml	24-h	Breast	US_06875744_B2
1795	None	2005	FAKLLAKLAKKLL	FLAK50	13	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =9 µg/ml	24-h	Breast	US_06875744_B2
1794	None	2005	GIGKFLKKAKKFGKAFVKILKK	MSI-78 AM	22	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =31 µg/ml	24-h	Breast	US_06875744_B2
1793	None	2005	FAKKLAKKLKKLAKLALAK	FLAK 06R-AM	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =98 µg/ml	24-h	Breast	US_06875744_B2
1792	None	2005	FALAKKALKKAKKAL	FLAK62 AM	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =760 µg/ml	24-h	Breast	US_06875744_B2
1791	None	2005	FAKKLAKLAKKALAL	FLAK44 AM	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =130 µg/ml	24-h	Breast	US_06875744_B2
1790	None	2005	FAKKLAKLAKKLLAL	FLAK43 AM	15	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =17 µg/ml	24-h	Breast	US_06875744_B2
1789	None	2005	FALALKALKKALkkLKKALKKAL	HECATE 2DAc	23	Linear	Mix	None	Free	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =14 µg/ml	24-h	Breast	US_06875744_B2
1788	None	2005	FAKKLAKLAKKLAKLALAL	FLAK 25 AM	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =9 µg/ml	24-h	Breast	US_06875744_B2
1787	None	2005	FAKKLAKLAKKLAKLAL	FLAK 26 AM	17	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =9 µg/ml	24-h	Breast	US_06875744_B2
1786	None	2005	FALALKKALKALKKAL	FLAK 17 AM	16	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =21 µg/ml	24-h	Breast	US_06875744_B2
1785	None	2005	VALALKALKKALKKLKKALKKAL	KAL V	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =72 µg/ml	24-h	Breast	US_06875744_B2
1784	None	2005	FAKKLAKKLKKLAKLALAL	FLAK06 R-AC	19	Linear	L	None	Free	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =140 µg/ml	24-h	Breast	US_06875744_B2
1783	None	2005	FALALKALKKLKKALKKAL	FLAK06 AC	19	Linear	L	None	Free	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =65 µg/ml	24-h	Breast	US_06875744_B2
1782	None	2005	FALALKALKKLKKALKKAL	FLAK06 AM	19	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =14 µg/ml	24-h	Breast	US_06875744_B2
1781	None	2005	FALAKLAKKAKAKLKKALKAL	FLAK05 AM	21	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =74 µg/ml	24-h	Breast	US_06875744_B2
1780	None	2005	FALALKALKKLAKKLKKLAKKAL	FLAK04 AM	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =10 µg/ml	24-h	Breast	US_06875744_B2
1779	None	2005	FALALKALKKLLKKLKKLAKKAL	FLAK03 AM	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =26 µg/ml	24-h	Breast	US_06875744_B2
1778	None	2005	FALAAKALKKLAKKLKKLAKKAL	FLAK01 AM	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =62 µg/ml	24-h	Breast	US_06875744_B2
1777	None	2005	FAKKLAKKLKKLAKKLAKLALAL	SHIVA 10 AC	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Breast	US_06875744_B2
1776	None	2005	MPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG	SB-37 AM	38	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =540 µg/ml	24-h	Breast	US_06875744_B2
1775	None	2005	MPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG	SB-37 AC	38	Linear	L	None	Free	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =175 µg/ml	24-h	Breast	US_06875744_B2
1774	None	2005	FALALKALKKALKKLKKALKKAL	Hecate AM	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =23 µg/ml	24-h	Breast	US_06875744_B2
1773	None	2005	FALALKALKKALKKLKKALKKAL	Hecate Ac	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =54 µg/ml	24-h	Breast	US_06875744_B2
1709	11691780	2001	KLAKLAKKLAKLAK	DP1	14	Linear	L	None	Free	Free	Antimicrobial	Protein transduction domain	MCA205	Renal Cancer	MTT/MTS assay	LC₅₀ =< 50 µM	168-h	Renal	None
1669	15796184	2005	LRVRLASHLRKLRKRLLRDADDLQKRLAVY	Apo E	30	Linear	L	None	Free	Free	Antibacterial	Apoprotein E	COLO-201	Colon Cancer	MTT/MTS assay	65 % Cytotoxity at 40 µg/ml	4-h	Colon	None
1668	15796184	2005	LRVRLASHLRKLRKRLLRDADDLQKRLAVY	Apo E	30	Linear	L	None	Free	Free	Antibacterial	Apoprotein E	MKN-7	Gastric Cancer	MTT/MTS assay	35 % Cytotoxity at 40 µg/ml	4-h	Stomach	None
1667	15796184	2005	LRVRLASHLRKLRKRLLRDADDLQKRLAVY	Apo E	30	Linear	L	None	Free	Free	Antibacterial	Apoprotein E	MKN-1	Gastric Cancer	MTT/MTS assay	60 % Cytotoxity at 40 µg/ml	4-h	Stomach	None
1666	15796184	2005	LRVRLASHLRKLRKRLLRDADDLQKRLAVY	Apo E	30	Linear	L	None	Free	Free	Antibacterial	Apoprotein E	Paca-2	Pancreatic Cancer	MTT/MTS assay	55 % Cytotoxity at 40 µg/ml	4-h	Pancreatic	None
1665	15796184	2005	LRVRLASHLRKLRKRLLRDADDLQKRLAVY	Apo E	30	Linear	L	None	Free	Free	Antibacterial	Apoprotein E	PANC-1	Pancreatic Cancer	MTT/MTS assay	55 % Cytotoxity at 40 µg/ml	4-h	Pancreatic	None
1664	11835991	2001	SIGAKILGGVKTFFKGALKELASTYLQ	maximin5	27	Linear	L	None	Free	Free	Antimicrobial	Bombina maxima	T-24	Bladder Cancer	MTT/MTS assay	IC₅₀=>50 µg/ml	48-h	Bladder	None
1663	11835991	2001	GIGVLLSAGKAALKGLAKVLAEKYAN	maximin4	26	Linear	L	None	Amidation	Free	Antimicrobial	Bombina maxima	T-24	Bladder Cancer	MTT/MTS assay	IC₅₀=>50 µg/ml	48-h	Bladder	None
1662	11835991	2001	GIGGKILSGLKTALKGAAKELASTYLH	maximin3	27	Linear	L	None	Free	Free	Antimicrobial	Bombina maxima	T-24	Bladder Cancer	MTT/MTS assay	IC₅₀ =18 µg/ml	48-h	Bladder	None
1661	11835991	2001	GIGTKILGGVKTALKGALKELASTYAN	maximin1	27	Linear	L	None	Amidation	Free	Antimicrobial	Bombina maxima	T-24	Bladder Cancer	MTT/MTS assay	IC₅₀ =35.4 µg/ml	48-h	Bladder	None
1660	11835991	2001	SIGAKILGGVKTFFKGALKELASTYLQ	maximin5	27	Linear	L	None	Free	Free	Antimicrobial	Bombina maxima	BIU-87	Bladder Cancer	MTT/MTS assay	IC₅₀ =>50 µg/ml	48-h	Bladder	None
1659	11835991	2001	GIGVLLSAGKAALKGLAKVLAEKYAN	maximin4	26	Linear	L	None	Amidation	Free	Antimicrobial	Bombina maxima	BIU-87	Bladder Cancer	MTT/MTS assay	IC₅₀ =>50 µg/ml	48-h	Bladder	None
1658	11835991	2001	GIGGKILSGLKTALKGAAKELASTYLH	maximin3	27	Linear	L	None	Free	Free	Antimicrobial	Bombina maxima	BIU-87	Bladder Cancer	MTT/MTS assay	IC₅₀=28 µg/ml	48-h	Bladder	None
1657	11835991	2001	GIGTKILGGVKTALKGALKELASTYAN	maximin1	27	Linear	L	None	Amidation	Free	Antimicrobial	Bombina maxima	BIU-87	Bladder Cancer	MTT/MTS assay	IC₅₀=20.5 µg/ml	48-h	Bladder	None
1656	11835991	2001	SIGAKILGGVKTFFKGALKELASTYLQ	maximin5	27	Linear	L	None	Free	Free	Antimicrobial	Bombina maxima	MOLT-4	Leukemia Cancer	MTT/MTS assay	IC₅₀ >50 µg/ml	48-h	Blood	None
1655	11835991	2001	GIGVLLSAGKAALKGLAKVLAEKYAN	maximin4	26	Linear	L	None	Amidation	Free	Antimicrobial	Bombina maxima	MOLT-4	Leukemia Cancer	MTT/MTS assay	IC₅₀ =53.4 µg/ml	48-h	Blood	None
1654	11835991	2001	GIGGKILSGLKTALKGAAKELASTYLH	maximin3	27	Linear	L	None	Free	Free	Antimicrobial	Bombina maxima	MOLT-4	Leukemia Cancer	MTT/MTS assay	IC₅₀ =25.2 µg/ml	48-h	Blood	None
1653	11835991	2001	GIGTKILGGVKTALKGALKELASTYAN	maximin1	27	Linear	L	None	Amidation	Free	Antimicrobial	Bombina maxima	MOLT-4	Leukemia Cancer	MTT/MTS assay	IC₅₀=24.3 µg/ml	48-h	Blood	None
1652	11835991	2001	SIGAKILGGVKTFFKGALKELASTYLQ	maximin5	27	Linear	L	None	Free	Free	Antimicrobial	Bombina maxima	C8166	Leukemia Cancer	MTT/MTS assay	IC₅₀=34.4 µg/ml	48-h	Blood	None
1651	11835991	2001	GIGVLLSAGKAALKGLAKVLAEKYAN	maximin4	26	Linear	L	None	Amidation	Free	Antimicrobial	Bombina maxima	C8166	Leukemia Cancer	MTT/MTS assay	IC₅₀=24.2 µg/ml	48-h	Blood	None
1650	11835991	2001	GIGGKILSGLKTALKGAAKELASTYLH	maximin3	27	Linear	L	None	Free	Free	Antimicrobial	Bombina maxima	C8166	Leukemia Cancer	MTT/MTS assay	IC₅₀=11.4 µg/ml	48-h	Blood	None
1649	11835991	2001	GIGTKILGGVKTALKGALKELASTYAN	maximin1	27	Linear	L	None	Amidation	Free	Antimicrobial	Bombina maxima	C8166	Leukemia Cancer	MTT/MTS assay	IC₅₀=15.3 µg/ml	48-h	Blood	None
1648	12366526	2002	PAWRKARRWARRMKKLAA	L15	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	HT-29	Colon Cancer	MTT/MTS assay	IC₅₀=178 µM	4-h	Colon	None
1647	12366526	2002	PAWRKARRWAWRMKKLAA	L14	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	HT-29	Colon Cancer	MTT/MTS assay	IC₅₀=423 µM	4-h	Colon	None
1646	12366526	2002	PAWRKAFRKAWRMLKKAA	L13	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	HT-29	Colon Cancer	MTT/MTS assay	IC₅₀=29 µM	4-h	Colon	None
1645	12366526	2002	PAWRKAFRWAKRMLKKAA	L12	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	HT-29	Colon Cancer	MTT/MTS assay	IC₅₀=25 µM	4-h	Colon	None
1644	12366526	2002	PAARKAARWAWRMLKKGA	L11	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	HT-29	Colon Cancer	MTT/MTS assay	IC₅₀=248 µM	4-h	Colon	None
1643	12366526	2002	PAARKAFRWAWRMLKKAA	L10	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	HT-29	Colon Cancer	MTT/MTS assay	IC₅₀=35 µM	4-h	Colon	None
1642	12366526	2002	PAWRKAARWAWRMLKKAA	L9	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	HT-29	Colon Cancer	MTT/MTS assay	IC₅₀=52 µM	4-h	Colon	None
1641	12366526	2002	PAWAKAFRAAARMKLKAA	L8	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	HT-29	Colon Cancer	MTT/MTS assay	IC₅₀=180 µM	4-h	Colon	None
1640	12366526	2002	PAWRKAFRAAWRMLKKAA	L7	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	HT-29	Colon Cancer	MTT/MTS assay	IC₅₀=16 µM	4-h	Colon	None
1639	12366526	2002	PAWRKAFRWAARMLKKAA	L6	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	HT-29	Colon Cancer	MTT/MTS assay	IC₅₀=15 µM	4-h	Colon	None
1638	12366526	2002	PAWRKAFRWAWRMLKKAA	L5	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	HT-29	Colon Cancer	MTT/MTS assay	IC₅₀=14 µM	4-h	Colon	None
1637	12366526	2002	PAWFKARRWAWRMLKKAA	L4	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	HT-29	Colon Cancer	MTT/MTS assay	IC₅₀=57 µM	4-h	Colon	None
1636	12366526	2002	PAWRKAFRWAWRMKKLAA	L3	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	HT-29	Colon Cancer	MTT/MTS assay	IC₅₀=141 µM	4-h	Colon	None
1635	12366526	2002	PAWFKARRWAWRMKKLAA	L2	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	HT-29	Colon Cancer	MTT/MTS assay	IC₅₀=>440 µM	4-h	Colon	None
1634	12366526	2002	PEWFKCRRWQWRMKKLGA	L1	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	HT-29	Colon Cancer	MTT/MTS assay	IC₅₀=>404 µM	4-h	Colon	None
1632	12366526	2002	PAWRKARRWAWRMKKLAA	L14	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	MT-1	Breast Cancer	MTT/MTS assay	IC₅₀=141 µM	4-h	Breast	None
1633	12366526	2002	PAWRKARRWARRMKKLAA	L15	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	MT-1	Breast Cancer	MTT/MTS assay	IC₅₀=92 µM	4-h	Breast	None
1631	12366526	2002	PAWRKAFRKAWRMLKKAA	L13	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	MT-1	Breast Cancer	MTT/MTS assay	IC₅₀=12 µM	4-h	Breast	None
1630	12366526	2002	PAWRKAFRWAKRMLKKAA	L12	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	MT-1	Breast Cancer	MTT/MTS assay	IC₅₀=10 µM	4-h	Breast	None
1628	12366526	2002	PAARKAFRWAWRMLKKAA	L10	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	MT-1	Breast Cancer	MTT/MTS assay	IC₅₀=20 µM	4-h	Breast	None
1629	12366526	2002	PAARKAARWAWRMLKKGA	L11	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	MT-1	Breast Cancer	MTT/MTS assay	IC₅₀=75 µM	4-h	Breast	None
1627	12366526	2002	PAWRKAARWAWRMLKKAA	L9	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	MT-1	Breast Cancer	MTT/MTS assay	IC₅₀=32 µM	4-h	Breast	None
1625	12366526	2002	PAWRKAFRAAWRMLKKAA	L7	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	MT-1	Breast Cancer	MTT/MTS assay	IC₅₀=11 µM	4-h	Breast	None
1626	12366526	2002	PAWAKAFRAAARMKLKAA	L8	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	MT-1	Breast Cancer	MTT/MTS assay	IC₅₀=87 µM	4-h	Breast	None
1624	12366526	2002	PAWRKAFRWAARMLKKAA	L6	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	MT-1	Breast Cancer	MTT/MTS assay	IC₅₀=12 µM	4-h	Breast	None
1622	12366526	2002	PAWFKARRWAWRMLKKAA	L4	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	MT-1	Breast Cancer	MTT/MTS assay	IC₅₀=16 µM	4-h	Breast	None
1623	12366526	2002	PAWRKAFRWAWRMLKKAA	L5	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	MT-1	Breast Cancer	MTT/MTS assay	IC₅₀=8 µM	4-h	Breast	None
1621	12366526	2002	PAWRKAFRWAWRMKKLAA	L3	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	MT-1	Breast Cancer	MTT/MTS assay	IC₅₀=18 µM	4-h	Breast	None
1620	12366526	2002	PAWFKARRWAWRMKKLAA	L2	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	MT-1	Breast Cancer	MTT/MTS assay	IC₅₀=>254 µM	4-h	Breast	None
1619	12366526	2002	PEWFKCRRWQWRMKKLGA	L1	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	MT-1	Breast Cancer	MTT/MTS assay	IC₅₀=>404 µM	4-h	Breast	None
1617	12366526	2002	PAWRKARRWAWRMKKLAA	L14	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	Meth A	Skin Cancer	MTT/MTS assay	IC₅₀=125 µM	4-h	Skin	None
1618	12366526	2002	PAWRKARRWARRMKKLAA	L15	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	Meth A	Skin Cancer	MTT/MTS assay	IC₅₀=87 µM	4-h	Skin	None
1616	12366526	2002	PAWRKAFRKAWRMLKKAA	L13	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	Meth A	Skin Cancer	MTT/MTS assay	IC₅₀=14 µM	4-h	Skin	None
1615	12366526	2002	PAWRKAFRWAKRMLKKAA	L12	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	Meth A	Skin Cancer	MTT/MTS assay	IC₅₀=7.9 µM	4-h	Skin	None
1614	12366526	2002	PAARKAARWAWRMLKKGA	L11	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	Meth A	Skin Cancer	MTT/MTS assay	IC₅₀=116 µM	4-h	Skin	None
1613	12366526	2002	PAARKAFRWAWRMLKKAA	L10	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	Meth A	Skin Cancer	MTT/MTS assay	IC₅₀=24 µM	4-h	Skin	None
1611	12366526	2002	PAWAKAFRAAARMKLKAA	L8	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	Meth A	Skin Cancer	MTT/MTS assay	IC₅₀=110 µM	4-h	Skin	None
1612	12366526	2002	PAWRKAARWAWRMLKKAA	L9	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	Meth A	Skin Cancer	MTT/MTS assay	IC₅₀=35 µM	4-h	Skin	None
1610	12366526	2002	PAWRKAFRAAWRMLKKAA	L7	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	Meth A	Skin Cancer	MTT/MTS assay	IC₅₀=16 µM	4-h	Skin	None
1609	12366526	2002	PAWRKAFRWAARMLKKAA	L6	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	Meth A	Skin Cancer	MTT/MTS assay	IC₅₀=11 µM	4-h	Skin	None
1608	12366526	2002	PAWRKAFRWAWRMLKKAA	L5	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	Meth A	Skin Cancer	MTT/MTS assay	IC₅₀=6.6 µM	4-h	Skin	None
1607	12366526	2002	PAWFKARRWAWRMLKKAA	L4	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	Meth A	Skin Cancer	MTT/MTS assay	IC₅₀=31 µM	4-h	Skin	None
1606	12366526	2002	PAWRKAFRWAWRMKKLAA	L3	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	Meth A	Skin Cancer	MTT/MTS assay	IC₅₀=32 µM	4-h	Skin	None
1604	12366526	2002	PEWFKCRRWQWRMKKLGA	L1	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	Meth A	Skin Cancer	MTT/MTS assay	IC₅₀=>404 µM	4-h	Skin	None
1605	12366526	2002	PAWFKARRWAWRMKKLAA	L2	18	Cyclic	L	None	Free	Free	Antimicrobial	Lactoferrin	Meth A	Skin Cancer	MTT/MTS assay	IC₅₀=144 µM	4-h	Skin	None
1444	12646578	2003	KLllKLKlKlLK	l3,4,8,10K5L7	12	Linear	Mix	None	Free	Free	Antibacterial	Diastereomeric peptide	D-122	Lung Cancer	XTT assay	LC₅₀ = >50 µM	24-h	Lung	None
1443	12646578	2003	KLlRLLkkLlRLlLK	l3,10,13K7,8K4R2L9	15	Linear	Mix	None	Free	Free	Antibacterial	Diastereomeric peptide	D-122	Lung Cancer	XTT assay	LC₅₀= 4.5 µM	24-h	Lung	None
1442	12646578	2003	KlllKLKlKlLK	l3,4,8,10K5L7	12	Linear	Mix	None	Free	Free	Antibacterial	Diastereomeric peptide	B16-F10	Skin Cancer	XTT assay	LC₅₀ = 100 µM	24-h	Skin	None
1441	12646578	2003	KLlRLLkkLlRLlLK	l3,10,13K7,8K4R2L9	15	Linear	Mix	None	Free	Free	Antibacterial	Diastereomeric peptide	B16-F10	Skin Cancer	XTT assay	LC₅₀ = 2.5 µM	24-h	Skin	None
1431	16269280	2005	KILRGVCKKIMRTFLRRISKDILTGKK	NK-2	27	Linear	L	None	Amidation	Free	Antibacterial	NK-lysin	SW-480	Leukemia Cancer	PI-uptake assay	LD₅₀=1-4 µM	Not Available	Blood	None
1430	16269280	2005	KILRGVCKKIMRTFLRRISKDILTGKK	NK-2	27	Linear	L	None	Amidation	Free	Antibacterial	NK-lysin	U-937	Lymphoma Cancer	PI-uptake assay	LD₅₀=30 µM	Not Available	Blood	None
1429	16269280	2005	KILRGVCKKIMRTFLRRISKDILTGKK	NK-2	27	Linear	L	None	Amidation	Free	Antibacterial	NK-lysin	SH-SY5Y	Brain Tumor	PI-uptake assay	LD₅₀=1-4 µM	Not Available	Brain	None
1428	16269280	2005	KILRGVCKKIMRTFLRRISKDILTGKK	NK-2	27	Linear	L	None	Amidation	Free	Antibacterial	NK-lysin	NB LA-N-1	Colorectal Cancer	PI-uptake assay	LD₅₀=1-4 µM	Not Available	Colon	None
1424	14508884, 21403917	2003	ILRWPWWPWRRK	OmigaNAn MBI-226	12	Linear	L	None	Amidation	Free	Antimicrobial	Helical peptide with a predominance of one or more amino acids tryptophane-rich	U-937	Lymphoma Cancer	MTT/MTS assay	27% Cytotoxicity at 0.5 µg/ml	6-h	Blood	None
1183	12005420	2001	KWKLFKKIPLKKF	C-9	13	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	K-562	Leukemia Cancer	MTT/MTS assay	IC₅₀=100.0 <µM	48-h	Blood	None
1184	12005420	2001	KWKLFKKIPKFLH	C-10	13	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	K-562	Leukemia Cancer	MTT/MTS assay	IC₅₀=100.0 <µM	48-h	Blood	None
1182	12005420	2001	KWKLFKKIPKFLHL	C-8	14	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	K-562	Leukemia Cancer	MTT/MTS assay	IC₅₀=30 µM	48-h	Blood	None
1180	12005420	2001	KWKLFKKIPKFLHLA	C-6	15	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	K-562	Leukemia Cancer	MTT/MTS assay	IC₅₀=27 µM	48-h	Blood	None
1181	12005420	2001	KWKLFKKIPLAKKF	C-7	14	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	K-562	Leukemia Cancer	MTT/MTS assay	IC₅₀=100.0 <µM	48-h	Blood	None
1179	12005420	2001	KWKLFKKIPHLAKKF	C-5	15	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	K-562	Leukemia Cancer	MTT/MTS assay	IC₅₀=67 µM	48-h	Blood	None
1177	12005420	2001	KWKLFKKIPLHLAKKF	C-3	16	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	K-562	Leukemia Cancer	MTT/MTS assay	IC₅₀=62 µM	48-h	Blood	None
1178	12005420	2001	KWKLFKKIPKFLHLAK	C-4	16	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	K-562	Leukemia Cancer	MTT/MTS assay	IC₅₀=25 µM	48-h	Blood	None
1176	12005420	2001	KWKLFKKIPKFLHLAKK	C-2	17	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	K-562	Leukemia Cancer	MTT/MTS assay	IC₅₀=23 µM	48-h	Blood	None
1175	12005420	2001	KWKLFKKIPFLHLAKKF	C-1	17	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	K-562	Leukemia Cancer	MTT/MTS assay	IC₅₀=31 µM	48-h	Blood	None
1174	12005420	2001	WKKIPKFLHLLKKF	N-5L	14	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	K-562	Leukemia Cancer	MTT/MTS assay	IC₅₀=10 µM	48-h	Blood	None
1173	12005420	2001	WFKKIPKFLHLLKKF	N-4L	15	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	K-562	Leukemia Cancer	MTT/MTS assay	IC₅₀=3 µM	48-h	Blood	None
1172	12005420	2001	KWFKKIPKFLHLLKKF	N-3L	16	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	K-562	Leukemia Cancer	MTT/MTS assay	IC₅₀=4.2 µM	48-h	Blood	None
1170	12005420	2001	WFKKIPKFLHLAKKF	N-4	15	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	K-562	Leukemia Cancer	MTT/MTS assay	IC₅₀=24 µM	48-h	Blood	None
1171	12005420	2001	WKKIPKFLHLAKKF	N-5	14	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	K-562	Leukemia Cancer	MTT/MTS assay	IC₅₀=100.0 <µM	48-h	Blood	None
1168	12005420	2001	FKLFKKIPKFLHLAKKF	N-2	17	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	K-562	Leukemia Cancer	MTT/MTS assay	IC₅₀=7 µM	48-h	Blood	None
1169	12005420	2001	KWFKKIPKFLHLAKKF	N-3	16	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	K-562	Leukemia Cancer	MTT/MTS assay	IC₅₀=11 µM	48-h	Blood	None
1166	12005420	2001	KWKLFKKISKFLHLAKKF	[S9]-P18	18	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	K-562	Leukemia Cancer	MTT/MTS assay	IC₅₀=3 µM	48-h	Blood	None
1167	12005420	2001	WKLFKKIPKFLHLAKKF	N-1	17	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	K-562	Leukemia Cancer	MTT/MTS assay	IC₅₀=6 µM	48-h	Blood	None
1165	12005420	2001	KWKLFKKILKFLHLAKKF	[L9]-P18	18	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	K-562	Leukemia Cancer	MTT/MTS assay	IC₅₀=3 µM	48-h	Blood	None
1164	12005420	2001	KWKFKKIPKFLHLAKKF	P18	17	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	K-562	Leukemia Cancer	MTT/MTS assay	IC₅₀=3.5 µM	48-h	Blood	None
1163	12005420	2001	KWKLFKKIPKFLHSAKKF	CA-MA-P	18	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	K-562	Leukemia Cancer	MTT/MTS assay	IC₅₀=25 µM	48-h	Blood	None
1162	12005420	2001	KWKLFKKIPKFLH	C-10	13	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	Jurkat	Blood Cancer	MTT/MTS assay	IC₅₀=100.0 <µM	48-h	Blood	None
1161	12005420	2001	KWKLFKKIPLKKF	C-9	13	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	Jurkat	Blood Cancer	MTT/MTS assay	IC₅₀=100.0 <µM	48-h	Blood	None
1160	12005420	2001	KWKLFKKIPKFLHL	C-8	14	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	Jurkat	Blood Cancer	MTT/MTS assay	IC₅₀=54 µM	48-h	Blood	None
1159	12005420	2001	KWKLFKKIPLAKKF	C-7	14	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	Jurkat	Blood Cancer	MTT/MTS assay	IC₅₀=100.0 <µM	48-h	Blood	None
1158	12005420	2001	KWKLFKKIPKFLHLA	C-6	15	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	Jurkat	Blood Cancer	MTT/MTS assay	IC₅₀=21 µM	48-h	Blood	None
1157	12005420	2001	KWKLFKKIPHLAKKF	C-5	15	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	Jurkat	Blood Cancer	MTT/MTS assay	IC₅₀=81 µM	48-h	Blood	None
1156	12005420	2001	KWKLFKKIPKFLHLAK	C-4	16	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	Jurkat	Blood Cancer	MTT/MTS assay	IC₅₀=31 µM	48-h	Blood	None
1155	12005420	2001	KWKLFKKIPLHLAKKF	C-3	16	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	Jurkat	Blood Cancer	MTT/MTS assay	IC₅₀=74 µM	48-h	Blood	None
1154	12005420	2001	KWKLFKKIPKFLHLAKK	C-2	17	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	Jurkat	Blood Cancer	MTT/MTS assay	IC₅₀=26 µM	48-h	Blood	None
1153	12005420	2001	KWKLFKKIPFLHLAKKF	C-1	17	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	Jurkat	Blood Cancer	MTT/MTS assay	IC₅₀=32 µM	48-h	Blood	None
1152	12005420	2001	WKKIPKFLHLLKKF	N-5L	14	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	Jurkat	Blood Cancer	MTT/MTS assay	IC₅₀=14 µM	48-h	Blood	None
1151	12005420	2001	WFKKIPKFLHLLKKF	N-4L	15	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	Jurkat	Blood Cancer	MTT/MTS assay	IC₅₀=6 µM	48-h	Blood	None
1150	12005420	2001	KWFKKIPKFLHLLKKF	N-3L	16	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	Jurkat	Blood Cancer	MTT/MTS assay	IC₅₀=4 µM	48-h	Blood	None
1149	12005420	2001	WKKIPKFLHLAKKF	N-5	14	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	Jurkat	Blood Cancer	MTT/MTS assay	IC₅₀=100.0 <µM	48-h	Blood	None
1148	12005420	2001	WFKKIPKFLHLAKKF	N-4	15	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	Jurkat	Blood Cancer	MTT/MTS assay	IC₅₀=23 µM	48-h	Blood	None
1147	12005420	2001	KWFKKIPKFLHLAKKF	N-3	16	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	Jurkat	Blood Cancer	MTT/MTS assay	IC₅₀=17 µM	48-h	Blood	None
1146	12005420	2001	FKLFKKIPKFLHLAKKF	N-2	17	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	Jurkat	Blood Cancer	MTT/MTS assay	IC₅₀=11 µM	48-h	Blood	None
1145	12005420	2001	WKLFKKIPKFLHLAKKF	N-1	17	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	Jurkat	Blood Cancer	MTT/MTS assay	IC₅₀=12 µM	48-h	Blood	None
1144	12005420	2001	KWKLFKKISKFLHLAKKF	[S9]-P18	18	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	Jurkat	Blood Cancer	MTT/MTS assay	IC₅₀=7 µM	48-h	Blood	None
1143	12005420	2001	KWKLFKKILKFLHLAKKF	[L9]-P18	18	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	Jurkat	Blood Cancer	MTT/MTS assay	IC₅₀=9 µM	48-h	Blood	None
1142	12005420	2001	KWKFKKIPKFLHLAKKF	P18	17	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	Jurkat	Blood Cancer	MTT/MTS assay	IC₅₀=4 µM	48-h	Blood	None
1141	12005420	2001	KWKLFKKIPKFLHSAKKF	CA-MA-P	18	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	Jurkat	Blood Cancer	MTT/MTS assay	IC₅₀=20 µM	48-h	Blood	None
1140	12005420	2001	KWKLFKKIPKFLH	C-10	13	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	MDA-MB-361	Breast Cancer	MTT/MTS assay	IC₅₀=100. <µM	48-h	Breast	None
1139	12005420	2001	KWKLFKKIPLKKF	C-9	13	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	MDA-MB-361	Breast Cancer	MTT/MTS assay	IC₅₀=100. <µM	48-h	Breast	None
1138	12005420	2001	KWKLFKKIPKFLHL	C-8	14	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	MDA-MB-361	Breast Cancer	MTT/MTS assay	IC₅₀=83 µM	48-h	Breast	None
1137	12005420	2001	KWKLFKKIPLAKKF	C-7	14	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	MDA-MB-361	Breast Cancer	MTT/MTS assay	IC₅₀=100. <µM	48-h	Breast	None
1136	12005420	2001	KWKLFKKIPKFLHLA	C-6	15	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	MDA-MB-361	Breast Cancer	MTT/MTS assay	IC₅₀=47 µM	48-h	Breast	None
1135	12005420	2001	KWKLFKKIPHLAKKF	C-5	15	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	MDA-MB-361	Breast Cancer	MTT/MTS assay	IC₅₀=100 µM	48-h	Breast	None
1134	12005420	2001	KWKLFKKIPKFLHLAK	C-4	16	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	MDA-MB-361	Breast Cancer	MTT/MTS assay	IC₅₀=54 µM	48-h	Breast	None
1133	12005420	2001	KWKLFKKIPLHLAKKF	C-3	16	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	MDA-MB-361	Breast Cancer	MTT/MTS assay	IC₅₀=79 µM	48-h	Breast	None
1132	12005420	2001	KWKLFKKIPKFLHLAKK	C-2	17	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	MDA-MB-361	Breast Cancer	MTT/MTS assay	IC₅₀=38 µM	48-h	Breast	None
1131	12005420	2001	KWKLFKKIPFLHLAKKF	C-1	17	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	MDA-MB-361	Breast Cancer	MTT/MTS assay	IC₅₀=26 µM	48-h	Breast	None
1130	12005420	2001	WKKIPKFLHLLKKF	N-5L	14	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	MDA-MB-361	Breast Cancer	MTT/MTS assay	IC₅₀=17 µM	48-h	Breast	None
1129	12005420	2001	WKKIPKFLHLLKKF	N-4L	14	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	MDA-MB-361	Breast Cancer	MTT/MTS assay	IC₅₀=5 µM	48-h	Breast	None
1128	12005420	2001	WFKKIPKFLHLLKKF	N-3L	15	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	MDA-MB-361	Breast Cancer	MTT/MTS assay	IC₅₀=5 µM	48-h	Breast	None
1127	12005420	2001	WKKIPKFLHLAKKF	N-5	14	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	MDA-MB-361	Breast Cancer	MTT/MTS assay	IC₅₀=100. <µM	48-h	Breast	None
1126	12005420	2001	WFKKIPKFLHLAKKF	N-4	15	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	MDA-MB-361	Breast Cancer	MTT/MTS assay	IC₅₀=32 µM	48-h	Breast	None
1125	12005420	2001	KWFKKIPKFLHLAKKF	N-3	16	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	MDA-MB-361	Breast Cancer	MTT/MTS assay	IC₅₀=17 µM	48-h	Breast	None
1124	12005420	2001	FKLFKKIPKFLHLAKKF	N-2	17	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	MDA-MB-361	Breast Cancer	MTT/MTS assay	IC₅₀=11 µM	48-h	Breast	None
1123	12005420	2001	WKLFKKIPKFLHLAKKF	N-1	17	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	MDA-MB-361	Breast Cancer	MTT/MTS assay	IC₅₀=9.5 µM	48-h	Breast	None
1122	12005420	2001	KWKLFKKISKFLHLAKKF	[S9]-P18	18	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	MDA-MB-361	Breast Cancer	MTT/MTS assay	IC₅₀=4 µM	48-h	Breast	None
1121	12005420	2001	KWKLFKKILKFLHLAKKF	[L9]-P18	18	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	MDA-MB-361	Breast Cancer	MTT/MTS assay	IC₅₀=3 µM	48-h	Breast	None
1120	12005420	2001	KWKFKKIPKFLHLAKKF	P18	17	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	MDA-MB-361	Breast Cancer	MTT/MTS assay	IC₅₀=8 µM	48-h	Breast	None
1119	12005420	2001	KWKLFKKIPKFLHSAKKF	CA-MA-P	18	Linear	L	None	Amidation	Free	Antibacterial	Ceropin A	MDA-MB-361	Breast Cancer	MTT/MTS assay	IC₅₀=20 µM	48-h	Breast	None
1039	14499271	2003	FLGALFKALSKLL	PTP7	13	Linear	L	None	Free	Free	Antibacterial	Gaegurin	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀=5.25 µg/ml	96-h	Breast	None
1040	14499271	2003	FLKLLAGLLKNFA	PTP8	13	Linear	L	None	Free	Free	Antibacterial	Gaegurin	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀=32.23 µg/ml	96-h	Breast	None
1037	14499271	2003	FLKLLKKLAAKLF	PTP5	13	Linear	L	None	Free	Free	Antibacterial	Gaegurin	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀=5.43 µg/ml	96-h	Breast	None
1038	14499271	2003	FLKLLKKLAAKLF	PTP6	13	Linear	L	None	Free	Free	Antibacterial	Gaegurin	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀=17.56 µg/ml	96-h	Breast	None
1035	14499271	2003	FAGLAANFLPTIICKISYKC	PTP2	20	Cyclic(C14-C20)	L	None	Free	Free	Antibacterial	Gaegurin	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀=>100 µg/ml	96-h	Breast	None
1036	14499271	2003	FLKLLKKLAAKFLPTIICKISYKC	PTP4	24	Linear	L	None	Free	Free	Antibacterial	Gaegurin	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀=18.1 µg/ml	96-h	Breast	None
1034	14499271	2003	LLAGLAANFLPTIICKISYKC	PTP1	21	Cyclic(C15-C21)	L	None	Free	Free	Antibacterial	Gaegurin	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀=>100 µg/ml	96-h	Breast	None
1031	14499271	2003	FLGALFKALSKLL	PTP7	13	Linear	L	None	Free	Free	Antibacterial	Gaegurin	Hep3B	Liver Cancer	MTT/MTS assay	IC₅₀=5.4 µg/ml	96-h	Liver	None
1032	14499271	2003	FLKLLAGLLKNFA	PTP8	13	Linear	L	None	Free	Free	Antibacterial	Gaegurin	Hep3B	Liver Cancer	MTT/MTS assay	IC₅₀=30.79 µg/ml	96-h	Liver	None
1033	14499271	2003	FLPLLAGLAANFLPTIICKISYKC	GGN6	24	Cyclic(C18-C24)	L	None	Free	Free	Antibacterial	Gaegurin	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀=4.88 µg/ml	96-h	Breast	None
1029	14499271	2003	FLKLLKKLAAKLF	PTP5	13	Linear	L	None	Free	Free	Antibacterial	Gaegurin	Hep3B	Liver Cancer	MTT/MTS assay	Not Available	96-h	Liver	None
1030	14499271	2003	FLKLLKKLAAKLF	PTP6	13	Linear	L	None	Free	Free	Antibacterial	Gaegurin	Hep3B	Liver Cancer	MTT/MTS assay	IC₅₀=15.07 µg/ml	96-h	Liver	None
1028	14499271	2003	FLKLLKKLAAKFLPTIICKISYKC	PTP4	24	Linear	L	None	Free	Free	Antibacterial	Gaegurin	Hep3B	Liver Cancer	MTT/MTS assay	IC₅₀=18.18 µg/ml	96-h	Liver	None
1027	14499271	2003	FAGLAANFLPTIICKISYKC	PTP2	20	Cyclic(C14-C20)	L	None	Free	Free	Antibacterial	Gaegurin	Hep3B	Liver Cancer	MTT/MTS assay	IC₅₀=>100 µg/ml	96-h	Liver	None
1025	14499271	2003	FLPLLAGLAANFLPTIICKISYKC	GGN6	24	Cyclic(C18-C24)	L	None	Free	Free	Antibacterial	Gaegurin	Hep3B	Liver Cancer	MTT/MTS assay	IC₅₀=4.91 µg/ml	96-h	Liver	None
1026	14499271	2003	LLAGLAANFLPTIICKISYKC	PTP1	21	Cyclic(C15-C21)	L	None	Free	Free	Antibacterial	Gaegurin	Hep3B	Liver Cancer	MTT/MTS assay	IC₅₀=>100 µg/ml	96-h	Liver	None
1023	14499271	2003	FLGALFKALSKLL	PTP7	13	Linear	L	None	Free	Free	Antibacterial	Gaegurin	PC-3	Prostate Cancer	MTT/MTS assay	IC₅₀=5.01 µg/ml	96-h	Prostate	None
1024	14499271	2003	FLKLLAGLLKNFA	PTP8	13	Linear	L	None	Free	Free	Antibacterial	Gaegurin	PC-3	Prostate Cancer	MTT/MTS assay	IC₅₀=28.9 µg/ml	96-h	Prostate	None
1021	14499271	2003	FLKLLKKLAAKLF	PTP5	13	Linear	L	None	Free	Free	Antibacterial	Gaegurin	PC-3	Prostate Cancer	MTT/MTS assay	Not Available	96-h	Prostate	None
1022	14499271	2003	FLKLLKKLAAKLF	PTP6	13	Linear	L	None	Free	Free	Antibacterial	Gaegurin	PC-3	Prostate Cancer	MTT/MTS assay	IC₅₀=13.27 µg/ml	96-h	Prostate	None
1020	14499271	2003	FLKLLKKLAAKFLPTIICKISYKC	PTP4	24	Linear	L	None	Free	Free	Antibacterial	Gaegurin	PC-3	Prostate Cancer	MTT/MTS assay	IC₅₀=18.63 µg/ml	96-h	Prostate	None
1018	14499271	2003	LLAGLAANFLPTIICKISYKC	PTP1	21	Cyclic(C15-C21)	L	None	Free	Free	Antibacterial	Gaegurin	293	Renal Cancer	MTT/MTS assay	IC₅₀=>100 µg/ml	96-h	Renal	None
1019	14499271	2003	FAGLAANFLPTIICKISYKC	PTP2	20	Cyclic(C14-C20)	L	None	Free	Free	Antibacterial	Gaegurin	293	Renal Cancer	MTT/MTS assay	IC₅₀=>100 µg/ml	96-h	Renal	None
1017	14499271	2003	FLPLLAGLAANFLPTIICKISYKC	GGN6	24	Cyclic(C18-C24)	L	None	Free	Free	Antibacterial	Gaegurin	293	Renal Cancer	MTT/MTS assay	IC₅₀=5.75 µg/ml	96-h	Renal	None
1015	14499271	2003	FLGALFKALSKLL	PTP7	13	Linear	L	None	Free	Free	Antibacterial	Gaegurin	293	Renal Cancer	MTT/MTS assay	IC₅₀=6.71 µg/ml	96-h	Renal	None
1016	14499271	2003	FLKLLAGLLKNFA	PTP8	13	Linear	L	None	Free	Free	Antibacterial	Gaegurin	293	Renal Cancer	MTT/MTS assay	IC₅₀=26.8 µg/ml	96-h	Renal	None
1013	14499271	2003	FLKLLKKLAAKLF	PTP5	13	Linear	L	None	Free	Free	Antibacterial	Gaegurin	293	Renal Cancer	MTT/MTS assay	IC₅₀=15.11 µg/ml	96-h	Renal	None
1014	14499271	2003	FLKLLKKLAAKLF	PTP6	13	Linear	L	None	Free	Free	Antibacterial	Gaegurin	293	Renal Cancer	MTT/MTS assay	IC₅₀=14 µg/ml	96-h	Renal	None
1012	14499271	2003	FLKLLKKLAAKFLPTIICKISYKC	PTP4	24	Linear	L	None	Free	Free	Antibacterial	Gaegurin	293	Renal Cancer	MTT/MTS assay	IC₅₀=26.15 µg/ml	96-h	Renal	None
1011	14499271	2003	FAGLAANFLPTIICKISYKC	PTP2	20	Cyclic(C14-C20)	L	None	Free	Free	Antibacterial	Gaegurin	293	Renal Cancer	MTT/MTS assay	IC₅₀=>100 µg/ml	96-h	Renal	None
1010	14499271	2003	LLAGLAANFLPTIICKISYKC	PTP1	21	Cyclic(C15-C21)	L	None	Free	Free	Antibacterial	Gaegurin	293	Renal Cancer	MTT/MTS assay	IC₅₀=>100 µg/ml	96-h	Renal	None
1008	14499271	2003	FLKLLAGLLKNFA	PTP8	13	Linear	L	None	Free	Free	Antibacterial	Gaegurin	A-549	Lung Cancer	MTT/MTS assay	IC₅₀=24.58 µg/ml	96-h	Lung	None
1009	14499271	2003	FLPLLAGLAANFLPTIICKISYKC	GGN6	24	Cyclic(C18-C24)	L	None	Free	Free	Antibacterial	Gaegurin	293	Renal Cancer	MTT/MTS assay	IC₅₀=5.62 µg/ml	96-h	Renal	None
1006	14499271	2003	FLKLLKKLAAKLF	PTP6	13	Linear	L	None	Free	Free	Antibacterial	Gaegurin	A-549	Lung Cancer	MTT/MTS assay	IC₅₀=13.94 µg/ml	96-h	Lung	None
1007	14499271	2003	FLGALFKALSKLL	PTP7	13	Linear	L	None	Free	Free	Antibacterial	Gaegurin	A-549	Lung Cancer	MTT/MTS assay	IC₅₀=8.01 µg/ml	96-h	Lung	None
1004	14499271	2003	FLKLLKKLAAKFLPTIICKISYKC	PTP4	24	Linear	L	None	Free	Free	Antibacterial	Gaegurin	A-549	Lung Cancer	MTT/MTS assay	IC₅₀=13.71 µg/ml	96-h	Lung	None
1005	14499271	2003	FLKLLKKLAAKLF	PTP5	13	Linear	L	None	Free	Free	Antibacterial	Gaegurin	A-549	Lung Cancer	MTT/MTS assay	IC₅₀=9.09 µg/ml	96-h	Lung	None
1003	14499271	2003	FAGLAANFLPTIICKISYKC	PTP2	20	Cyclic(C14-C20)	L	None	Free	Free	Antibacterial	Gaegurin	A-549	Lung Cancer	MTT/MTS assay	IC₅₀=>100 µg/ml	96-h	Lung	None
1001	14499271	2003	FLPLLAGLAANFLPTIICKISYKC	GGN6	24	Cyclic(C18-C24)	L	None	Free	Free	Antibacterial	Gaegurin	A-549	Lung Cancer	MTT/MTS assay	IC₅₀=6.49 µg/ml	96-h	Lung	None
1002	14499271	2003	LLAGLAANFLPTIICKISYKC	PTP1	21	Cyclic(C15-C21)	L	None	Free	Free	Antibacterial	Gaegurin	A-549	Lung Cancer	MTT/MTS assay	IC₅₀= >100 µg/ml	96-h	Lung	None
4682	15289344	2004	PGDSTRKCMDLKGNK	PCK3145	15	Linear	L	None	Free	Free	Anticancer and Antitumor	Derived from prostate secretory protein PSP-94	Mat Ly Lu	Prostate Cancer	TUNEL assay	Not available	15 days	Prostate	None